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Until recently it was assumed that the healthy mammalian lung did not harbour a microbiota, unlike 
other body sites. However, through the use of sequencing based technologies this has been shown to 
not be the case. Low biomass communities of microbes can be identified in the healthy lung and the 
lung microbiota in various diseases states hDVEHHQVKRZQWRGLIIHUIURPWKHVHµKHDOWK\¶FRPPXQLWLHV 
The sheep respiratory microbiota is of interest from both an animal health perspective and due to the 
potential use of the sheep as a large animal model for studying the lung microbiota. In this thesis I 
seek to characterise the composition and variability of the sheep lung microbiota; the differences 
between the sheep upper and lower respiratory tract bacterial communities and to assess whether 
exhaled breath condensate collection can be used as a non-invasive lung microbiota sampling method. 
To study the bacterial communities present in samples I have used 16S rRNA gene sequencing and 
analysis.  
In Chapter 3 I examine the inter-individual and spatial variability present within the sheep lung 
microbiota. Protected specimen brushings were collected from three lung segments in six animals at 
three time-points. In a separate sheep a greater number of brushings was taken (n=16) in order to 
examine the amount of variability over a smaller spatial scale. I find that there can be large differences 
between the bacterial communities isolated from different locations within the lung, even over short 
distances. Samples also cluster by the sheep from which they were taken, indicating a host specific 
influence on the lung microbiota. In Chapter 4 I compare whole lung washes and oropharyngeal swabs 
from 40 lambs in order to examine the differences between the upper and lower respiratory tract 
microbiotas. I find that oropharyngeal swabs separate into rumen-like or upper respiratory tract-like 
bacterial communities. Despite the fact that in humans the upper and lower respiratory microbiotas 
have been shown to have similar compositions, the sheep lung microbiota samples in this study do not 
resemble either oropharyngeal samples or reagent only controls. 
In my first two results chapters, lung sampling methods were used which involved either anaesthesia 
combined with a bronchoscopic procedure (Chapter 3) or samples being taken from dead animals 
(Chapter 4). In Chapter 5 I assess whether there is a less invasive way of taking lung microbiota 
samples from a living individual, both to minimise the procedural stress on animals used as models 
and to increase the pool of potential volunteers for human lung microbiota studies. I compared 
samples taken via protected specimen brushings to samples taken via exhaled breath condensate 
collection, a less invasive sampling technique. I find that condensate samples contain less bacterial 
DNA and different bacteria than brushing samples, indicating that it is unlikely they could be used as 
a replacement for invasive sampling methods. In my final results chapter I compare the results across 
Chapters 3, 4 and 5 to identify bacteria which occur consistently in the sheep lung and could therefore 
potentially be described as core lung microbiota members.  
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In conclusion, while I have found that there are large differences between the sheep lung microbiota 
and that which has previously been described in humans, the sheep can still be of use as a model in 
studies where these differences would not have a significant impact, such as in Chapter 5 of this 
thesis. I have identified several bacterial members of the core sheep lung microbiota which in future it 




During health, communities of microorganisms can be found inhabiting the mammalian lung; these 
are FRPPRQO\UHIHUUHGWRDVWKHµOXQJPLFURELRWD¶7KHVWXG\RIWKHOXQJPLFURELRWDLVDUHODWLvely 
new field as until recently it was assumed that the healthy lung was sterile. However, using DNA 
sequencing this has been shown to be incorrect. In this thesis I examine the types of bacteria which 
can be found in the sheep lung. This area of research is of interest as not only is the sheep an 
important agricultural animal but it is often used as a model in studies of respiratory diseases due to 
the similarity of the sheep respiratory and immune systems to those of humans. In order to work out 
what types of bacteria are in respiratory samples, I first extract all of the DNA from the samples then 
from this DNA mixture I sequence a gene known as the 16S rRNA gene. This gene is found in all 
bacteria and its DNA sequence varies depending on the species of bacteria it originates from. 
Therefore, if we examine the 16S rRNA genes in a sample we can work out which types of bacteria it 
originally contained.  
In my first results chapter I look at how lung bacterial communities differ at different lung locations 
and between sheep. I find that there is often a lot of variability between samples taken from different 
parts of the same lung, even when these samples were taken a few centimetres away from each other. 
However, I also find that despite this variation, lung microbiota samples from an individual sheep are 
more similar to each other than they are to samples from another sheep. This might mean that the 
FRQGLWLRQVLQDQLQGLYLGXDOVKHHS¶VOXQJVKHOSGHWHUPLQHZKDWNLQGRIEDFWHULDLQKDELWLW 
In my second results chapter I compare throat swabs and lung fluids from a larger number of animals 
(40 lambs) in order to see whether the types of bacteria in the upper respiratory tract are different from 
those in the lower respiratory tract. I find that, unlike in humans, there are large differences between 
the lower and upper sheep respiratory tract microbiotas. In this results chapter I sampled the lung 
microbiota by collecting lung fluid from dead animals while in my first results chapter lung samples 
were taken using invasive bronchoscopic procedures in live animals. I wanted to see whether there 
was a less invasive way of sampling the lung microbiota from live individuals, as reducing the 
invasiveness of sampling could minimise the procedural stress on animals which are part of lung 
microbiota studies and could also increase the pool of potential human volunteers for these studies. 
Therefore, in my third results chapter I compare samples taken via bronchial brushings and exhaled 
breath condensate collection, a sampling technique which does not require bronchoscopy. I find that 
far less bacterial DNA was able to be collected from exhaled breath condensate than from bronchial 
brushings and the bacterial communities found in the two sample types were different. This means 
that it is unlikely that exhaled breath condensate collection will be able to be used to replace more 
invasive lung microbiota sampling techniques. In my final results chapter I compare the results from 
all of my previous results chapters to identify bacteria which can often be found in the sheep lung.  
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I conclude that while there are differences between the lung microbiota in sheep and that which had 
previously been found in humans, the sheep can still be useful as a large animal model in some lung 
microbiota studies. I also conclude that in future studies it would be interesting to study some of the 
bacteria I identified as common inhabitants of the sheep lung, to attempt to understand whether they 
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advanced this complexity is much increased. Each living creature must be looked at as a microcosm--a 
little universe, formed of a host of self-propagating organisms, inconceivably minute and as numerous 
DVWKHVWDUVLQKHDYHQ´- Charles Darwin (3) 
 
The microbiota can be defined as the commensal, symbiotic and pathogenic microbes which inhabit a 
particular ecological niche. Microbiota have been associated with even the most simple of animal life, 
such as nematodes (4), indicating that the microbiota is likely to have evolved alongside animals from 
an early evolutionary stage. This co-evolution has allowed animals and the microbes that inhabit them 
to benefit nutritionally and has also helped prevent the colonisation of the host by pathogenic 
organisms and contributed towards the development of the adaptive immune system (5-8). The 
microbiota has also been found to play a role in various diseases states including inflammatory, 
autoimmune and infectious diseases, allergies, cancer and psychiatric disorders (9, 10). Sequencing 
the 16S rRNA genes contained within a sample allows the taxonomic identification of the bacteria 
present without being biased by whether they are culturable. Using this technique, great strides have 
been made in our understanding of the microbiotas at different body sites and the impact they have in 
health and disease. However, our knowledge of the lung microbiota is still in its infancy.  
In this thesis I will explore the composition, diversity and dynamics of the lung microbiota in sheep. 
There is a pressing need for a large animal model of the lung microbiota, as the lungs of rodents and 
other small mammals are anatomically very different from the lungs of humans and lung sampling 
techniques are often quite invasive which may deter human volunteers from taking part in studies. As 
well as being important as livestock animals, sheep are commonly used as models of respiratory 
disease due to the anatomical and immunological similarity of their lungs to those of humans (11, 12). 
In the following introductory chapter I will review the current literature on the lung microbiota, 
mainly focusing on human studies, and I will then describe how sheep may have a place in this area of 
research. Lastly, I will describe the specific methodological problems which arise during lung 
microbiota studies.   
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1.1 The lung microbiota 
1.1.1 Classical view of lung sterility  
Until recently, it was widely believed that the healthy human lung was a sterile environment (13, 14). 
This view was supported by the belief that the lung would be rapidly cleared of any potential bacterial 
colonisers. The lung environment provides a suitable habitat for the growth of many potentially 
harmful microorganisms due to the availability of nutrients, the presence of oxygen and a temperature 
of ~37°C. It is therefore essential that a robust immune response to potential pathogens is present in 
the lower airways. Microbes attempting to colonise the lungs will first encounter a thick layer of 
mucus which coats the epithelium of the upper airways and the bronchi (15). Mucus containing 
bacteria is then transported up the airways via the action of ciliated epithelial cells whereupon it is 
either swallowed or expelled by coughing or sneezing. The bronchioles and alveoli do not contain a 
mucus layer but several antibacterial molecules are secreted into the lung lumen at these sites as well 
as in the upper airways.  
Polymeric IgA molecules make up the majority of antibodies present in the lung mucosa but IgM and 
to a lesser extent IgG and IgE can also be found at the lung epithelium (16). Antimicrobial products 
are also secreted into the airway surface liquid, including lysozymes, lactoferrins, cathelicidins, 
defensins and various other peptides (17). Another layer of protection for the lung epithelium is added 
by the presence of alveolar macrophages which are able to phagocytose invading microbes and initiate 
and resolve inflammatory responses. 
It was previously assumed that the immune mechanisms described above were sufficient to keep the 
healthy lung sterile. However, several papers published in 2010 and 2011 questioned this idea, 
describing the presence of bacteria in a number of healthy humans using 16S rRNA gene sequencing 
(18-20). Since these publications, various studies have been performed to attempt to better 
characterise the mammalian lung microbiota.  
 
1.1.2 Establishment of the lung microbiota and the maintenance of 
homeostasis 
One of the first papers to examine the healthy lung microbiota concluded that the upper and lower 
respiratory tracts were indistinguishable from one another, except that a far lower bacterial biomass 
could be found in the lungs in comparison to oral washes and oropharyngeal swabs (20). A potential 
conclusion from this study would be that the human lung does not contain a distinct microbiota and 
the presence of bacteria is merely due to their passive diffusion from further up the respiratory tract. 
This is one of several postulated models of how the lung microbiota may be established, more of 
which will be discussed below.  
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Microaspiration is normal in healthy adults and studies in humans point to this being the origin of the 
majority of the microbes inhabiting the lung (21). The neutral dispersal model hypothesises that once 
microbes have dispersed from the upper respiratory tract into the lung there is no selective pressure 
from the lung environment for particular bacterial species and any changes in species abundance are 
merely due to ecological drift. As a result, the lung microbial communities would be highly similar to 
those of the aspirated fluid. If this were the case then one would expect to see not only the same 
bacteria in the upper and lower respiratory tracts but also the same bacteria at different locations 
within the lung, as regional differences in pH, temperature and oxygen level (producing 
µPLFURKDELWDWV¶(22)) should not affect the lung microbiota composition. Venkataraman et al. 
concluded that the neutral model accurately described what they observed when comparing oral 
washes and bronchoalveolar lavage (BAL) fluid in 62 healthy volunteers (23). While Venkataraman et 
al. did not find any bacterial operational taxonomic units (OTUs) which appeared to be consistently 
under environmental pressure from the lungs, other studies have identified OTUs which were 
significantly disproportionally represented in the lungs, including both bacteria (24) and fungi (25).  
Another model which has been suggested to explain how microbes migrate to the lung and how these 
microbial communities achieve homeostasis is the adapted island model of biogeography. This model 
is an adaptation of the equilibrium model of island biogeography proposed by MacArthur and Wilson 
in 1963 (26). The original model postulates that the species richness of an island is due to the balance 
of immigration from the main landmass and extinction of species on the island. Islands which are 
smaller and farther from the land mass would have low species richness whereas large islands located 
near the land mass would have high species richness (Fig. 1.1). The adapted island model 
hypothesises that, in a similar fashion to communities on islands closer to the mainland, the lung 
microbial communities located nearer the upper respiratory tract would be richer than those which 
were located in the lower airways (27). This difference in richness was demonstrated in a study of 15 
healthy humans where communities in the right upper lung lobe were found to be richer and to more 





Figure 1.1: A basic diagram depicting the island biogeography model. This model 
states that community richness is established by a combination of immigration and 
elimination elements. In this simple example there are three islands (originally 
containing no species and of approximately equal size) which are located different 
distances from the mainland (originally containing numerous species). The extinction 
rate of these species is assumed to be the same on each island thereby community 
richness is related only to immigration from the mainland or other islands. Islands 
which are further away from the source community (the mainland) have a lower 
community richness than those which are nearer. When applied to the lungs, this 
model would assume that the further locations in the lung were from the source 
community (the upper respiratory tract), then the less rich they would be (if 
elimination rates are the same across the lung). 
 
For all microbial communities there are three main factors which drive their composition: 
immigration, elimination and reproduction. While microaspiration of oral bacteria is the main source 
of immigrant species in the human lung (29), it is probable that environmental bacteria contained in 
air are also inhaled in smaller quantities. It is also possible that bacteria could migrate from other body 
sites if they entered the bloodstream, as occurs in sepsis-induced acute respiratory distress syndrome 
where the lung microbiota is temporarily enriched with gut microbes (30). The elimination of lung 
bacteria is due to a combination of mucociliary clearance, coughing and immune mechanisms, while 
reproduction is believed to have only a small impact on the healthy human lung microbiota. 
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Another factor which may drive the composition of the lung microbiota is early life microbial 
exposure. While no well-controlled studies have been published on the establishment and 
development of the lung microbiota in healthy human neonates, this has been examined in mice (31). 
The quantity of bacteria in the lungs was found to significantly increase over the first two weeks of 
life and communities shifted from being predominantly composed of Gammaproteobacteria and 
Firmicutes towards communities which were dominated by Bacteroidetes. This study did not examine 
the origin of these bacteria but it is probable that they originated from the upper respiratory tract, as in 
adults. Babies born by caesarean section are more likely to develop respiratory disease (32, 33) which 
has led researchers to examine whether different modes of delivery lead to different microbes 
inhabiting the upper respiratory tract. One study examined several time-points over the first months of 
life and observed a similar development of the nasopharyngeal communities to the microbiota at other 
body sites, with keystone microbes colonising the site, followed by the development of a more 
complex, niche specific microbiota over time (34). This study also showed that there were some 
differences in the microbiota compositions based on mode of delivery. Differences in the upper 
respiratory tract communities of babies delivered either naturally or by caesarean section have also 
been observed in other studies (35, 36). Whether these changes in the upper respiratory microbiota 
correlate with changes in the lung is currently unknown.  
The proportion of bacterial DNA detected in healthy human lungs originating from dead vs live 
bacteria is also currently unknown. Pezzulo et al. concluded that 94% of the bacterial 16S rRNA gene 
sequences found in pig lung homogenates and 63% of bacteria in pig BAL fluid originates from dead 
bacteria (37). It has also been shown that removing the DNA originating from dead bacteria in cystic 
fibrosis lungs leads to different communities of bacteria being identified by sequencing (38). It must 
be noted that it is not required that bacteria be alive for them to be able to elucidate an immune 
response, meaning that dead bacteria may still influence the development and maturation of the 
immune system and therefore have an impact on respiratory disease. 
 
1.1.3 The lung microbiota in health 
As the main origin of lung microbes during health appears to be the upper respiratory tract, it is worth 
briefly considering the composition of the microbial communities present at these sites. While the 
lower airways have historically been considered sterile, the upper airways including the oral and nasal 
cavities, pharynx and larynx have long been known to harbour a diverse community of commensal 
organisms. It is more accurate to think of the upper respiratory tract as multiple niches harbouring 
diverse microbial communities rather than one unified microbiota. In a study by Bassis et al. the 
human lung microbiota was found to more closely resemble oral wash samples than nasal swabs (39), 
therefore I will focus my discussion on this area of the upper respiratory tract. 
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In humans the predominant bacterial phyla present in the oral microbiota are Firmicutes, 
Bacteroidetes, Proteobacteria and Actinobacteria with smaller numbers of Spirochaetes, Fusobacteria, 
TM7, Synergistetes, SR1, Tenericutes and Cyanobacteria (40). This niche also contains small 
numbers of fungi, archaebacteria, protozoa and viruses (41). Studies examining non-human mammals 
have found large differences between humans and other mammals in terms of their upper respiratory 
tract microbiota compositions (42-46). When using animal models it is therefore important to keep in 
mind these differences. Some of the common oral microbiota found in sheep will be covered more 
specifically in Section 1.2.  
The composition of the human oral microbiota is more dependent on environment than genetics. 
Twins have been shown to have more similar salivary microbiotas to each other than when compared 
with the general population yet monozygotic twins show equally similar salivary microbiotas to 
dizygotic twins (47). Also, dysbiosis of the oral microbiota is well known to cause periodontal disease 
which is closely related to environmental factors (48).  
Unlike the upper respiratory tract where 65.6% of the microbial taxa identified by sequencing have 
also been cultured (40), the microbial communities in the lungs have been far less amenable to 
culturing, therefore the most common microbial taxa found in the lungs were only recently identified. 
In a study of healthy human smokers and non-smokers, the taxonomic groups Haemophilus and 
Enterobacteriaceae were found in higher abundance in the lung in comparison to the upper airways 
and the opportunistic pathogen Tropheryma whipplei was found in a quarter of individuals (24). While 
it is likely that in humans the majority of lung microbes are sourced from the upper airways, this does 
not necessarily mean that the relative abundances of microbes will be the same in both niches as 
certain microbes may be able to survive/multiply within the lung more easily or may be aspirated 
more often.  
It also does not necessarily follow that every individual will have a lung microbiota which is 
composed of microbes from the upper airway. Two papers by Segal et al. identified two lung bacterial 
pneumotypes (49, 50). One pneumotype reflected saline background controls while the other 
pneumotype was similar to supraglottic samples. This indicates that while some individuals do 
aspirate upper airway bacteria into their lungs, this is not observed at a detectable level in others. 
These studies also highlighted a link between the presence of supraglottic bacteria in the lung and 
increased inflammation.  
Once bacteria have entered the lungs, it is also important to ask which lung structures they colonise. 
Yun et al. used fluorescence in situ hybridisation to attempt to visualise bacteria in the mouse lung 
(51). In germ-free and specific pathogen free (SPF) mice no fluorescence signal was discovered, 
whereas in non-SPF mice and wild mice fluorescence was detected around the epithelial lining of the 
alveoli, despite no obvious signs of inflammation being present. The researchers stated that while 
some of the fluorescence signals seemed to indicate single bacteria, there are also appeared to be 
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biofilm-like structures present. Dickson et al. also suggested that members of the lung microbiota may 
form biofilms, as removing the host cells from BAL fluid reduces the quantity of bacteria and changes 
the types of bacteria identified (52). This suggests that a significant proportion of the lung bacteria are 
host cell associated which may arise through biofilm formation, bacteria being located intracellularly 
in macrophages or by specific cell to cell adhesion mechanisms.  
Regardless of how and where bacteria are located in the lung during health, they must come into 
contact regularly with the host immune system. That the presence of supraglottic bacteria is linked to 
an inflammatory phenotype points to a relationship between the lung microbiota and the immune 
system. Changes in mouse lung bacterial communities over the first two weeks of life have been 
correlated with decreased house dust mite aeroallergen responsiveness (31). The same paper found 
that this decrease in responsiveness did not occur in germ-free mice over this two week period and 
concluded that airway microbiota formation induces regulatory immune cells in early life. However, 
several papers have suggested that the gut microbiota is also linked to changes in lung immunity (53, 
54). It is therefore not possible to conclude whether the difference between germ-free and wild type 
mice in this study are due to the absence of the lung or gut microbiota. It has also been suggested that 
studies which show that the gut microbiota affects susceptibility to respiratory infections may 
unintentionally be changing the lung microbiota and that this may be the true cause of changes in 
susceptibility (55). However, as of yet, this is purely speculative.  
It must also be stated that the vast majority of lung microbiota research in humans has been carried out 
in individuals from developed countries and that demographic information for study participants is 
often not reported. A study comparing healthy adult Malawians who were exposed to high or low 
levels of airborne particulate matter due to domestic combustion of biomass fuels found significant 
changes in the abundances of several lung bacteria (56). This may indicate that environment can have 
an effect on the lung microbiota during health and would suggest that lung microbiota research should 
be carried out in more diverse human populations who are exposed to different environmental 
conditions. 
 
1.1.4 The lung microbiota in disease 
Some non-infectious diseases were known to be correlated with bacterial lung infection before the 
common use of 16S rRNA gene sequencing, including cystic fibrosis and chronic obstructive 
pulmonary disease. Modern sequencing techniques have been able to further explore the dynamics of 
lung microbiota changes during these diseases and have also discovered relationships between the 
lung microbiota and various other diseases. I will briefly describe some of these relationships in order 





Due to a combination of culture-based and sequencing-based studies, cystic fibrosis has probably the 
best understood lung microbiota phenotype of any disease. Lung inflammation occurs in cystic 
fibrosis patients shortly after birth but bacteria are not always cultured when inflammation starts to be 
detectable (57). This could be due to the presence of pathogens in unsampled sections of the lung; 
infection being at low and thereby undetectable levels; unculturable bacteria being the cause of 
infection or dead bacterial components being the original initiators of the inflammatory response. As it 
is possible to detect bacterial DNA in the lungs of young children with cystic fibrosis, even at the age 
of one month (58, 59), a lack of cultured bacteria is unlikely to indicate a lack of lung bacteria 
altogether.  
During childhood Streptococcus, Haemophilus, Pseudomonas, Staphylococcus and Achromobacter 
are the most dominant genera identified by 16S rRNA gene sequencing, whereas in adults 
Pseudomonas, Burkholderia, Streptococcus, Haemophilus and Staphylococcus are dominant (60). 
This reflects culture based studies where Staphylococcus aureus and Haemophilus influenzae are 
commonly cultured from infant patients and as individuals age the quantities of these bacterial species 
in the lungs decreases and Pseudomonas aeruginosa becomes the principal infecting bacterium (61). 
P.aeruginosa is antagonistic to specific members of the lung microbiota such as S.aureus (62, 63), 
potentially leading to its dominance at later disease stages. One interesting finding is that stable cystic 
fibrosis patients, who are not demonstrating a decline in lung function, have more inter-connected, 
ecologically-dependent communities of lung microbes than patients demonstrating a decline in lung 
function, suggesting that their lung microbiotas may be more resistant to the effects of opportunistic 
pathogens such as Pseudomonas (64). This suggests the possibility of deliberately colonising the lung 
with certain bacterial species to form a more resilient community of microbes. However, the field of 
lung microbiota research is still in its infancy and it is likely to be some time before such a therapy 
would be feasible.  
The main factors which increase the ability of bacterial species to colonise the cystic fibrosis lung are 
related to changes in the airway surface liquid. One theory states that the airway surface liquid in 
cystic fibrosis lungs contains high levels of salt which have been shown to inactivate antimicrobial 
defensins and that water levels are also depleted producing a more viscous airway surface liquid and 
impaired mucus clearance (65-67). Another theory states that while the cystic fibrosis airways do not 
contain high salt levels, the cystic fibrosis airway surface liquid has a reduced pH and thereby has 
decreased antimicrobial peptide activity (68). These factors may increase the ability of bacteria to 
colonise this environment but they do not explain why specific bacterial species are more able to do 
so. The ability of H.influenzae and P.aeruginosa to infect the cystic fibrosis lung may be partly due to 
their ability to form biofilms on the airway epithelia (69, 70). Indeed, the highly viscous cystic fibrosis 
lung mucus may promote biofilm formation in P.aeruginosa colonies due to restricted bacterial 
motility and small molecule diffusion (71).  
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Fodor et al. and Cuthbertson et al. found that once a community of bacteria had established itself in 
the adult cystic fibrosis lung, the overall community structure remained relatively stable over time, 
even during exacerbations and after antibiotic treatment (72, 73). This seems to agree with Li et al. 
who found that after treating exacerbations with antibiotics the lung microbiota was only transiently 
changed during the period of treatment (74) and Whelan et al. who found that exacerbations were not 
consistently associated with changes in the microbiota (75). Although the adult lung microbiota 
appears stable over time, this does not mean that there are not differences based upon where in the 
lung the bacteria are located. Spatial variability in the bacterial lung microbiota and in P.aeruginosa 
clones has been observed (76, 77). This variability may be one of the reasons why there are 
differences in the bacterial communities extracted from lung microbiota samples taken from cystic 
fibrosis patients using different methods (78, 79). 
 
COPD (chronic obstructive pulmonary disease) 
After cystic fibrosis, the next most studied disease in relation to the lung microbiota is COPD. The 
term COPD describes a collection of lung diseases caused by long-term exposure to irritants such as 
tobacco or cooking fire smoke, causing lung inflammation leading to narrowing of the airways and 
reduced air flow in the lungs. COPD patients are frequently subject to respiratory infections which 
may be partially due to impaired mucus clearance (80).  
The effect of COPD on lung microbiota diversity is as yet not well agreed upon. Patients with 
moderate and severe COPD were shown by Erb-Downward et al. to have reduced lung microbiota 
diversity in comparison to healthy controls and to display, as in cystic fibrosis, spatial variability in 
their lung microbiota (19). However, Pragman et al. observed that rather than showing a decrease in 
diversity, patients with moderate COPD actually had more diverse lung bacterial communities than 
controls and patients with severe disease displayed an even greater increase in diversity (81). This 
agrees with a previous finding by Sze et al. (82). The sample sizes in these studies were quite small, 
particularly for the severe COPD groups which consisted of <10 individuals. A more recent study of 
healthy smokers (n=8), non-smokers (n=11) and individuals with COPD (n=18) used both culture and 
DNA sequencing based methods to analyse the lung microbiota (83). This study concluded that 
microbiota diversity is decreased in COPD lungs in comparison to the other groups. To confuse 
matters further, a study comparing patients with mild COPD to healthy controls found no difference in 
diversity between the two groups (84).  
Despite disagreements about diversity, all of the studies mentioned above do agree that there are 
differences in terms of the microbiota composition of COPD affected vs healthy lungs. The 
mechanisms which drive airway inflammation in COPD are not very well understood but it has been 
suggested that the local microbiota may be partially responsible. Richmond et al. tested this 
hypothesis in a strain of mice which did not secrete IgA, as reduced IgA secretion has been previously 
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shown in COPD affected lungs (85). These mice developed a lung phenotype which closely resembled 
COPD and changes were observed in their lung microbiota compositions. However the same mouse 
strain, raised in germ-free conditions did not develop airway inflammation, leading the authors to 
speculate that IgA deficiency may lead to the innate immune systems always being activated by 
members of the lung microbiota which could lead to airway remodelling.  
 
Other diseases 
As well as cystic fibrosis and COPD, several other diseases have been correlated with changes in the 
lung microbiota. Studies examining these diseases can suggest how lung microbiota homeostasis is 
established and maintained during health. 
For example, lung transplantation studies can provide us with a clue as to how the lung microbiota is 
established, as at the point of transplantation the lung should contain microbes from only the original 
host but it will be exposed to different types of bacteria from the upper respiratory tract in the new 
host. In lung transplants of cystic fibrosis patients, the strains of P.aeruginosa IRXQGLQSDWLHQWV¶OXQJV
pre and post-transplantation are usually found to be the same, whereas the general community 
structure of the microbiota is not as consistently similar (86). Bernasconi et al. suggested that the 
presence of different types of bacterial communities in transplanted lungs is correlated with changes in 
the lung inflammatory markers, specifically lungs which were dominated by one phylum (dysbiosis) 
showed different immune cell activation profiles than lungs which were not dominated by one phylum 
(no dysbiosis) (87).However, I feel that the use of phylum abundance as a measurement of dysbiosis 
in this study is overly simplistic as it is possible to have a highly diverse ecosystem which contains 
many species which originate from the same phylum, therefore caution should be taken when 
interpreting these findings. 
It is well known that the immune system plays a key role in maintaining microbiota homeostasis at 
other body sites, such as the gut, and that the absence of a microbiota leads to changes in immune 
system development (88, 89). Preventing members of the microbiota from crossing epithelial barriers 
GHFUHDVHVWKHLPPXQHV\VWHP¶VH[SRVXUHWRWKHVHFRPPHQVDOPLFUREHVDQGWKHUHE\SUHYHQWVDQ
excessive inflammatory response. Immunoglobulin A (IgA) molecules specific to members of the gut 
microbiota are secreted into the gut lumen whereupon they bind to these bacteria and prevent them 
from crossing the epithelial barrier (90). Treg cells also play an important role in maintaining gut 
microbiota homeostasis; when Treg cells are depleted in the host this leads to an increase in 
CD4+ TH cells which are specific to commensal bacteria and this further leads to increased 
inflammation (91)7KHSUHVHQFHRIGLIIHUHQWW\SHVRI.-defensins has also been linked to changes in 
the gut microbiota composition of mice (92). 
12 
 
The microbiota is also important in the development of the immune system, with germ free mice 
developing significantly smaller gut lymphoid follicles than specific pathogen free mice (93). Specific 
commensal gut bacteria have also been linked to the proliferation of particular T-cell subsets. For 
example, segmented filamentous bacteria have been shown to increase Th17 cell differentiation in the 
gut (94). It has also been demonstrated that neomycin-sensitive members of the microbiota play a role 
in regulating the mucosal immune response to viral pathogens in the lung by inflammasome activation 
(95). 
While the interactions between the lung microbiota and the immune system are not currently as well 
understood as those in the gut, the fact that changes can be observed in the lung microbiota in patients 
with immunological disease indicates that the immune system is likely to be a key driver of lung 
microbiota composition. That HIV infection leads to changes in the lung microbiota (25), particularly 
during advanced disease (96), adds more evidence that the immune system is instrumental in driving 
microbial population dynamics. Fungi have also been found to be more likely to infect the lungs of 
those with severe, uncontrolled asthma, indicating a potential role of airway inflammation (97). A 
study examining lipopolysaccharide induced lung injury in mice adds further evidence that 
inflammation plays a role in changing the lung microbiota, and specifically attributes this to the 
outgrowth of opportunistic pathogens from within the host (98). Lipopolysaccharide induced lung 
injury resulted in an increase in endogenous Proteobacteria in the lung which the authors suggested 
was due to increased substrates in the lung environment which these bacteria could use for growth. 
The authors also highlighted that the types of bacteria seen in their lung injury model were similar to 
those observed during complications in ventilated patients in intensive care units. It has also been 
suggested that disruption of the lung microbial communities (eg. by inflammation or antibiotic 
treatment) may lead to changes in immune function, producing a more inflammatory immune 
environment and thereby further driving the colonisation of the lung by pathogens which are able to 
cause chronic infection (99). 
The lung microbiota of ventilated human patients has recently been examined in two studies via the 
collection of endotracheal aspirate and it was found that bacterial diversity decreased as time on the 
ventilator increased, suggesting the outgrowth of a small number of bacterial species (100, 101). The 
authors of the 2016 study suggest that if it were possible for sequence based methods to be used in 
clinical practice it might aid clinicians, as during their study it may have allowed for earlier clinical 
intervention or for antibiotic treatment to have been tailored when unexpected species of bacteria were 
found to be dominating the lung. 
One study in non±cystic fibrosis bronchiectasis patients also highlighted the importance of genetics in 
determining the composition of the lung microbiota (102). The FUT2 (fucosyltransferase 2) gene 
encodes IRUD., 2)fucosyltransferase which facilitates the expression of ABH, Lewisb and 
Lewisy glycans on mucosal surfaces. As some microbes have been found to utilise these glycans to 
adhere to mucosal surfaces (103) this group hypothesised that individuals who had homozygous loss-
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of-function mutations in the FUT2 gene may have different airway microbiota compositions to those 
who had a functional copy of the gene. This study found that individuals who did not carry a 
functional copy of the FUT2 gene were found to have lung microbiota profiles which were 
significantly less likely to be dominated by Pseudomonas aeruginosa than those patients who had at 
least one functional copy of the gene. It is well known that the gut microbiota composition is 
influenced by a wide range of both environmental and genetic factors (104) and it seems logical to 
assume that this would also be the case for the lung microbiota, although the impact of genetics on the 
healthy human lung microbiota has not currently been studied. It is also possible that sequencing 
could be used to predict whether a patient was likely to experience future disease exacerbations, as 
differences in lung microbiota compositions have been associated with worse future clinical outcomes 
in some diseases, such as in non±cystic fibrosis bronchiectasis (105). Specifically, the presence of 
P.aeruginosa (which is linked to a worse clinical outcome) is able to competitively exclude 
H.influenzae, which when present is related to a less severe disease outcome (106). Interestingly, 
unlike in bronchiectasis, Haemophilus colonisation has been correlated to a poorer response to inhaled 
fluticasone treatment in asthma (107). Differences in the resident microbiota of sheep have also been 
shown to affect their chances of developing lung disease and I shall discuss this further in the next 
section. 
 
1.2 The sheep lung 
1.2.1 Use as a model of human disease 
Sheep lungs (Fig. 1.2) are often used as a model in respiratory disease research due to their increased 
similarity to human lungs in comparison to rodent models, including having similar immunological 
responses to allergic stimuli and structural similarity to human lungs (11, 12, 108). Despite the fact 
that lamb lungs at birth are more advanced than in humans and that they demonstrate less 
morphological changes postnatally, they are still more useful as a model of human lung development 
than rodents due to the far less advanced state of rodent lungs at birth (109).  
Sheep have been used as models for asthma (110), transfusion-related lung damage (111), pulmonary 
embolism (112), acute respiratory distress syndrome (113) and gene therapy for cystic fibrosis (114). 
My research group developed a model of P.aeruginosa infection in the sheep lung which was used to 
investigate how P.aeruginosa infection and treatment with intravenous antibiotics changed the lung 
microbiota in sheep (115) (Appendix 1). Briefly, we found that bacterial DNA could be identified in 
the lungs of Pseudomonas infected and uninfected animals. Despite finding that lung microbiota 
samples from within the same animal were more similar to each other than to samples taken from a 
different animal, we observed high levels of inter- and intra-individual variation in the bacterial 
communities within the lungs which led us to ask the research questions discussed during Chapter 3. 
We also observed a decrease in the relative abundance of Gram negative bacteria (excluding 
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Pseudomonadales) after sheep were treated with intravenous colistimethate sodium (CMS), indicating 
that it may be possible to cause changes in the sheep lung microbiota through targeted antimicrobial 
treatment. This finding led us to explore whether aerosolised CMS treatment could lead to larger 
changes in the lung microbiota due to increased deposition of the drug in the airway lining fluid (see 
Chapter 5) (116).  
Another large animal which is commonly used in respiratory research is the pig (108), and it could be 
argued that as pigs do not ruminate they may be a better model for studying the lung microbiota. 
However, there are several advantages to using sheep over pigs as respiratory models. While absent in 
pigs, both sheep and humans have networks of small airway connections which are present between 
adjacent lung segments, allowing for collateral ventilation (12, 108). Currently it is unknown whether 
this would cause microbial communities to be dispersed throughout the lung in a different manner in 
animals which were not capable of collateral ventilation. Also, sheep are generally more docile than 
pigs and are easier to handle, allowing for greater ease when conducting experiments in conscious 
animals (such as is performed in Chapter 5 of this thesis).  
 
Figure 1.2: Diagram of the sheep lung divided into segments. These include the right 
apical (RA), right cardiac (RC), right ventral diaphragmatic 1 and 2 (RVD1 and RVD2), 
right caudal diaphragmatic (RCD), left caudal diaphragmatic (LCD), left ventral 
diaphragmatic 1 and 2 (LVD1 and LVD2) and the left cardiac (LC) segments. Adapted 




1.2.2 The sheep lung microbiota during health 
Prior to the study by my group summarised in the previous section, no one had previously examined 
the healthy lung microbiota of sheep using non-culture based methods. A small number of culture 
based studies had been performed and showed variable results. 
One study examining the differences between normal and pneumonic sheep lungs found that bacteria 
could be isolated and grown from 9% of healthy sheep lungs in comparison to 66% of pneumonic 
lungs (118). The most common microbe isolated from both lung types was Pasteurella haemolytica 
(aka Mannheimia haemolytica), a common member of the upper respiratory tract microbiota and a 
causative agent of the respiratory disease pasteurellosis in sheep. In pneumonic lungs, Moraxella 
catarrhalis (a common member of the upper respiratory tract microbiota but found very rarely in 
healthy lungs) was unlikely to be found by itself but was commonly found co-infecting with 
P.haemolytica. It was also observed that in pneumonic sheep lungs if P.haemolytica or M.catarrhalis 
were present it was very rare for them to not also be present in the nasal cavity. While we cannot be 
certain that the presence of these bacteria in the lungs is due to outgrowth from the upper respiratory 
tract, it is reasonable to assume that, as in humans, the sheep lung microbiota would be established by 
microaspiration of microbes form the upper respiratory tract. This study also highlighted that 
P.haemolytica and M.catarrhalis were likely to dominate the nasal flora during the autumn, 
potentially indicating that the sheep respiratory microbiota may be seasonal.  
A separate study examining the respiratory tracts of apparently healthy sheep at an Ethiopian abattoir 
also reported seasonal changes in the respiratory microbiota, showing a substantially larger ratio of 
Gram positive to Gram negative bacteria in February to April but a slightly larger Gram negative to 
Gram positive ratio in November to January (119). This study identified far higher colonisation rates 
RIWKHµKHDOWK\¶OXQJWKDQWKHSUHYLRXVO\discussed study, with 62.5%.of lungs showing bacterial 
colonisation (with the nasal cavity, tonsils and trachea being colonised 97.9%, 93.8% and 79.2% of 
the time respectively). Several microbes were cultured from the lungs of over 10% of the animals 
tested including Arcanobacterium pyogenes (now named Trueperella pyogenes), Bacillus spp., 
Citrobacter spp., coagulase-negative staphylococci, Corynebacterium spp., Enterococcus faecalis, 
Klebsiella spp., P.haemolytica, Micrococcus spp., Pasteurella multocida, Pseudomonas spp. and 
Enterococcus spp.  
In contrast to these results, which seem to indicate that colonisation of the healthy lung is quite 
common, a study of Nadji and Somalian sheep found that lung colonisation was very rare and the only 
bacterium reported to have been found in healthy animal lungs was Corynebacterium 
pseudotuberculosis, which was found in 8.7% of the Najdi sheep (120). This differing level of lung 





1.2.3 The upper respiratory tract as a harbour for disease causing 
microbes 
Various microorganisms have been linked to lung disease in sheep including P.haemolytica, 
Pasteurella spp., Mycoplasma ovipneumoniae, Chlamydia psittaci, Mycoplasma capricolum, 
Parainfluenza 3 virus and viruses of the Retroviridae family. Some of the bacteria listed here can also 
commonly be found in the upper respiratory tract.  
For example, P.haemolytica is a common commensal of the ovine upper respiratory tract (121, 122) 
and is a leading cause of bronchopneumonia in sheep. A study looking at the microbiota of the nasal 
cavity and tonsils of domestic and Bighorn sheep identified several common commensal bacteria, 
including the potential pathogens P.haemolytica, P.multocida. S.aureus and A.pyogenes (123). It has 
been suggested that lung infections caused by P.haemolytica may be due to outgrowth from the upper 
respiratory tract, rather than by the inhalation of pathogenic strains, as P.haemolytica serotypes 
isolated from pneumonLFVKHHSOXQJVXVXDOO\FRUUHODWHZLWKWKRVHFRORQLVLQJWKHVDPHVKHHS¶VQDVDO
passages (124).  
Lung infection by other microorganisms can change the likelihood of a sheep developing respiratory 
disease. For example, the presence of viruses in the lungs pre P.haemolytica infection has often been 
linked with poorer clinical outcomes (125-128) and the presence of M.ovipneumoniae has been shown 
to predispose Bighorn sheep to fatal P.haemolytica infections (129). On the other hand, co-infection 
by either Bibersteinia trehalosi or P.multocida may lead to better clinical outcomes as these bacteria 
are able to inhibit the growth of P.haemolytica in a proximity-dependant manner (130, 131). 
Attempting to change the sheep respiratory microbiota through the use of probiotics or antibiotics to 
SURPRWHµGLVHDVH-SUHYHQWLQJ¶PLFURELDOFRPPXQLWLHVWKHUHIRUHVHHPVOLNHDUHDVRQDEOHJRDO:KLOH,
am not aware of any previous research that compares the composition of respiratory tract microbiota 
pre and post antibiotic treatment in sheep, this research has been done in cattle, which share many 
members of their respiratory microbiota with sheep. In both healthy calves and calves with respiratory 
disease, Allen et al. found that P.multocida, P.haemolytica, Haemophilus somnus, Mycoplasma bovis 
and Mycoplasma bovirhinis could be commonly isolated from the lower airways pre-antibiotic 
treatment (132). Subsequent antibiotic treatment (penicillin +/- trimethoprimsulfadoxine) did cause a 
decrease in Pasteurella spp. and H.somnus but for the Pasteurella spp. this effect was short lived as 
after the cessation of treatment rapid recolonisation of the respiratory tract was observed for these 
bacteria. This echoes the findings of Li et al. (74) in cystic fibrosis and may indicate that causing a 
long term change in the respiratory tract using antibiotics to promote lung health may not be possible. 
However, this meta-analysis by Li et al. analysed samples from 18 different studies which used 
varying methodologies, both in terms of lung microbiota sample collection techniques 
(bronchoalveolar lavage and sputum collection) and 16S analysis. Despite the cumulatively large 
sample size generated by combining data from these studies, caution should always be taken when 
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comparing 16S sequence data which has been produced using different methodologies as these can 
introduce differing biases into datasets (see Section 1.3).  
Further research is required to characterise the sheep lung microbiota before therapeutic attempts to 
manipulate its composition can be attempted. 16S rRNA gene sequencing is a method by which we 
can research the bacterial communities of the lung without the biases associated with traditional 
culturing methods. This method and the biases associated with it are discussed further in the following 
chapter.  
 
1.3 Sequencing low biomass bacterial communities 
1.3.1 The 16S rRNA gene 
A commonly used method for the identification of bacterial communities by non-culture based 
methods is through 16Ss rRNA gene sequencing. The 16S rRNA gene is ubiquitous amongst bacteria 
and contains nine variable regions flanked by conserved regions which can be used during primer 
design (Fig. 1.3). These variable regions can be sequenced in order to allow the taxonomic 
identification of the bacteria from which they originate. It is important to note that while using such a 
method removes the bias towards culturable microbes, it introduces new forms of bias which I will 
briefly describe below.  
 
Figure 1.3: The 16S rRNA gene with the base pair locations of the variable regions 
indicated by their common identifier (V1-V9). Base pair numbering is based on 
the Escherichia coli system of nomenclature. Data adapted with permission from 
(133). 
 
The copy number of the 16S rRNA gene per cell has been found to range from 1-15 copies per cell, 
depending upon bacterial taxonomy, although copy numbers of above 7 are only rarely identified 
(134). This means that, in a given sample, the relative abundances of 16S genes from multiple 
bacterial species are unlikely to be equivalent to the relative abundances of these bacteria in the 
original sample population. Also, as it is not possible to sequence the entire 16S rRNA gene using 
most sequencing technologies, it is necessary to select a specific region of the gene to amplify and 
sequence. This can be a source of bias, with several commonly used primers having been associated 
18 
 
with non-coverage of certain bacterial groups (135). It is unlikely that any variable region will be 
completely free of bias but some regions have been shown to provide generally good taxonomic 
coverage and depth, such as the V1-V2 and V2-V3 regions (133, 136, 137). Despite these sources of 
bias, as long as consistent protocols are used it is still possible to accurately and quantitatively 
measure changes in the relative abundances of different bacterial taxonomies between groups (138). 
 
1.3.2 The impact of contamination 
As well as the general difficulties arising from using 16S rRNA gene sequencing to study the 
microbiota, there are specific problems related to studying low biomass microbial communities such 
as those found in the lung. The most important of these is the increased impact of contamination, 
which if not appreciated and controlled for can lead to spurious results. Studies amplifying DNA from 
small quantities of bacteria risk amplifying DNA from contaminating bacteria along with genuine 
members of the bacterial community being studied. Contamination may originate from various 
sources including reagents, laboratory equipment or lab users (139).  
The lower the level of bacterial template contained in the original sample, the greater the proportion of 
bacterial sequences originating from contamination will be after sequencing. This has been 
demonstrated in a study by Salter et al. which sequenced the 16S rRNA genes of serial dilutions of a 
pure Salmonella bongori culture (five dilutions of 108 to 103 cells) which were amplified by PCR for 
either 20 or 40 cycles prior to sequencing (140). For both 40 and 20 PCR cycles, when the template 
was reduced to 103 bacterial cells the majority of sequences were derived from contamination. 
Contaminants were found to vary between laboratories and DNA extraction kits (by manufacturer and 
lot number). Studies examining the lung microbiota usually find around 103-105 16S rRNA gene copy 
numbers per µl in lung samples (19, 20, 49), therefore it is possible that a large proportion of the 
sequences generated during these studies will originate from contamination (a separate study by 
Biesbroek et al. found that contamination began to have an effect on the apparent microbiota of a 
saliva sample when the sample contained < 1x10-6 ng/µl of template DNA (141)). Common 
contaminants identified by Salter et al. included soil and water bacteria, many of whom are nitrogen 
fixing; the authors suggest that this may be due to the use of nitrogen in ultrapure water storage tanks. 
Background contamination from extraction kit controls was found to be around 500 16S rRNA gene 
copies per µl while a separate study by Segal et al. found that in saline bronchoscope wash controls 
contamination reached the level of 41,195 16S gene copies per µl (49).  
This level of contamination potentially explains some of the results from studies which have 
examined environments not normally considered to have a microbiota, such as the placenta, amniotic 
fluid, meconium, the surface of the eye and the brain (142-145). These studies frequently identify 
environmental nitrogen fixing bacteria such as Methylobacterium, Nitrobacter and Beijerinckia which 
may arise from contamination. A recent, well-controlled study examining placental samples 
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concluded that the placenta did not have a distinct microbiota as placental samples contained 
predominantly soil and plant associated bacteria which were also found in extraction kit reagent 
controls (146). It is important to keep in mind the effect of contamination while performing lung 
microbiota studies and to be cautious about any bacteria identified which are known to be nitrogen-
fixing. 
 
1.3.3 Controlling contamination and bias in low biomass samples  
While it is often not possible to eradicate all possible sources of contamination there are ways of 
reducing it. Sources of contamination which are specific to lung microbiota studies are the upper 
respiratory tract (a problem when collecting sputum samples) and the bronchoscope channel, both of 
which can be avoided through the use of a sampling method which does not come into contact with 
these surfaces. BAL is a common method for sampling the lung which involves flushing phosphate 
buffered saline (PBS) or saline through the bronchoscope channel into the lung then collecting the 
fluid back through the channel. Unless saline flushes of the channel are included prior to each lung 
sampling, potentially leading to double the amount of samples needing to be sequenced, it is not 
possible to analyse the effect that the contaminated channel may have had on the lung samples (147). 
Protected specimen brushings, which do not come into contact with either the upper respiratory tract 
or the bronchoscope channel and thereby avoid contamination from these environments (29), can be 
used to avoid the need for these controls (see Section 2.5.3). 
Contamination can also arise from the equipment and reagents used to collect samples, perform DNA 
extractions and amplify DNA by PCR. The quantity of contaminating bacterial DNA from these 
sources can be reduced by various techniques, including the use of standard sterile techniques and 
ultra violet (UV) treatment of reagents, workstations and equipment. However, UV treatment is 
unlikely to destroy all of the contaminating DNA (148) and it is not possible to UV certain reagents 
such as deoxynucleotide triphosphates or taq polymerase (149). Other methods have been tried, 
including deoxyribonuclease treatment, restriction endonuclease digestion and DNA intercalation 
(150-152) but if the compounds used in these methods are not completely inactivated or removed they 
may inhibit PCR reactions. Other researchers sharing the same lab space have also been suggested as 
a risk factor for contamination (153), but obviously this is often unavoidable. 
In order to further reduce the quantity of contaminating DNA on surfaces and equipment, it is possible 
to combine other techniques with chemical treatment. Bleach and copper-bis-(phenanthroline)-
sulfate/H202 solution have been found to be the most effective chemical treatments but as these 
compounds are corrosive and therefore cannot be used on certain materials, commercial products such 
as DNA away by Molecular Bioproducts have been suggested as an adequate alternative (149).  
In conclusion, there is currently no generally accepted method which will completely eradicate all 
contaminating DNA while not affecting PCR efficiency or damaging reagents/equipment and it is 
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therefore highly important to process reagent only controls alongside samples when carrying out 
studies on the lung microbiota, allowing the researcher to identify which bacterial sequences in 
samples may be due to contamination. As of yet there is also no generally accepted method for 
removing contaminating sequences from datasets although methods for doing so have been suggested 
including identifying likely contaminants using the neutral model (39) or by combining sequencing 
information from negative controls with quantitative PCR (qPCR) data (154). Other than 
contamination, the largest source of bias related to sequencing low biomass bacterial communities is 
the large amount of PCR cycles which are needed to amplify the small quantity of DNA in the 
samples. This can affect the apparent diversity of the bacterial communities sampled and can lead to 
increased taxonomic bias (155, 156). Low PCR template concentrations (0.1 ng per reaction) have 
also been shown to give lower amplification reproducibility in comparison to higher template 
concentrations (5 to 10 ng per reaction) (157). While it is likely to be impossible to eradicate PCR bias 
completely, the inclusion of a mock community control made up of known quantities of a mixture of 




The overall aim of my thesis is to characterise the lung microbiota of sheep in order to assess its 
potential usefulness as a model of the human lung microbiota or to study sheep respiratory disease. 
The following outline provides a brief description of the objectives of each of my results chapters.  
x Chapter 3: Variability of the Lung Microbiota ± To analyse the amount of inter- and intra-
individual variability present in the sheep lung microbiota (n=6 animals). Also, to offer a 
better understanding of the types of bacteria which can be found in the sheep lung. 
x Chapter 4: Comparing Microbiotas in the Upper Aerodigestive and Lower Respiratory Tracts 
of Lambs ± To characterise the lung microbiota composition in a larger number of animals 
(n=40). Also, to discover whether, as in humans, the sheep lung microbiota is similar to that 
of the upper respiratory tract.  
x Chapter 5: Microbiota in Exhaled Breath Condensate and the Lung ± To assess whether it is 
possible to replace invasive lung sampling methods with the less invasive sampling method 
of exhaled breath condensate (EBC) collection. Also, to discover whether it is possible to 
manipulate the lung microbiota using nebulised antibiotic treatment.  
x Chapter 6: Identifying Core Members of the Sheep Lung Microbiota ± To analyse the inter-
study variability of my results and to attempt to identify bacteria commonly isolated from the 
sheep lung in all of my studies tRLGHQWLI\DµFRUH¶ sheep lung microbiota.  
The following methodology chapter covers the materials and methods I used during my results 
chapters and the reasoning behind their use.   
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Chapter 2: Methodology  
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2.1 Ethical statement 
Experimental protocols were subject to the Animals (Scientific Procedures) act 1986 and all studies 
involving animals were approved by the Roslin Institute Animal Welfare and Ethics Committee. A 
statistician (Dr. Helen Brown) was consulted to advise on appropriate sample sizes.  
 
2.2 Sheep details 
Table 2.1 contains the available information about the sheep used in each results chapter. Due to the 
outbred nature of the sheep used in my thesis, genetic variation is likely to be high and it is possible 
that this variation will impact the types of bacteria which can be found as members of the lung 
microbiota. 
Table 2.1: Sheep used in this thesis 
Chapter Gender Age Breed Weight (mean ± SD at 
first sampling) 
3 (contains two 
studies, one using 
n=6 sheep and 
one using n=1) 
N=6: 5 females 







Suffolk-cross N=6: 60.3 ± 7.3 kg  
N=1: 60 kg 







20.6 ± 2.6 kg 
5 6 castrated males 14 months Suffolk-cross 49.2 ± 3.4 kg 
 
2.3 Removal of contaminating DNA 
Due to the low quantities of DNA present in the healthy lung, it is important to reduce the levels of 
potentially contaminating bacterial DNA from reagents and equipment used to process samples. 
During DNA extraction and PCR setup, all experiments were carried out in either a safety cabinet or a 
PCR cabinet to prevent contamination from aerosolised bacteria. Prior to use, cabinets were either 
treated with 30 mins of UV radiation or with Ambion DNAZap PCR DNA Degradation Solutions 
(Ambion inc., USA). All pipettes, tubes and reagents used during DNA extraction, PCR and qPCR, 
were UV treated in a Hoefer UVC 500 Crosslinker (Hoefer inc., USA) except for the DNA template, 
deoxynucleotide triphosphates and the Q5 Hot Start High-Fidelity 2X Master Mix (New England 
Biolabs, UK). UV treatment has previously been shown to be effective at decreasing contaminating 




2.4 Anaesthesia  
Before anaesthesia, food was withheld from animals for 24 hours. Anaesthesia was induced by 
injecting 6-8 mg/kg of propofol (Fresenius propofol, 1%, Fresenius Kabi Ltd, UK) and maintained by 
positive pressure ventilation using a 50:50 mix of nitrous oxide and oxygen with 1-3% isoflurane. 
Tidal volume was adjusted to 10 ml/kg body-weight and end-tidal CO2 at 4.5-5.5% by adjusting the 
respiration rate.  
 
2.5 Sample collection 
2.5.1 Bronchoscope wash controls 
To act as a control for some bronchoscopic procedures, 7.5 ml sterile PBS was passed through the 
bronchoscope channel prior to sample collection (see Chapter 3). The wash was collected in a sterile 
tube and stored on ice for up to three hours. 
 
2.5.2 Exhaled breath condensate (EBC) collection 
For Chapter 5, EBC was collected from both conscious and anaesthetised animals using an 
RTubeVENT breath condensate collection device (Respiratory Research, USA). RTubeVENTs were 
treated with UV before use as they are not provided sterile. EBC was collected for 10 mins from 
conscious sheep held in a holding crate. A face mask was attached to the sheep and an RTubeVENT 
within an insulaWHGFRROLQJVOHHYHFRROHGWR-20°C) was attached to the face mask as shown in 
Chapter 5 (Fig. 6). EBC was collected from anaesthetised sheep for 10 mins, as also shown in 
Chapter 5 (Fig. 6), to bypass and reduce contamination from the upper respiratory tract.  
After EBC collection, the RTubeVENTs were capped and transferred to a microbiological safety 
cabinet where an aluminium plunger was used to pool the EBC. This is performed in the following 
manner: the RTubeVENT is pushed down over the plunger which forces a piston at the bottom of the 
tube up through the tube, gathering the condensate from the tube along its rim and pushing it towards 
the top of the tube. A second piston at the top of the tube is removed which allows the condensate 
collected around the edge of the first piston to be accessible. The condensate is collected using a 




2.5.3 Protected specimen brushings (PSBs) 
For Chapters 3 and 5, brushings were taken using a protected specimen brush (ConMed Disposable 
Microbiology Brush, Conmed, USA) to prevent contamination of lung samples by the upper airways 
and to allow greater spatial precision when taking samples from the lung epithelium (Fig. 2.1). 
The bronchoscope was positioned at the sampling site then the protected specimen brush catheter was 
advanced 1-3 cm from the bronchoscope and the protective carbon wax plug was ejected into the lung 
where it will have safely dissolved. The brush was then advanced from the catheter to the epithelium; 
the sampling area was brushed thoroughly before the brush was retracted into the catheter sleeve and 
the catheter was removed from the bronchoscope. Brushes were cut using sterile scissors into 1 ml 
PBS so that the bacteria on the brushes would diffuse into the PBS. After centrifugation for 15 mins at 
13,000g (Biofuge Fresco, Heraeus, Germany), a portion of the supernatant was removed, leaving 500 
µl fluid.  
 
 
Figure 2.1: Protected specimen brushings of the lung epithelium. A) The protected 
specimen brush sits within a catheter, protected from contamination by the presence 
of a carbon wax plug. B) Once the catheter is positioned near the sampling site, the 
inner catheter is advanced forward. This ejects the wax plug into the lung where it 
safely dissolves. The brush is then advanced and a sample is taken from the lung 
epithelium. C) The brush and inner catheter are withdrawn inside the outer catheter 
and removed from the bronchoscope. The sample is then transferred to a safety 
cabinet where the end of the outer catheter is removed using sterile scissors (dashed 
line). D) The inner catheter is advanced fully and the brush is retracted 5mm within the 
inner catheter. The inner catheter is cut 5mm from the tip (dashed line). E) The brush 




2.5.4 Bronchoalveolar lavage (BAL) 
The bronchoscope was advanced and wedged in the segment to be sampled then 2 x 20 ml PBS was 
used to collect BAL fluid which was transferred into sterile tubes (through sterile gauze in order to 
remove mucus which would have interfered with the quantification of colistimethate sodium by high 
performance liquid chromatography) and immediately stored on ice (see Chapter 5).  
 
2.5.5 Throat swabs 
For Chapter 4, cotton tipped swabs contained within a protective plastic sheath (Swab Plain Wood 
Cotton Tip Sterile, Copan, Italy) were used to prevent contamination. The swab was retracted within 
the sheath and the end of the sheath (closest to the swab tip) was removed with sterile scissors. The 
end of the sheath was placed at the back of the mouth and the swab was advanced to sample the throat 
before being retracted into the sheath prior to removal from the mouth (Fig. 2.2). The swab was 
transferred into a fresh sheath before being stored on ice. The swab tip was cut into 500 µl of sterile 
PBS for storage.  
 
 
Figure 2.2: Throat swab sampling site. A sheep head dissected to show the position in 
the throat from which throat swabs were taken. The swab did not pass the soft palette 
and can therefore be said to have sampled the oropharynx and not the nasopharynx. 
A) Ventral aspect of mandibles. B) Tongue (reflected back). C) Ventral aspect of 




2.5.6 Collection of lamb lung fluid by syringe 
For Chapter 4, the ventral aspect of the neck of the animals was shaved before the ventral trachea was 
exposed using a scalpel. A sampling site on the trachea was identified and an area proximal to this site 
was tightly closed using string and a clamp. The sampling site was seared using a heated spatula 
before 50 ml PBS was injected into the tracheal lumen. The head and neck were raised to encourage 
flowing of the PBS caudally into the lower airways then a clamp was placed below the site of 
injection to prevent leakage from the injection site. A site on the thorax caudal to the clamp was 
seared as above and the sheep was tipped so that the fluid flowed into the tracheal lumen to enable 
maximum fluid collection. Fluid was collected through the seared section using a syringe and 
transferred to sterile tubes.  
 
2.6 Sample storage 
Samples were stored on wet or dry ice within 30 mins of collection and were then stored at -80°C or 
underwent DNA extraction within 4 hours. Storage for this length of time has previously been shown 
to have minimal impacts on sputum bacterial communities (161). Extracted DNA was stored at -80°C. 
Several studies have found that storage of samples at -80°C has little impact on the apparent 
composition of bacterial communities (162, 163) whereas others have shown a significant impact on 
the ratios of different bacterial groups (164, 165). 
In Chapter 3, samples from the baseline and 1 month time-points were stored at -80°C then underwent 
DNA extraction within 1 month. Samples from the 3 month time-point underwent DNA extraction 
within four hours of sample collection. Samples from the 36 month old sheep also underwent DNA 
extraction within four hours of sample collection. In Chapter 4, samples were stored at -80°C for nine 
months prior to DNA extraction. In Chapter 5, samples were stored at -80°C and underwent DNA 
extraction within one month.  
 
2.7 Colistimethate sodium (CMS) treatment 
In Chapter 5, treatment of sheep with CMS is used to assess whether there is a quick, simple and non-
invasive way to influence the sheep lung microbiota composition. CMS is one of only a small number 
of antibiotics which have been specifically formulated and manufactured for aerosolised use, which is 
a more efficient way of delivering antibiotics to the lung (116). It is commonly used in its aerosol 
form to treat exacerbations in cystic fibrosis caused by Gram negative pathogens. Colistin is a 
polymyxin type antibiotic which only has activity against Gram negative bacteria; CMS is a less toxic 
prodrug of colistin which is hydrolysed to colistin in aqueous solution.  
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Information on CMS dosing is often confusing due to the use of different units by manufacturers (166, 
167) and the need for better information on the pharmacokinetic-pharmacodynamic relationship of 
colistin in different patient populations (168). The usual dose for humans over 2 years of age is 1-2 
million units two to three times per day (maximum 6 million units per day) (169); unlike colistin, 
CMS has been shown to have minimal renal toxicity in humans, even at very high doses (9,000,000 
units twice daily (170)).  
As we intended this to be a simple method for changing the lung microbiota composition, we designed 
our dosaJHUHJLPHVWRUHTXLUHQRµRXW of hours¶ animal work and for one course to not last longer than 
a week. Two million international units (IU) of CMS (Colomycin Injection, Forest Laboratories UK 
ltd., UK) was dissolved in 4 ml distilled water and added to the nebulisation chamber of an eFlow 
Rapid Nebuliser System (PARI, UK). Sheep were held in a holding crate and were fitted with a face 
mask which was connected to the nebuliser via plastic tubing fitted with valves to ensure that 
breathing only occurred unidirectionally. Doses were delivered until both the full dose was delivered 
and the machine automatically switched off or until 15 mins had elapsed, so that the sheep were not 
overly stressed due to longer periods of restraint.  
Two dosage regimes were used: 
x Dosage regime 1: A single dose of 2,000,000 IU CMS per day was administered. This was 
repeated every day for seven days after which blood and BAL fluid samples were collected 
24 and 48 hours after the final dose. This dosage regime was used to establish that we were 
able to successfully administer a bactericidal dose of colistin to the lung using nebulisation 
(see Section 5.1).  
x Dosage regime 2: Two doses of 2,000,000 IU CMS were administered with an interval of 6 
hours. Blood and BAL fluid samples were collected 24 hours after the final dose. This 
dosage regime was used to test whether it was possible to cause a change in the lung 
microbiota using a single dose of nebulised antibiotic (see Section 5.2).  
Due to the lack of controlled clinical trial information and the fact that different brands of CMS have 
been shown to lead to different exposures to the active form of colistin in rats (171), we decided to 
measure the quantity of colistin in the treated sheep after treatment. Serum was produced by 
centrifuging blood for 15 mins at 2500g (Megafuge 1.0, Heraeus, Germany). As the concentration of 
urea in epithelial lining fluid and serum should be equal (172) it is possible to find the dilution factor 
of the epithelial lining fluid to PBS in BAL fluid samples by calculating the difference between serum 
and BAL fluid urea concentrations. The urea concentrations in serum and BAL fluids were quantified 
by the Easter Bush Clinical Pathology Unit. Colistin was quantified in BAL fluid using High 
Performance Liquid Chromatography (HPLC) (performed by Andy Gill), using previously described 
methods (173, 174) (methods described in more detail in Chapter 5). The calculated colistin 
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concentration was then multiplied by the BAL fluid dilution factor in order to calculate the 
concentration of colistin in the epithelial lining fluid.  
 
2.8 Differential cell counting 
It is possible that the presence of infection in the lungs may lead to changes in the lung microbiota. To 
check whether infection is present, BAL fluid samples can be taken and the immune cells present 
counted. A high eosinophil count may indicate helminth infection while a high neutrophil count can 
also be a sign of infection.  
BAL fluid was centrifuged at 1400g for 5 mins (Megafuge 1.0, Heraeus, Germany) and the 
supernatant was poured off leaving a small amount of liquid and a cell pellet. The pellet was 
resuspended in the remaining liquid and up to 2 ml PBS, depending on the size of the pellet. An 
improved Neubauer cell counting chamber and a light microscope were used to calculate the total 
white blood cell count and the live/dead white blood cell ratio. 10 µl nigrosin (Nigrosin water soluble, 
Sigma, UK) was mixed with 10 µl of the cell suspension and added to the haemocytometer. Nigrosin 
stains dead cells dark grey/black and can therefore be used to differentiate live from dead cells. 10 µl 
white blood cell counting fluid (made in house by Steven Wright using glacial acetic acid and crystal 
violet) was mixed with 10 µl of the cell suspension and added to a separate section of the 
haemocytometer. This counting fluid lyses red blood cells but not white blood cells.  
Before loading the samples into the ctyospin (Ctyospin 2, Shandon, UK) the cell solution needed to be 
diluted to 5 x 104 cells/100 µl. The total quantity of fluid needed for the cytospin was calculated using 




To this was then added 200 J of PBS. Two cytospin slides per sample were prepared by adding 100 
J of this solution to each slide, with the cytospin machine set for 5 mins at 600 rpm. Slides were 
allowed to air dry. They were then stained iQPO/HLVKPDQ¶VVWDLQ/HLVKPDQ6WDLQLQ
Methanol, Fisher Chemical, UK) for 2 mins then in this plus 2 ml water for a further 8 mins. Slides 
were thoroughly washed in water, allowed to air dry then mounted in DPX mountant (DPX Mounting 
Medium, Agar Scientific, UK) before differential cell counting using a light microscope. Cells were 
classified as alveolar macrophages, neutrophils, mast cells, eosinophils, monocytes, lymphocytes and 
epithelial cells according to standard morphological criteria (175). The normal cellular composition of 
healthy sheep BAL fluid is <7.5 x 106 cells/ml, >77.7% alveolar macrophages, <9.5% neutrophils, 
<7.5% eosinophils, <0.6% mast cells, <11.2% lymphocytes and <3.4% of other cell types (Personal 
communication, Steven Wright and David Collie). Differential cell counting was performed for all 
sheep in Chapter 5. Differential cell counts were found to be within normal ranges except for sheep 
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ED952 which had an elevated eosinophil count (19.2%) and sheep ED956 which had a high 
lymphocyte count (19.6%).  
 
2.9 DNA extraction 
Different DNA extraction kits and methodologies can affect not only the quantity of DNA but also the 
apparent composition of the bacterial communities extracted from samples, making it difficult to 
compare results obtained using different methods (176, 177). I have therefore used the PowerSoil 
DNA Isolation Kit (Mo Bio, USA) and the same extraction protocol for all experiments. A bead 
beating step is included in this protocol as bead beating has been shown to produce a more 
representative bacterial community structure (178, 179).  
7KH3RZHU6RLO'1$,VRODWLRQ.LWZDVXVHGDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVH[FHSW
where adjustments were made to facilitate the processing of different sample types; an added heating 
step prior to bead beating to increase cell lysis and the use of less DNA eluent to increase the final 
DNA concentration. Extraction kit reagent controls were produced using the same protocol to identify 
any potential bacterial DNA originating from the kit. All centrifugation steps were carried out in a 
Biofuge Fresco (Heraeus, Germany).  
For protected specimen brushes, lamb lung fluids, and PBS controls: Samples were briefly vortexed 
and centrifuged at 13,000g for 5 mins. The supernatant was removed leaving any cell pellets, brushes 
and ~100 µl of liquid. 60 µl of PowerSoil Solution C1, a cell lysis agent, was added to each sample 
and was used to resuspend pelleted cells. The suspension and brushes (where present) were transferred 
to bead beating tubes along with 750 µl of PowerSoil Bead Solution. Swabs were placed directly in 
bead beating tubes containing 750 µl PowerSoil Bead Beating Solution and 60 µl PowerSoil Solution 
C1. 
Samples were then heated at 65°C for 15 mins before being placed in a FastPrep FP120 Cell Disrupter 
for 45 s at 5.0 m/s. This heating step was included to increase cell lysis. Tubes were centrifuged at 
10,000g for 30 s and 250 µl of Powersoil Solution C2 was mixed with the supernatant in separate 2 ml 
tubes. Samples were incubated at 4°C for 5 mins then centrifuged at 10,000g for 1 min. 600 µl of the 
supernatant was transferred to new 2 ml tubes and mixed with 200 µl Powersoil Solution C3. 
Solutions C2 and C3 both act to precipitate any non-DNA organic and inorganic material from the 
samples. Samples were again incubated at 4°C for 5 mins then centrifuged at 10,000g for 1 min. The 
supernatant was transferred to new 2 ml tubes and mixed with 1.2 ml of Powersoil Solution C4 (a 
concentrated salt solution which will allow DNA binding to silica). This was then centrifuged through 
a silica filter at 10,000g for 1 min followed by 500 µl of Powersoil Solution C5 (an ethanol based 
wash solution) at 10,000g for 30 s. The filter was then centrifuged at 10,000g for 1 min to remove any 
residual Solution C5. 50 µl PowerSoil Solution C6 (eluent) was added to the silica filter and incubated 
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at room temperature for 5 mins before centrifugation at 10,000g for 30 s. The resulting fluid was 
collected in separate 2 ml tubes and the DNA concentrations were measured using a Nanodrop 2000 
(Thermo Fisher Scientific, USA).  
 
2.10 16S rRNA gene amplification 
The primers I used for 16S rRNA gene amplification were originally chosen as they would produce a 
~450 bp product covering the V2-V3 regions of the gene which it was thought would give greater 
taxonomic depth than using a shorter amplicon as using sequences of >250 bp was recommended for 
the best taxonomic coverage (137, 180). At the time they were designed it was not appreciated that as 
the Illumina MiSeq could only produce 250 bp paired end reads the overlap between the reverse and 
forward reads for a 450 bp sequence would be very small which would lead to bioinformatic programs 
being less able to detect sequencing errors in the non-overlapping regions. This increases 
bioinformatic processing time and also increases the sequencing error rate. As described in my 
introduction (Section 1.3.1), primer choice can greatly influence the apparent composition of the 
microbiota. The primers were designed and used by my group to produce sequence data on the sheep 
lung microbiota prior to my PhD (115) and in order to be able to compare my data with these findings 
it was decided that I would continue to use them, as long as the error rate was not found to be high. A 
two-step nested PCR protocol was used to reduce potential bias caused by sequence barcodes, which 
increases in relation to the number of PCR cycles (181). However, it must be noted that a high number 
of PCR cycles was still used and this has been related to increased PCR bias (155, 156). 
For both PCR steps, 25 µl of Q5 High-Fidelity 2X Master Mix (New England Biolabs) and 2.5 µl of 
each primer (10 µM) were used. A positive and negative control was included during each PCR run. 
The positive control consisted of DNA extracted from P.aeruginosa Strain PA0579 and the negative 
control consisted of nuclease free water (Qiagen, USA). Mock communities were included to control 
for PCR or sequencing bias. In Chapters 3 and 4 the Human Microbiome Project mock community 
HM-782D (Genomic DNA from Microbial Mock Community B (Even, Low Concentration), v5.1L, 
for 16S rRNA Gene Sequencing) was used while in Chapter 5 the Human Microbiome Project mock 
community HM-783D (Genomic DNA from Microbial Mock Community B (Staggered, Low 
Concentration), v5.2L, for 16S rRNA Gene Sequencing) was used. HM-782D contained genomic 
DNA from 20 bacterial species with 100,000 ribosomal RNA operon copies per organism per µl. The 
twenty bacterial species included were Acinetobacter baumannii, Actinomyces odontolyticus, Bacillus 
cereus, Bacteroides vulgatus, Clostridium beijerinckii, Deinococcus radiodurans, Enterococcus 
faecalis, Escherichia coli, Helicobacter pylori,, Lactobacillus gasseri, Listeria monocytogene, 
Neisseria meningitides, Propionibacterium acnes, Pseudomonas aeruginosa, Rhodobacter 
sphaeroides, Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae, 
Streptococcus mutans and Streptococcus pneumoniae. HM-783D contained the same species but there 
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were 1,000 to 1,000,000 ribosomal RNA operon copies per organism per µl. Both mock communities 
were supplied by BEI Resources.  
The first PCR step amplified the V1-V4 region of the 16S rRNA JHQHXVLQJWKHSULPHUV)¶-
GAGTTTGATCNTGGCTCAG-¶DQG5¶-GACTACCAGGGTATCTAATC-¶7KH3&5
conditions were: 94°C for 2 mins followed by 20 cycles of 94°C for 1 min, 55°C for 45 s and 72°C for 
1.5 mins followed by 72°C for 20 mins. Amplicons were purified using the AMPure XP PCR 
Purification system (Beckman Coulter, UK) (described in Section 2.11). Amplicons were eluted into 
20 µl nuclease free water. 
The second PCR step amplified the V2-V3 region of the 16S rRNA gene using the barcoded primers 
1)¶-GGCGVACGGGTGAGTAA-¶DQG5¶-GTNTTACNGCGGCKGCTG-¶7KHVH
were Integrated DNA Technologies primers with Trugrade processing and Truseq (i5 and i7) and 
Nextera (i5) index barcodes. The PCR conditions were: 98°C for 30 s followed by 20 cycles of 98°C 
for 10 s, 67°C for 30 s and 72°C for 10 s followed by 72°C for 2 mins. The resulting amplicons were 
purified using the AMPure XP system and amplicons were eluted into either 30 µl nuclease free water 
or 0.1% Tween20 in Qiagen Elution Buffer. Amplicons were viewed on a 1.2% agarose gel (made in 
house using TAE buffer and agarose (Sigma, UK)) using SYBR Safe DNA Gel Stain (Thermo Fisher 
Scientific, UK) and a UV illuminator. Labels were affixed to gel images using ImageJ 
(http://imagej.net/).  
 
2.11 Ampure purification 
To purify amplicons from PCR mixtures I used the AMPure XP PCR Purification system. This 
method allows the purification of DNA of above a user specified length by the reversible binding of 
the DNA to beads coated in carboxyl molecules. This method of purification is recommended by 
Edinburgh Genomics (https://genomics.ed.ac.uk/resources/sample-requirements). 
The PCR mixture was mixed with the Ampure reagent by pipetting 10 times. At first I used a 1.8:1 
ratio of beads to sample fluid, as recommended by the manufacturer, but at a later stage in my PhD 
(for results found in Chapter 5) this was changed to a 1:1 ratio which was found to be equally efficient 
at purifying the amplicons. This mixture was then incubated for 5 mins at room temperature then 
placed on a magnet for 2 mins to pellet the beads. The liquid was aspirated and the beads were washed 
three times with 200 µl 70% ethanol (30 s incubation followed by aspiration for every wash). After 
the final aspiration, beads were allowed to air dry for 5 mins. The samples were then removed from 
the magnet and 30 µl of eluent was mixed with the beads, followed by 5 mins of incubation at room 
temperature. The samples were then placed onto the magnet for 1 min and the eluent containing the 




2.12 Sequencing strategy 
2.12.1 Library preparation 
It is necessary to ensure that equimolar quantities of each sample are added to the sequencing library. 
Samples were pooled into sequencing libraries by either Edinburgh Genomics or by myself using the 
protocol described below.  
The concentration of DNA in PCR amplicons was calculated using a Qubit 3.0 Fluorometer (Life 
Technologies) and the Qubit dsDNA HS Assay Kit (Life Technologies) according to the 
PDQXIDFWXUHU¶VLQVWUXFWLRQV$ZRUNLQJVROXWLRQZDVFUHDWHGE\GLOXWLQJWKH4XELWGV'1$+6
Reagent 1:200 in Qubit dsDNA HS Buffer. 190 µl of the working solution was mixed with 10 µl of 
the two Qubit Standards and 198 µl of the working solution was mixed with 2 µl of each sample. All 
samples and standards were allowed to incubate at room temperature for >2 mins to 1 hour. On the 
Qubit 3.0 fluorometer, the dsDNA High Sensitivity assay was selected and the standards were read 
prior to every batch of sample readings. The concentration of each sample was outputted as ng/µl and 
this was used to calculate the nM concentration. 
Equimolar amounts of samples were pooled, except where the amount of sample to be added to the 
library would have been greater than 10 µl in which case 10 µl of sample was added to the pool. All 
DNA pools contained >5 nM of DNA. Pooled libraries were quality tested using High Sensitivity 
D1K ScreenTape (Agilent Technolgies) by Edinburgh Genomics (Fig. 2.3). 
 
Figure 2.3: Comparison of pooled sequencing libraries. DNA from sequencing 
libraries was visualised by Edinburgh Genomics using an Agilent Bioanalyser 2100 
DNA 1000, High Sensitivity chip. In A) samples were pooled into a library by 
Edinburgh Genomics and in B) samples were pooled by me. Both libraries show a 
clear peak at around 550bp which was the expected fragment size. The pool in A) 





Various sequencing platforms are available which can be used for 16S rRNA gene sequencing 
including the MiSeq/HiSeq (Illumina), Pacific Biosciences, Ion Torrent (Thermo Fisher Scientific), 
and 454 (Roche) platforms. Of these, the Illumina MiSeq has been shown to produce more accurate 
data (138, 182). The MiSeq was therefore selected as the optimal sequencer. However, due to a 
problem with a version of the Illumina chemistry which resulted in low quality reads for 16S rRNA 
gene sequences, some of my samples were sequenced using the Illumina HiSeq (some samples from 
Chapters 3 and 4). The HiSeq uses similar chemistry to the MiSeq but produces a higher number of 
reads and a lower error rate (183). Libraries were sequenced by Edinburgh Genomics using either the 
Illumina MiSeq or HiSeq2500 (Rapid mode) producing paired 250-nucleotide reads.  
 
2.13 Quality control and processing of sequences 
2.13.1 Primer removal 
Primers were removed from fastq files using cutadapt (184) which has been shown to provide a good 
balance between sensitivity (ratio of properly trimmed reads to improperly trimmed reads) and 
specificity (ratio of correctly untrimmed reads to reads which were trimmed but should not have been) 
(185)¶DGDSters were removed along with any sequences proceeding them. A maximum sequence 
error rate of 10% was allowed for primers which included errors due to mismatches, deletions and 
insertions. All sequences with higher error rates were discarded. 
 
2.13.2 Quality control and OTU clustering 
The mothur program (186) was used for quality control of sequences, alignment of sequences to a 
reference database, taxonomic assignment and OTU clustering, following a modified version of the 
MiSeq pipeline designed by the mothur creators (187). The mothur program has been shown to 
demonstrate similar or better results to other commonly used 16S rRNA gene bioinformatic pipelines 
such as QIIME and MG-RAST (188, 189). 
Sequences were constructed from aligned forward and reverse reads. Where there was disagreement 
between the overlapping portions of the forward and reverse reads, if one base had a quality score 6 
points greater than the corresponding base on the opposite read it was used in the final sequence. 
Where there was not a 6 point difference between the base quality scores the base was assigned an N. 
If there was a gap at the same position as a base then the base was only considered to be genuine if it 
KDGDTXDOLW\VFRUHRI25 points. Any reads which did not have matching forward or reverse reads 
were discarded.  
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Sequences with ambiguous base calls, which were less than 369 bases in length or contained 
homopolymers of greater than 9 base pairs were discarded. Sequences were aligned against the 
SILVA database (190) as this has demonstrated better alignment quality than Greengenes, MUSCLE 
and RDP alignments and thereby creates less artificial sequence variation (180). Sequences which did 
not align with the V2-V3 region of the 16S rRNA gene were discarded. Chimeras were identified and 
removed using Uchime (191) within mothur. 
6HTXHQFHVZHUHFODVVLILHGXVLQJPRWKXU¶V%D\HVLDn classifier and the Greengenes database (192) 
trimmed to the V2-V3 region of the 16S rRNA gene to improve classification depth (193). The 
Greengenes database was selected for sequence classification as it has been demonstrated to be able to 
identify a greater proportion of sequences than SILVA or RDP training sets (137, 193). However, the 
Greengenes database has not been updated since 2013 and this should be taken into account when 
interpreting my results (194). Sequences which did not originate from bacteria were discarded. OTUs 
were clustered by phylotype using a database dependent approach and were then sub-sampled prior to 
statistical analysis. Samples were subsampled to the lowest number of reads found in any of the 
samples within the study, prior to statistical analysis. The sequencing error rate was calculated by 
comparing a sequenced mock community control to a reference file containing the correct mock 
community sequences.  
 
2.14 16S rRNA qPCR 
Triplicate reactions of 20 µl were carried out in a LightCycler 480 (Roche), targeting the V3 region of 
the 16S rRNA gene. This protocol was designed by Ms Tina Baker. Primers were included at a final 
concentration of 0.4 µM. The reaction mixture consisted of 1 µl of extracted DNA solution, 0.2 µl of 
SULPHU8QL)¶±ACTCCTACGGGAGGCAGCAGT±¶ORISULPHU8QL5¶±
ATTACCGCGGCTGCTGGC±¶O/LJKW&\FOHU® 480 SYBR Green I Master mix (Roche) and 
8.6 µl water. After the addition of the reaction mixtures, qPCR plates were sealed and centrifuged at 
15,000g for 2 mins (Megafuge 1.0, Heraeus, Germany). The PCR parameters used are described in 
Table 2.2. While a melting curve program was ran, this is of limited use due to the heterogeneous 






Table 2.2: qPCR protocol for the V3 region of the 16S rRNA gene  
Program Cycles Target (°C) Hold (mins:s) Ramp rate (°C/s) 
Pre-incubation  1 50 02:00 4.80 
  95 10:00 4.80 
Amplification  45 95 00:30 4.80 
  63 00:30 2.50 
Melting curve  1 95 00:05 4.80 
  65 01:00 2.50 
  97 Continuous 
(Acquisitions per 
1°C = 5) 
0.11 
 
A standard curve was constructed from amplicons generated by DNA extracted from a P.aeruginosa 
culture which had undergone the first round of PCR as described in Section 2.10, except that 30 cycles 
were performed rather than 20. These amplicons were purified using the Ampure system and their 
DNA concentration was measured using a Qubit 3.0 Fluorometer. A standard curve was constructed 
as shown in Fig. 2.4.  
 
Figure 2.4: Example of a standard curve for 16S rRNA gene qPCR. Constructed using 
777 bp 16S rRNA gene amplicons generated by PCR from DNA extracted from a 




2.15 Statistical and graphical analysis 
Statistical tests were carried out within either mothur, R (R version 3.2.5), Minitab (Minitab 16 
Statistical Software) or SPSS (IBM, SPSS Statistics 21). Graphs were constructed in either SPSS, 
Excel (Microsoft, Excel 2013), Minitab or R. GIMP 2.8 (www.gimp.org) was used to improve the 
image quality of graphs. 
 
2.15.1 OTUs: Alpha-diversity 
All tests were carried out within mothur. 
*RRG¶VFRYHUDJH 
7KH*RRG¶VFRYHUDJHLQGLFDWRULQGLFDWHVZKDWproportion of the total species present in a community 
is represented in a sample (195). A value of 1.0 would indicate that all of the species in the 
community were represented. I chose this as a means of estimating sequencing depth adequacy rather 
than rarefaction curves as it is a more easily interpretable measure of sequencing depth adequacy eg, if 
WKH*RRG¶VFRYHUDJHHVWLPDWRUYDOXHLVWKLVZRXOGPHDQWKDWRIWKHEDFWHULDLQWKHRULJLQDO
sample had been identified via sequencing.  
Inverse Simpson diversity estimate 
The Simpson diversity estimate estimates the likelihood that two sequences selected randomly from 
the same sample will belong to the same OTU. The inverse of this value can be used so that an 
increase in its value reflects an increase in diversity (196). I decided to use this measure of diversity as 
it is more weighted towards dominant OTUs. This means that any low abundance OTUs caused by 
sequencing errors which have not been removed during quality control will not greatly affect the 
observed diversity. 
Chao1 richness estimator 
The inverse Simpson diversity estimator is largely unaffected by low abundance OTUs and while this 
reduces the potential for sequence errors to influence results, it is possible that low abundance OTUs 
could also be biologically relevant but would not be taken into account using this estimator. 
Therefore, I decided to also calculate the Chao1 richness estimator which is calculated using the 





2.15.2 OTUs: Beta-diversity 
All tests were carried out within mothur.  
Distance matrix creation 
Lower-triangle distance matrices describing the similarity of samples by their bacterial compositions 
were created in order to perform AMOVAs (analysis of molecular variance) and to construct PCOA 
(principle coordinate analysis) graphs. Distance matrices were created using Yue and Clayton theta 
values (198) which take into account both the number and abundance of OTUs.  
AMOVA (analysis of molecular variance) 
AMOVA is a non-parametric analogue of the analysis of variance which analyses whether two groups 
of samples cluster significantly separately from each other using a distance matrix (199). This test was 
chosen as when comparing two groups of samples which have the same amount of diversity but 
different centroids, AMOVA is better at identifying the significantly separate clustering of these 
groups in comparison to other commonly used tests such as weighted and unweighted UniFrac (200).  
Clustering of samples into metacommunities 
It is possible to identify whether samples cluster into separate microbial community types without 
supplying any meta-information. This can be useful when attempting to identify clustering of samples 
by an unknown variable. The get.communitytype command in mothur clusters samples into 
metacommunities by their microbial communities using Dirichlet multinomial mixtures (201). This 
technique models the data using increasing numbers of metacommunities and the model which is 
found to have the lowest Laplace approximation value is assumed to best fit the data. This test is used 
in Chapter 4 of this thesis. 
Identifying significantly different OTUs between groups 
The Metastats package within mothur (202) was used to identify OTUs which were significantly 
different between groups. This is a non-parametric version of the T-test which controls for multiple 
statistical tests by employing a false discovery rate. For example, with a P-value = 0.05 you would 
expect 5 false positives if testing 100 OTUs. Metatstats assumes that the P-values of actually null tests 
are normally distributed and uses this assumption to test for true positives (q-value <0.05 is truly 
positive). The indicator command within mothur can also be used to test for OTUs which are more 





2.15.3 Parametric and non-parametric statistics 
When comparing the richness and diversity estimate values of groups there are various tests which can 
be used depending upon whether the data is parametric or non-parametric and whether the samples are 
independent or related. Prior to statistical analysis, data were tested for normality both by the 
construction of histograms and by performing the Shapiro-Wilk test (SPSS) or the Anderson-Darling 
test (Minitab). For parametric data, I used the standard T-test for independent groups and the paired T-
test for related groups. For non-parametric data, I used the Mann-Whitney U or Kruskal-Wallis tests 
IRULQGHSHQGHQWJURXSVDQGWKH:LOFR[RQ6LJQHG5DQNWHVWRU)ULHGPDQ¶VWHVWIRUUHODWHGJURXSV
Tests were carried out within either Minitab or SPSS.  
 
2.15.4 Graphs 
The relationships between samples based upon the bacterial OTUs they contain are often highly 
complex and are usually best modelled in dimensions of over three. As such, it is usually impossible 
to completely accurately represent the relationships between samples visually. PCOA graphs attempt 
to reduce this complexity as much as possible into 2 or 3 dimension. Each dimension is then assigned 
a value depicting the percentage of variability it depicts which can be used to calculate how much of 
the total variability is represented on the graph. PCOA axis coordinates and axis variability percentage 
values were calculated in mothur and graphs were constructed within Excel or SPSS. Ellipses were 
added using Inkscape (www.inkscape.org). To identify which OTUs are responsible for moving 
sample points along the PCOA axes in a specific direction I ran the corr.axes command in mothur 
which uses the Spearman's rank correlation coefficient to correlate OTUs to axes.  
Another way of visualising sample clustering by OTU composition is by the use of heatmaps. 
Heatmaps were constructed in R Version 3.2.2 (204) using the gplots (205), heatplus (206), 
RColorBrewer (207) and Vegan (208) packages. Clustering by OTU composition within heatmaps 
was performed using the Bray-Curtis dissimilarity (209). Other simple graphs such as box-plots and 
pie-charts were constructed in either Minitab, SPSS or Excel.  
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3.1 Introduction and aims 
While the use of protected specimen brushings reduces the chance that samples will be contaminated 
by upper respiratory tract bacteria in comparison to those collected by bronchoalveolar lavage, only a 
small area of the lung epithelium is able to be sampled using this method. If there is a large amount of 
variation in the types of microbes found across the lung then it may be difficult to acquire a truly 
representative set of samples without the number of brushings becoming prohibitively large.  
This paper seeks to address the extent of inter- and intra-individual variation present in the sheep lung 
microbiota. In this study, all work was performed by myself except as further specified: anaesthesia 
was induced and monitored by Steven Wright, David Collie and Peter Tennant. Bronchoscopic 
procedures were carried out by Peter Tennant. DNA libraries were sequenced by Edinburgh 
Genomics. Manuscript authors had input on the paper design and wording. Sheep showed no 
clinically overt signs of respiratory illness during this study. A mock community which had been 
diluted 1:100 was included in this study so that the effect of a low PCR template concentration on 
PCR bias could be assessed.  
 
3.2 Research paper 
7KLVUHVHDUFKZDVSXEOLVKHGDVµ9DULDELOLW\RIWKH6KHHS/XQJ0LFURELRWD¶ in Applied and 
Environmental Microbiology (1). For papers published in American Society of Microbiology journals, 
the American Society of Microbiology does not require authors to obtain permission to include these 
papers in their thesis, provided the original work is properly cited. Supplemental figures and tables 
can be found in Appendix 2.  Data Set S1 can be found as Additional file 3_1.xlsx. Data Set S2 can 
be found as Additional file 3_2.xlsx.
 
  
Variability of the Sheep Lung Microbiota
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The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, Midlothian, United Kingdoma; Monogastric Science Research
Centre, Scotland’s Rural College (SRUC), Edinburgh, Midlothian, United Kingdomb
ABSTRACT
Sequencing technologies have recently facilitated the characterization of bacterial communities present in lungs during health
and disease. However, there is currently a dearth of information concerning the variability of such data in health both between
and within subjects. This study seeks to examine such variability using healthy adult sheep as our model system. Protected speci-
men brush samples were collected from three spatially disparate segmental bronchi of six adult sheep (age, 20 months) on three
occasions (day 0, 1 month, and 3 months). To further explore the spatial variability of the microbiotas, more-extensive brushing
samples (n  16) and a throat swab were taken from a separate sheep. The V2 and V3 hypervariable regions of the bacterial 16S
rRNA genes were amplified and sequenced via Illumina MiSeq. DNA sequences were analyzed using the mothur software pack-
age. Quantitative PCR was performed to quantify total bacterial DNA. Some sheep lungs contained dramatically different bacte-
rial communities at different sampling sites, whereas in others, airway microbiotas appeared similar across the lung. In our spa-
tial variability study, we observed clustering related to the depth within the lung from which samples were taken. Lung depth
refers to increasing distance from the glottis, progressing in a caudal direction. We conclude that both host influence and local
factors have impacts on the composition of the sheep lung microbiota.
IMPORTANCE
Until recently, it was assumed that the lungs were a sterile environment which was colonized by microbes only during disease.
However, recent studies using sequencing technologies have found that there is a small population of bacteria which exists in the
lung during health, referred to as the “lung microbiota.” In this study, we characterize the variability of the lung microbiotas of
healthy sheep. Sheep not only are economically important animals but also are often used as large animal models of human re-
spiratory disease. We conclude that, while host influence does play a role in dictating the types of microbes which colonize the
airways, it is clear that local factors also play an important role in this regard. Understanding the nature and influence of these
factors will be key to understanding the variability in, and functional relevance of, the lung microbiota.
Within the past 5 years, a diverse array of bacteria has beendetected in healthy lungs through the use of non-culture-
based methods (1, 2). These bacterial communities are commonly
referred to as the lung microbiota and are thought to originate
predominantly from the upper respiratory tract (3, 4). The pres-
ence of particular bacterial communities in the lung has been as-
sociated with several human diseases, including cystic fibrosis (5),
chronic obstructive pulmonary disease (6), bronchiectasis (7),
and lung transplant rejection (8).
While variation in the microbial communities present in the
human lung exists at both large and small scales, based upon the
location of the bacteria within the lungs (9) and the host cell types
present (10), intraindividual variation has been found to be sig-
nificantly less than interindividual variation, indicating that each
individual may play host to a specific lung microbiota (9).
The lung microbiota of healthy domestic sheep has previously
been investigated using culture-based methods (11–14), but these
studies have shown conflicting descriptions of the extent of lung
colonization by bacteria. A study of pneumonic Bighorn sheep
lungs found that, for most sheep studied, bacterial 16S rRNA gene
amplification and sequencing was able to identify additional bac-
terial species which were not found by culturing (15). Previous
studies have also examined the upper respiratory tracts of healthy
sheep by culture-based methods (11, 12, 14, 16). These studies are
highly varied in the types and proportions of microbes identified.
Previously, our group studied the composition of the lung mi-
crobiota in sheep pre- and postinfection with Pseudomonas
aeruginosa (17). That study included the first description of the
lung microbiota communities of healthy domestic sheep by next-
generation sequencing. A diverse community of microbes was
identified, and variability was seen to be high, both within and
between animals. The variability of the healthy lung microbiotas
at specific lung sites over time has not been reported for any ani-
mal, although serial sampling of nondiseased humans is planned
as part of the Lung HIV Microbiome Project (LHMP) (18).
In the present study, protected specimen brush samples were
collected from three spatially disparate segmental bronchi at three
time points (baseline, 1 month, and 3 months) to examine the
compositions and variability of the lung microbiotas in healthy
domestic sheep. In addition, samples were also taken from a sep-
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arate sheep from a greater number of respiratory tract locations to
further explore the extent of spatial variability.
Such studies are fundamental to understanding the functional
relevance of lung microbiota in health and disease in ruminants.
Indeed, bacterial pneumonia is well recognized in cattle and sheep
and is often associated with high morbidity and mortality. Nota-
bly, regional predilection is evident in that infection by Pasteurella
occurs most frequently in the apical and cardiac lobes in both
sheep (12, 19) and cattle (20, 21). Coinfections with other respi-
ratory pathogens are commonplace; it is already well known that
infection by Bordetella parapertussis and Mycoplasma ovipneu-
moniae can lead to more-severe disease caused by Mannheimia
(Pasteurella) haemolytica (22–25), and there are well-recognized
links to stressful events, such as housing or transport. As it is
conceivable that changes in the lung microbiota may precipitate
or associate with such events, it is vital to ground future disease-
related studies on a firm basis of understanding normal variation
in health. While the immediate focus of such studies relates to
animal health, it is also important to acknowledge that sheep are
frequently used as models for human respiratory research (26, 27)
and that there is an ongoing need to highlight any comparative
contrasts and consistencies as and when they arise.
MATERIALS AND METHODS
Animals and airway sampling. Six 20-month-old Suffolk cross sheep
were used in this study (Table 1) (5 females, 1 castrated male) and were
housed indoors in pens for the trial duration. No animals had undergone
bronchoscopic examination during the 4 months preceding the study.
Animal procedures were subject to the Animals (Scientific Procedures)
Act of 1986 and were approved by the Roslin Institute Animal Welfare and
Ethics Committee.
Anesthesia was performed as described previously (28). Sheep were
sampled by protected specimen brushings (disposable microbiology
brush; ConMed, New York, NY, USA) at 0 days (baseline), 1 month, and
3 months. Sampling sites are shown in Fig. 1. Bronchoscopy was per-
formed via an endotracheal tube by the same operator for all sheep at all
time points. The sample harvest dates can be found in Table S1 in the
supplemental material. Before sampling of every sheep on any given day,
7.5 ml of phosphate-buffered saline (PBS) was passed through the bron-
choscope channel to act as an environmental quantitative PCR (qPCR)
control. Bronchoscope washings were centrifuged at 13,000  g for 15
min, and the pellet was resuspended in 500 l of PBS.
A throat swab and brushing samples (harvested as described above)
were also taken from another sheep (female; age, 36 months; 60-kg body
weight) at a single time point to further explore the spatial variability of
the lung microbiotas (sampling date 1 May 2015). Brushing sites were
dorsal and ventral trachea and paired sites from either side of airway
bifurcations progressing along the anterior-to-caudal lung axis (Fig. 2).
DNA extraction, amplification, and sequencing. DNA extraction was
performed using the Mo Bio (Carlsbad, CA, USA) PowerSoil DNA isola-
tion kit. Brushes were transferred into PowerSoil bead tubes with Power-
Soil solution C1 and PowerSoil bead solution. Bead tubes were heated at
65°C for 10 min and then placed in a FastPrep FP120 cell disrupter (Qbio-
gene, Inc., France) for 45 s at 5.0 m/s. From this point onward, the man-
ufacturer’s instructions were followed, except for the final elution step.
Purified DNA was eluted into 50 l rather than 100 l of PowerSoil
solution C6 to increase the DNA concentration.
All PCR steps used Q5 high-fidelity 2 master mix (New England
BioLabs, Beverly, MA, USA). A nested PCR was performed with Illumina
adaptor sequences and barcodes (see Table S2 in the supplemental mate-
rial) included only on the primers for the second round in an attempt to
reduce bias caused by barcoded primers when amplifying low-biomass
samples (29). The conditions for the first round of PCR, amplifying the
V1-to-V4 16S hypervariable regions (primers 28F [5=-GAGTTTGATCN
TGGCTCAG-3=] and 805R [5=-GACTACCAGGGTATCTAATC-3=]),
were as follows: 94°C for 2 min, followed by 20 cycles of 94°C for 1 min,
55°C for 45 s, and 72°C for 1.5 min, followed by 72°C for 20 min. The
conditions for the second round of PCR, amplifying the V2-to-V3 16S
hypervariable regions (primers 104F [5=-GGCGVACGGGTGAGTAA-3=]
and 519R [5=-GTNTTACNGCGGCKGCTG-3=]), were as follows: 98°C
for 30 s, followed by 20 cycles of 98°C for 10 s, 67°C for 30 s, and 72°C for
10 s, followed by 72°C for 2 min. Amplicons from both rounds of PCR
were purified using the AMPure XP PCR purification system (Beckman
Coulter, La Brea, CA, USA). Amplicons were sequenced using an Illumina
MiSeq or HiSeq (Illumina, San Diego, CA) run producing paired-end
250-nucleotide reads (30). Those samples sequenced by two MiSeq runs
are listed in Data Set S1 in the supplemental material, and those sequenced
by HiSeq are listed in Data Set S2. When samples from the MiSeq runs
were found to have low read numbers, they were sequenced again on a
separate MiSeq run (samples 2D618 RA [right apical] at 3 months and
2D619 RA at 3 months). We previously confirmed cross-run stability by
comparing separate runs made on the same samples (Fig. S1).
FIG 1 Diagram of a sheep lung, divided into anatomical segments. Boxes
indicate the segments where protected specimen brushings were performed in
the lungs of six sheep at three time points; these correspond to the right apical
(RA), right caudal diaphragmatic (RCD), and left caudal diaphragmatic
(LCD) segments.






2D618 Female 51  3.1 39.0  0.06
2S066 Male (castrated) 69  2.6 39.6  0.20
2D619 Female 59  1.7 39.3  0.20
2D620 Female 64  4.6 39.1  0.21
2D644 Female 65  1.0 39.3  0.06
2D645 Female 70  2.0 39.4  0.06
Glendinning et al.
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Extraction kit controls were produced by carrying out a reagent-only
extraction using the Mo Bio PowerSoil DNA isolation kit. PCR reagent
controls were constructed by adding 20 l of nuclease-free water to the
PCR mixture. The Human Microbiome Project Mock Community HM-
782D (100,000 copies per organism per l; BEI Resources, ATCC, Manas-
sas, VA, USA), extraction kit controls, and PCR reagent-only controls and
positive controls (DNA extracted from Pseudomonas aeruginosa strain
PA0579) were amplified and sequenced by the same methods as were used
for samples.
A separate mock community sample was sequenced using an Illumina
HiSeq. For this sample, the solution produced from the first round of PCR
was diluted 1:100 in nuclease-free water before being used in the second
round of PCR. This was carried out to ascertain the effect on PCR bias of
placing different concentrations of DNA into the second PCR round.
Bioinformatic and statistical analysis. Primers were removed using
Cutadapt (31). Sequences which contained more than one base error per
10 primer bases were removed from further analysis. The following steps
were carried out in mothur (32) and were based upon a protocol devel-
oped for MiSeq by the mothur creators (30). Forward and reverse reads
were aligned to form one continuous DNA sequence; any sequences
which failed to align were discarded. Sequences which contained ambig-
uous bases, were less than 369 bp in length, or contained homopolymers
of greater than 9 bp were also discarded. Chimeras were identified and
removed using UCHIME (33). Sequences were aligned to the SILVA ref-
erence alignment (34) and were classified using mothur’s Bayesian classi-
fier against the Greengenes database (35), which was trimmed to the
V2-V3 hypervariable region of the 16S rRNA gene to improve classifica-
tion depth (36). Sequences identified as not originating from bacteria
were removed from further analysis. Operational taxonomic units
(OTUs) were clustered into phylotypes using a database-dependent ap-
proach and then subsampled.
Distance matrices were created using Yue and Clayton theta values
(37). Analysis of molecular variance (AMOVA) (38) was used to deter-
mine significant differences between the bacterial compositions of
groups. Principal-coordinate analysis (PCoA) graphs were constructed to
visualize similarities between samples. The inverse Simpson index was
used to quantify diversity. Where data were nonparametric, the Friedman
test was used to identify significant differences in diversity, using Minitab
16 for Windows (Minitab, Coventry, United Kingdom). All other statis-
tical tests were carried out within mothur. Metastats (39) was used to
identify OTUs which were different between groups. Good’s coverage
(40) was used to estimate sample coverage, and the Chao 1 index was used
to calculate richness. Indicator OTUs (OTUs which are indicative of a
particular group of samples) were identified using the indicator metric
within mothur (41). Repeated-measures analyses of variance (ANOVAs)
were carried out using the Vegan package in R (42–44).
qPCR. qPCRs were performed using the LightCycler 480 SYBR green
I master mix (Roche Applied Science, Indianapolis, IN, USA), 1 l of
extracted DNA solution, and the 16S rRNA gene qPCR primers UniF340
(5=-ACTCCTACGGGAGGCAGCAGT-3=) and UniR514 (5=-ATTACCG
CGGCTGCTGGC-3=) at a final concentration of 0.4 M.
The qPCR run consisted of a preincubation step of 50°C (ramp rate,
4.80°C/s for 2 min) and then 95°C (ramp rate, 4.80°C/s for 10 s) and an
amplification step consisting of 45 cycles of 95°C (ramp rate, 4.80°C/s for
FIG 2 Locations of brushings within sheep lungs. Protected specimen brushings were performed in the sections of the lung labeled A1 to A9 and A13 to A19 in
one sheep at one time point.
Sheep Lung Microbiota
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30 s) and then 63°C (ramp rate, 2.50°C/s for 30 s). This was followed by a
melting cycle consisting of 95°C (ramp rate, 4.80°C/s for 5 s) and then
65°C (ramp rate, 4.80°C/s for 1 min), followed by 97°C (ramp rate,
0.11°C/s; acquisition mode, continuous).
Negative controls consisted of both water and extraction kit reagent
controls. For water controls, 1 l of nuclease-free water was added to the
qPCR mixture. For extraction kit controls, DNA extractions were carried
out using the Mo Bio PowerSoil DNA isolation kit (Carlsbad, CA, USA)
by following the same protocol as was used to extract DNA from samples,
except that no sample was added, meaning that any bacterial DNA in the
final elution must have been derived from the extraction kit reagents.
Then, 1 l of this elution was added to the qPCR mixture.
In order for us to compare the quantities of bacterial DNA found in
bronchoscope wash and brushing samples, it was necessary to use a unit of
measurement which could be applied to both sample types. Bacterial
DNA concentrations are therefore reported as the 16S copy numbers pres-
ent per microliter of eluent produced from samples by the Mo Bio Power-
Soil DNA isolation kit. Statistical analysis was carried out in Minitab 16
for Windows. When data were nonparametric, the Mann-Whitney U test
was used to statistically compare groups.
Nucleotide sequence accession numbers. The unassembled reads,
with primers removed, are publicly available through the NCBI Sequence
Read Archive (SRA) under the BioProject accession no. PRJNA298882.
RESULTS
Quality control and adequacy of sequencing. After DNA se-
quences were constructed from the forward and reverse reads gen-
erated by sequencing, various quality control steps were per-
formed to decrease the number of artifacts and poor-quality
sequences used in subsequent analyses.
For the MiSeq runs, these steps resulted in a 15% loss of se-
quences (sequencing error rate  0.39%). On average, samples
contained 205,625  27,232 (mean  standard error of the mean
[SEM]) sequences and a total of 925 bacterial OTUs were identi-
fied (see Data Set S1 in the supplemental material). Sequences
were assigned to OTUs based on their taxonomic classifications.
Each OTU does not necessarily represent an individual bacterial
species but instead represents the lowest taxonomic level to which
its bacterial sequences could be assigned. For example, 77.4% of
reads could be identified to the genus level, while 31.1% could be
assigned to the species level. If two species from the same genus
could be assigned only to the genus level, then both were binned
into the same OTU.
For the HiSeq run, samples contained on average 233,505 
69,735 (mean  SEM) sequences, and the sequencing error rate
was 0.39%. Six hundred thirty-three OTUs were identified (see
Data Set S2 in the supplemental material), and the total reduction
in sequence numbers due to quality control was 5%.
Good’s coverage estimate values exceeded 97% for all samples.
This indicates that at least 97% of the bacteria present in our
original samples were likely to have been identified, demonstrat-
ing that the depth of sequencing was adequate.
Of the 20 bacteria contained in the mock community, all could
be taxonomically identified down to genus level, except that Ba-
cillus cereus, Escherichia coli, and Listeria monocytogenes could be
identified only to the family level. This indicates that the primers
were able to amplify a wide diversity of bacteria. While the pro-
portions of bacterial DNA were different from the proportions
anticipated if no PCR bias was present (Table 2), this was less
apparent in the sample which had been diluted 1:100 after the first
round of PCR. In the undiluted mock community, the propor-
tions of bacterial orders differed from the expected proportions by
an average of 9.48% (SEM, 2.24%; range, 0.99% to 19.48%),
whereas the orders in the diluted mock community differed on
average by 4.33% (SEM, 1.12%; range, 0.29% to 12.71%). This
diluted mock community may be more comparable to the kind of
biases we found in our samples, as the undiluted mock commu-
nity contained a far higher concentration of template DNA
(2,000,000 16S copies per l) than our samples did on average
(13,133 16S copies per l).
We assumed that PCR bias could reasonably be expected to
apply equally across all samples and, therefore, that any statistical
tests between samples should still be valid. The two bacterial spe-
cies most overrepresented in the undiluted mock community
(Deinococcus radiodurans and Helicobacter pylori) are not com-
monly associated with the respiratory tract, and bacteria from
these genera were very rare within our data set.
Longitudinal study in 6 sheep over 3 months. To examine the
spatial, longitudinal, and interindividual variations of the sheep
lung microbiota, lung brushing samples were taken from 3 spa-
tially disparate lung locations (right apical [RA], right caudal dia-
phragmatic [RCD], and left caudal diaphragmatic [LCD]) in 6
sheep at 3 time points (baseline, 1 month, and 3 months). Esti-
mates of total bacterial yield from qPCR analysis indicated that
sheep lung brushing samples contained an average of 13,133 
894 (mean  SEM) 16S copy numbers/l (range, 1,032 to 37,627
16S copy numbers/l). Bronchoscope wash control samples con-
tained significantly lower bacterial 16S rRNA gene concentrations
than lung brushing samples (Mann-Whitney U test, P  0.0001),
containing an average of 1,471  279 (mean  SEM) 16S copy
numbers/l (range, 397 to 4,792 16S copy numbers/l) (Fig. 3).
The qPCR-negative water controls were found to contain 190,
479, and 739 16S copy numbers/l, and the extraction kit controls
were found to contain 347 and 511 16S copy numbers/l.
After sequencing and subsampling, bacterial communities iso-
lated from the extraction kit and 16S PCR-negative controls were
found to cluster separately from those found in sheep lung brush-
ing samples (AMOVA, P  0.001). Extraction kit controls were
included from two different lots. The most abundant OTUs found
in the first extraction kit control were Corynebacterium (36%),
Enterobacteriaceae (13%), Mycobacterium llatzerense (7%), and
Staphylococcus haemolyticus (5%). The most predominant OTUs
in the second extraction kit control were Aerococcus (13%), Derm-
abacteraceae (11%), Micrococcus (10%), Enhydrobacter (9%), and
Leuconostoc (7.2%). The predominant bacterial order present in
both extraction kit controls was Actinomycetales (50.1% and
40.5%, respectively).
The bacteria isolated from lung brushing samples predomi-
nantly belonged to the orders Bacillales (26%), Actinomycetales
(21%), Clostridiales (11%) and Lactobacillales (9%), while com-
mon genera included Staphylococcus (16%), Corynebacterium
(9%), Jeotgalicoccus (5%), and Streptococcus (5%).
The underlying changes in bacterial OTUs between sampling
points were examined. The bacterial communities found in lung
brushing samples clustered significantly by time point (AMOVA,
P  0.001) (Fig. 4). The OTUs causing this clustering were iden-
tified by applying Metastats (see Tables S3 and S4 in the supple-
mental material). The largest difference observed between the first
and second time points was an 11% increase in the abundance of
an OTU identified as Corynebacterium. This is also the most abun-
dant OTU in one of our extraction kit controls. OTU 12, Myco-
bacterium llatzerense, was also significantly more abundant at the
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1-month time point and was the third-most-abundant OTU in
the same extraction kit control. It therefore is likely that our time
points were affected to different degrees by reagent contamination
and that the analysis of segments over time is not possible. How-
ever, all samples taken in the same sheep at the same time point
were processed using the same extraction kit; therefore, an analy-
sis of spatial variability could be performed.
Visual perceptions of community structure indicated that, in
some sheep, samples taken from separate lung sites differed ap-
preciably, whereas in other sheep, there appeared relative concor-
dance between such samples (see the example shown in Fig. 5). A
full visual summary of the results can be found in Fig. S2 in the
supplemental material. There were no significant differences be-
tween the levels of diversity of communities located at different
lung sites (inverse Simpson index, Friedman test, P  0.5).
Sheep clustered separately by the compositions of their lung
bacterial communities at the baseline time point (AMOVA, P 
0.001) and at the 3-month time point (AMOVA, P  0.045), in-
dicating that samples taken from within the same sheep were more
similar to one another than to samples taken from other sheep. At
the 1-month time point, sheep did not cluster in this manner
(AMOVA, P  0.394), though this is likely due to the presence of
contamination causing a homogenization of our 1-month sam-
ples. Pairwise comparisons of samples showed no significant re-
sults. The similarity of samples to one another can be visualized
using PCoA graphs (Fig. 6).
Spatial variability of the lung microbiota in an individual
sheep. The observed variability between spatially disparate lung
sites in some sheep prompted enquiry as to the consistency of
bacterial communities sampled from sites in close spatial apposi-
tion.
Further samples were derived by systematically sampling mul-
tiple sites of the lungs of an individual animal at one time point.
While the 3-month experiment did not include a control for every
lot of extraction kit used, emerging literature and opinion within
the field have since indicated the value of using the same extrac-
tion kit for all samples. This strategy, therefore, was adopted for
these latter samples, which were all processed at the same time.
The extraction kit control was mainly composed of one OTU
(OTU 18: 79%), which was also present in our brushing samples
(mean  SEM, 51.1%  3.3%). We felt confident in removing this
OTU from all of our samples prior to analysis, as it could be iden-
tified to the species level (Methylobacterium komagatae) and was
considered highly unlikely to be found within the sheep lung. No
further OTUs were removed before analysis.
Lung brushing samples contained on average 2,116 16S copy
TABLE 2 Proportions of DNA sequence reads belonging to bacterial members of a mock community






Mock community speciesUndiluted 1:100 dilution
Order
Deinococcales 5 24.48 7.65 Deinococcus radiodurans
Campylobacterales 5 22.05 12.65 Helicobacter pylori
Bacteroidales 5 19.59 10.91 Bacteroides vulgatus
Bacillales 20 8.60 22.40 Bacillus cereus, Listeria monocytogenes, Staphylococcus aureus,
Staphylococcus epidermidis
Lactobacillales 25 5.10 12.29 Enterococcus faecalis, Lactobacillus gasseri, Streptococcus agalactiae,
Streptococcus mutans, Streptococcus pneumoniae
Clostridiales 5 4.01 7.86 Clostridium beijerinckii
Rhodobacterales 5 3.92 5.29 Rhodobacter sphaeroides
Pseudomonadales 10 3.42 5.97 Acinetobacter baumannii, Pseudomonas aeruginosa
Enterobacteriales 5 3.33 5.52 Escherichia coli
Neisseriales 5 2.17 3.49 Neisseria meningitidis
Actinomycetales 10 1.27 2.92 Actinomyces odontolyticus, Propionibacterium acnes
Other/unclassified 0 2.03 3.08
Genusa
Deinococcus 5 24.33 7.61 Deinococcus radiodurans
Helicobacter 5 22.04 12.65 Helicobacter pylori
Bacteroides 5 19.59 10.90 Bacteroides vulgatus
Rhodobacter 5 3.91 5.29 Rhodobacter sphaeroides
Clostridium 5 3.73 7.59 Clostridium beijerinckii
Staphylococcus 10 3.04 7.58 Staphylococcus aureus, Staphylococcus epidermidis
Lactobacillus 5 2.77 6.59 Lactobacillus gasseri
Pseudomonas 5 2.33 3.70 Pseudomonas aeruginosa
Neisseria 5 2.15 3.27 Neisseria meningitidis
Enterococcus 5 1.40 2.63 Enterococcus faecalis
Acinetobacter 5 0.97 1.62 Acinetobacter baumannii
Propionibacterium 5 0.76 1.77 Propionibacterium acnes
Actinomyces 5 0.48 1.12 Actinomyces odontolyticus
Streptococcus 15 0.47 1.63 Streptococcus agalactiae, Streptococcus mutans, Streptococcus pneumoniae
Other/unclassified 0 12.03 26.05
a The species Bacillus cereus, Escherichia coli, and Listeria monocytogenes could not be classified to the genus level.
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numbers per l (SEM, 365 copy numbers per microliter), while
the throat swab and extraction kit control contained 42,480 and 43
16S copy numbers per microliter, respectively. The richness and
diversity of the lung samples (Chao, 103.77  7.32; inverse Simp-
son index, 14.24  2.14) were found to be far lower than in the
throat swab (Chao, 257.038; inverse Simpson index, 9.19). Sample
A1, taken from the ventral aspect of the trachea just caudal to
the bifurcation with the right apical lobe segmental bronchus, had
the second-highest richness (Chao, 155.024) and diversity (in-
verse Simpson index, 8.713). However, sample A2, which was
taken at the same level as sample A1 but from the dorsal aspect of
the trachea, had much lower richness (Chao, 76.038) and diversity
(inverse Simpson index, 4.925).
The compositions of the communities taken from the respira-
tory tract showed some variation, even between paired samples
located very close to one another (Fig. 7). Subtracheal samples
paired to their most proximate neighbor did not cluster together
significantly when OTUs were defined at the lowest taxonomic
depth (AMOVA, P  0.30). However, paired samples did cluster
significantly by the bacterial orders which they contained
(AMOVA, P  0.046). Subtracheal samples also clustered signif-
icantly (by order) based upon the depth in the lung from which
samples were taken (AMOVA, P  0.033) (Fig. 8) (lung depth in
this context refers to increasing distance from the glottis, pro-
gressing in a caudal direction). An indicator OTU for the group
which included the samples A4, A5, A14, and A15 was found to be
OTU 4, Pseudomonadales (P  0.042). The most abundant bacte-
rial orders identified from brushings were Clostridiales (25.8%),
FIG 3 qPCR of lung brushing and control specimens. The bronchoscope
channel was flushed with 7.5 ml of PBS, and the wash was collected (wash
control, n  18) prior to protected specimen brushing being performed on the
lungs of sheep (lung brushings, n  54). DNA was extracted from wash control
and lung brushing specimens, and the quantity of bacterial DNA was calcu-
lated using 16S rRNA gene qPCR. Lung brushing specimens were found to
contain significantly higher quantities of bacterial DNA than did wash controls
(Mann-Whitney U test, P  0.0001). Negative controls consisted of either
water (n  3) or extraction kit (n  2) controls. Boxes, interquartile ranges;
diamonds, outliers.
FIG 4 Clustering of time points by lung microbiota composition. A PCoA graph shows the similarities between bacterial communities sampled from three sheep
lung segments in six sheep at three time points. Samples were found to cluster significantly by the time point at which they were taken (AMOVA, P  0.001).
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Pseudomonadales (18.3%), and Actinomycetales (16.0%), while
the throat swab was dominated by Pasteurellales (36.5%) and
Pseudomonadales (15.1%). The extraction kit control was pre-
dominantly composed of Actinomycetales (31.1%) and Pseu-
domonadales (31.0%).
As the Pasteurellales order contains several species which are
known to act as sheep lung pathogens and which display regional
patterns of infection, we felt it would be interesting to investigate
where OTUs belonging to this order were found within the respi-
ratory tract (Table 3). By far, the largest proportion of these OTUs
was found in the throat swab and in one of the tracheal brushing
samples (sample A1).
DISCUSSION
In order to better understand the variability present in the sheep
lung microbiotas, we compared the lung bacterial communities of
six sheep at three different lung sites over a duration of 3 months.
To further explore the extent of spatial variability, we also took 17
samples from the respiratory tract of one sheep.
Previously, the bacteria in healthy domestic sheep lungs had
FIG 5 Bacterial communities found in three separate lung segments within two sheep. Protected specimen brushings were performed on the lungs of sheep at
three different lung segments (RA, RCD, and LCD) at day 0. Sheep A (2S066) had highly different bacterial communities at each lung segment, whereas sheep B
(2D644) had similar bacterial communities at all three lung sites.
FIG 6 Clustering of individuals by lung microbiota composition. PCoA graphs show the similarities between the bacterial communities extracted from protected
specimen brushing samples taken from sheep lungs at three time points (baseline [0 days], 1 month, and 3 months). Samples were taken from three separate lung
segments (RA, RCD, and LCD). Samples from within the same sheep were found to cluster significantly at baseline (AMOVA, P  0.001) and at 3 months
(AMOVA, P  0.045) but not at 1 month. This is likely to be due to the presence of contaminants originating from the extraction kits in the 1-month samples.
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been investigated by culture-based methods, which seemed to in-
dicate that bacterial colonization of the sheep lung was rare or did
not occur in all sheep (11, 12, 14). In contrast, using non-culture-
based methods, we have found that all of the sampled sites in our
seven sheep harbored diverse communities of bacteria, although
in far smaller numbers than is generally found in other niches,
such as the gut or upper respiratory tract.
Bacteria belonging to genera previously isolated from goat and
sheep lungs (11, 12) were found in our samples. These included
Corynebacterium, Bacillus, Enterococcus, Klebsiella, Mannheimia,
Micrococcus, Moraxella, Pasteurella, Pseudomonas, Staphylococcus,
and Streptococcus. Of the most common genera observed within
our animals, Staphylococcus, Streptococcus, and Corynebacterium
are commonly isolated from the upper respiratory tracts and skin
of many animals, whereas Jeotgalicoccus is a less well-known genus
(45) which has not been found to make up a substantial part of the
lung microbiota communities in any previous studies. However, it
has been isolated from the small intestinal mucosa of calves (46),
the canine oral cavity (47), aerosol samples from a poultry house
(48, 49), cattle teats (50), lamb meat (51), the rumen of cattle (52),
and aerosol samples near a dairy (53).
The most common bacterial orders found in the sheep lung
during the 3-month study were Bacillales, Actinomycetales, and
Clostridiales. This agrees with the findings of a previous study
carried out by our group, which examined the sheep lung micro-
biota before and after infection with Pseudomonas aeruginosa (17).
Pseudomonadales (mainly Pseudomonas) was also commonly
found in the lungs during our single-sheep study, while the throat
swab from this study was dominated by Pasteurellales and Pseu-
domonadales.
Coinfection with Bordetella parapertussis or Mycoplasma ovi-
pneumoniae has been shown to lead to more-severe disease caused
by Mannheimia (Pasteurella) haemolytica (22–25). Mycoplasmas
were very rare within our data set, with only one sheep segment
containing reads from this genus at one time point. We did not
identify any OTUs as Bordetella; however, we did find an OTU
FIG 7 Diagram of the bacterial orders found in the sheep lung. Bacterial orders found in protected specimen brushing samples from the lung and trachea (A1
to A9 and A13 to A19), a throat swab, and an extraction kit control taken during a study of one sheep at one time point.
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designated Alcaligenaceae (the family to which Bordetella be-
longs), though this was uncommon and occurred in low abun-
dance. We identified several OTUs which were classified as
members of the Pasteurellaceae family, including Mannheimia,
Bibersteinia, and, less commonly, Aggregatibacter segnis, Haemo-
philus parainfluenzae, Bibersteinia trehalosi, and Actinobacillus
parahaemolyticus. All of these microbes have previously been iso-
lated from the lungs or upper respiratory tract (54–58). Despite
the fact that disease caused by members of this family is often
located in the apical and cardiac lobes (12, 19), we observed mem-
bers of this family to be present across the lung.
The composition of the lung microbiota found in our sheep
shows some differences from that previously identified in hu-
mans, where Bacteroidales are found in higher numbers and there
are generally fewer members of the Actinomycetales and Clostridi-
ales orders (2, 9, 59). Segal et al. identified various bacterial taxa
that were commonly found in high relative abundance in human
lungs (1). These included taxa which were found in all of our sheep
samples in high relative abundance (Streptococcus, Staphylococcus,
Corynebacterium), taxa which were found in the majority of our
samples but in lower abundances (Propionibacterium, Pseudomo-
nas), and taxa which were found only sporadically in our samples
and were usually in low abundance (Stenotrophomonas, Prevotella,
Veillonella, Fusobacterium, Porphyromonas).
Such differences may at least in part reflect the different sur-
roundings in which sheep live, as well as behavioral or physiolog-
ical features, such as rumination. A study using buccal swabs to
identify bacteria originating from the rumen suggested that, as the
time between regurgitation and sampling increases, the orally as-
sociated bacterial populations in the buccal cavity increase and the
FIG 8 Clustering of lung brushing samples by depth within the lung. A PCoA graph shows the similarity of samples taken at different lung depths based upon
the bacterial orders present. Lung depths are represented by color and correspond to different distances from the glottis, progressing in a caudal direction.
Adjacent pairs of samples are represented by the same symbol and color. For the exact location of each sampling site, see Fig. 2. Subtracheal samples (A3)
clustered significantly by lung depth (AMOVA, P  0.033), as did paired samples (AMOVA, P  0.046).
TABLE 3 Abundances of the OTUs within the Pasteurellaceae family found in different locations of the sheep respiratory tract
Specimen type, location, or sample
% of organisms that were in:
OTU 5, Mannheimia OTU 6, Pasteurellaceae OTU 7, Bibersteinia OTU 9, Bibersteinia trehalosi
Throat swab 23.7 10.1 1.8 0.7
Trachea
A1 5.5 4.5 28.4 5.3
A2 0 0.03 0 0.01
Left lung
A3 0 3.04 0.01 0.03
A4 1.2 0.006 0 0
A5 0 0.2 0.006 0
A6 0 0 0 0
A7 0.7 1.4 0.006 0.006
A8 0 0 0.8 0
A9 0.006 0.02 0.2 0
Right lung
A13 0.9 0 0 0.006
A14 0.006 0.3 0 0
A15 0 0.6 0.006 0.006
A16 2.3 0.6 0.006 0
A17 0.10 0 1.3 0.01
A18 0 0.02 0.01 0
A19 3.2 0 1.3 0
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rumen-associated bacteria decrease, potentially contributing to
interanimal variation (58). In future studies, it may be useful to
take rumen and upper respiratory tract samples alongside lung
samples to explore whether the variations between these sites and
the lung are related.
Regardless of the highlighted differences between sheep and
human lung microbiotas, there is a pressing need to understand
the mechanisms that underlie the spatial and temporal variability
of microbiota in the mammalian lung. These fundamental studies
are difficult to facilitate in healthy human subjects as a conse-
quence of the invasive nature of the repeated sampling protocol as
well as the difficulty of controlling for the influence of environ-
mental and/or lifestyle factors. Large-animal models can, how-
ever, play an important role in filling this need. Indeed, the phys-
iological and immunological similarities between sheep and
human lungs (60, 61) have contributed to the widespread use of
sheep as translational models for human lung research (26, 27),
including for asthma (62–65), the delivery of drugs via the upper
respiratory tract (66–68), emphysema (69–71), pulmonary hyper-
tension (72–74), physical lung injury (75–78), lung infection (28,
79–81), respiratory distress syndromes (82–85), asbestosis (86–
88), and lung cancer (89, 90).
In our study, we examined the variability of the lung microbi-
ota in sheep. Bacterial populations were often different between
lung segments and between individuals, which confirms our pre-
vious observations (17). There was more similarity between sam-
ples from the same sheep at the baseline and 3-month time points
than between samples taken from different sheep, but this was not
found to be the case at the 1-month time point. Lung sample
clustering by individuals has previously been identified in humans
(9) and sheep (17).
Clearly, large differences can exist in the microbiota sampled
from different lung segments at the same time point. This spatial
variability of lung microbial populations can be observed in P.
aeruginosa infections in cystic fibrosis patient lungs (91). The
mechanisms underlying such observations have yet to be eluci-
dated; however, possible candidate influences may include re-
gional variability of physiological parameters, such as gas concen-
trations, osmolality, temperature, pH, and blood flow (92–96),
which may lead to the creation of microhabitats providing a selec-
tive advantage to certain bacteria (97). It has previously been dem-
onstrated that differences in pH can lead to changes in the colonic
microbiota (98) and that temperature combined with humidity
can lead to changes in the composition of the skin microbiota
(99).
A longitudinal analysis of the lung microbiota at specific lung
sites in healthy individuals has not previously been reported. Our
goal was to define the variability of the lung microbiota over time
and to detect whether there was a sheep lung microbiota “signa-
ture” which remains stable. Unfortunately, at the time of carrying
out this study, the extent of the variability of bacterial DNA found
within different lots of extraction kits was not yet known (100).
While we, therefore, did include some extraction kit controls for
our longitudinal study, we did not include controls for all lots
which were used. Samples from different time points were also
processed at different times. Due to our small sample sizes and the
fact that samples clustered significantly by time point, we do not
feel that accurate conclusions can be drawn about the temporal
stability of the microbiota from our data. However, all samples
taken from the same time point in the same sheep were processed
at the same time. Therefore, we can be confident that the spatial
variability that we observed within animals was not due to our
methodology.
In some individuals, samples taken from different lung seg-
ments were found to be highly different from one another,
whereas in others, the lung microbiota appeared to be quite stable
across the lung sites. Another finding was the disappearance of the
significantly separate clustering of sheep samples at the 1-month
time point. This was correlated with an increase in the proportions
of several OTUs found in sheep lungs, the most noticeable in-
crease arising from an OTU classified as Corynebacterium, which
was also the most abundant OTU in samples from one of our
extraction kit controls. It is likely that the disappearance of signif-
icant clustering by individual at the 1-month time point is due to
the increased presence of contamination in our samples.
OTUs that were identified in both samples and negative PCR
and extraction kit controls were not removed from the analysis for
the 3-month sheep study. The reason for this decision was that a
number of bacteria commonly associated with the upper and
lower respiratory tracts were present in these controls, including
the genera Streptococcus and Pseudomonas, and it was judged that
their removal would merely introduce another source of bias.
Equally, any specific a priori manipulation based around as-
sumptions gleaned from the human literature regarding microbi-
ota in the upper and lower respiratory tract are potentially ill ad-
vised. Indeed, it has been demonstrated that the microbes found
in the lungs of animals often match those found in their bedding
and hay (101). It is therefore not possible to dismiss environmen-
tal microorganisms as being due only to the contamination of
samples.
In our spatial-variation study, one OTU was removed before
analysis, as we felt confident that its presence was due to contam-
ination of our extraction kit. Clustering of organisms in lung
brushing samples by the lung depth from which they were taken
was observed when OTUs were defined by bacterial order. Micro-
organisms in samples paired with their proximate neighbors were
also found to cluster significantly separately from those in brush-
ing samples taken elsewhere in the lung, but this may just be due to
the fact that these samples were taken from the same lung depth.
Certainly, further research to explore the relationship between
lung depth and community composition appears warranted.
After sequencing a mock community of bacteria which con-
tained equimolar concentrations of each bacterial species, we did
find some bias present, with some bacterial species being overrep-
resented or underrepresented. These biases, which may be caused
by various factors, including primer mismatching, PCR cycle
number, and the bioinformatic pipeline used, are quite common
in 16S sequencing (102–105). We also sequenced a 1:100 dilution
of the same mock community and found that the apparent biases
were far smaller. As the concentration of bacterial DNA in our
samples was far lower than that of the undiluted mock com-
munity, we feel that the 1:100 dilution is likely to better repre-
sent the biases which may be present in our samples, as it is
closer to their bacterial DNA concentrations. We believe that
this vindicates our choice of DNA amplification strategy, in-
cluding the use of nested PCR.
It may not be possible to claim that the bacterial abundances
identified via 16S sequencing quantitatively represent the relative
abundances of bacteria in the sample. Indeed, this is made even
more difficult, as different bacterial taxa contain different copy
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numbers of the 16S rRNA gene (106). However, it seems logical to
assume that, if the same methodology is used for all samples
within a study, then the biases present will be the same for all
samples, and therefore, comparisons between groups or claims
about the types of microbes present in samples would still be valid.
In conclusion, we observed variability in sheep lung microbio-
tas both between and within individuals. In some animals, differ-
ent lung segments contained highly different bacterial communi-
ties, whereas other animals showed similar communities at all
lung sites. While spatial variation was observed to occur over both
large and small distances across the lung, samples taken at the
same lung depth clustered together separately from those taken at
different lung depths. Further studies are needed to explore the
stability of the healthy lung microbiota over time.
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The spatial variation observed in the sheep lung microbiota, even across very small distances, 
suggests that it is unlikely to be possible to characterise the entire lung microbiota of an individual 
sheep using protected specimen brushings. For some studies it may therefore be desirable to perform 
lung washes which would be able to sample a greater area and give a better representation of the lung. 
However, performing whole lung washes while minimising contamination in live animals would be 
difficult if not impossible. Additionally, if sampling to investigate the effect of certain treatments or 
diseases which may have localised lung effects, protected specimen brushings may still prove to be 
more useful.  
The predominant types of bacteria identified in the lungs of sheep during this study were different to 
those previously reported for humans. However, we were limited by the number of sheep used and it 
is possible that these six sheep, who were all pen mates, were not representative of other sheep 
populations or breeds. The high level of inter-individual variation observed also merits a study 
involving a larger number of animals.  
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Chapter 4: Comparing Microbiotas in the 
Upper Aerodigestive and Lower 




4.1 Introduction and aims 
The results in Chapter 3 give a first glimpse into the types of bacteria which may inhabit the sheep 
lung. We identified differences between the microbiota we observed in sheep and that which had 
previously been described in humans. This led us to question whether, as in healthy humans (23, 39), 
the upper and lower respiratory tract microbiotas are similar to one another or whether there are 
differences between these niches which may point to the sheep lung microbiota being formed through 
different mechanisms than are responsible in humans.  
The following manuscript was submitted to Microbiome on 19/07/2016. The inclusion of this 
submitted manuscript as part of this thesis does not conflict with any Biomed Central editorial 
policies. The manuscript characterises the composition of the sheep lung microbiota in a larger 
number of animals than was used in Chapter 3. Upper and lower respiratory tract samples are also 
compared in order to explore the differences between the microbiota at these niches. In this study, all 
work was performed by myself except as further specified: lung fluid samples were collected by 
myself with the help of Steven Wright and David Collie. DNA libraries were sequenced by Edinburgh 
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Background: Recently, the importance of the lung microbiota during health and disease has been 
examined in humans and in small animal models. Whilst sheep have been proposed as an appropriate 
large animal model for studying the pathophysiology of a number of important human respiratory 
diseases, it is clearly important to continually define the limits of agreement between these systems as 
new concepts emerge. In humans it has recently been established that the lung microbiota is seeded by 
microbes from the oral cavity. We sought to determine whether the same was true in sheep. 
Results: We took lung fluid and upper aerodigestive tract (oropharyngeal) swab samples from forty 
lambs (seven weeks old). DNA extraction was performed and the V2-V3 region of the 16S rRNA 
gene was amplified by PCR then sequenced via Illumina MiSeq. Oropharyngeal swabs were either 
dominated by bacteria commonly associated with the rumen or by bacteria commonly associated with 
the upper aerodigestive tract. Lung microbiota samples did not resemble either upper aerodigestive 
tract samples or reagent only controls. Some rumen associated bacteria were found in lung fluids, 
indicating that inhalation of ruminal bacteria does occur. We also identified several bacteria which 
were significantly more abundant in lung fluids than in upper aerodigestive tract swabs, the most 
predominant of which was classified as Staphylococcus equorum.  
Conclusions: In contrast to humans, we found that that the lung microbiota of lambs is dissimilar to 
that of the upper aerodigestive tract and we suggest that this may be related to physiological 
differences between sheep and humans. Understanding the comparative physiology underlying 
differences in lung microbiota between species will provide a foundation upon which to interpret 
changes associated with disease and/or environment.  






The use of 16S ribosomal RNA (rRNA) gene sequencing has facilitated the study of difficult to 
culture, low biomass microbial communities present in the lower respiratory tract. The impact of the 
lung microbiota on human health is a rapidly growing area of research. In order to understand this 
impact it is important to also understand the lung microbiota dynamics during health and to include 
healthy controls in disease studies. To achieve this, the majority of previous studies have relied on 
human volunteers.  
However, many individuals are hesitant to participate in research bronchoscopy due to the percieved 
inconvenience and a fear of complications (210), despite the low risk involved. Mice and rats have 
been used to explore the relationship between the lung microbiota and airway inflammation (211-
213), microbiota at different body sites (214), the environment (51) acute lung injury (98) and 
antibiotic (215) and corticosteroid exposure (216). However, rodents are of limited use when 
exploring spatial or longitudinal lung microbiota dynamics due to their small lung size. Recognising 
the utility of large animal models in this regard, and the anatomical and immunological relevance of 
sheep as models (11, 12, 217, 218) our group has previously used this species to explore the changes 
in the lung microbiota upon Pseudomonas aeruginosa infection (115) and to explore the spatial 
variability present within the healthy lung (1).  
Subclinical microaspiration of pharyngeal secretions is a feature of health and this can contribute to 
the lung microbiota composition (14) and the microbiome of the human lungs more closely resembles 
that of the mouth than the nose or the lower gastrointestinal tract (39). It is not yet known whether the 
same relationship holds for species other than humans. In ruminating sheep, where the oropharynx is 
exposed to ruminal contents on a frequent basis one would anticipate that lung microbiota would 
similarly reflect this influence. In this paper we find that the presence of rumen-like bacteria in the 
upper aerodigestive tract is correlated with changes in the lung microbiota and rumen type bacteria are 
present in lamb lungs. We also identify bacteria which are more indicative of the lungs than the 
oropharynx, indicating that the presence of the sheep lung microbiota is not merely due to passive 





4.2.3 Methods  
Animals and sampling 
Scottish Mule X Suffolk lambs (20 males and 20 females), raised on pasture from 48 hours after birth, 
were used in this study. These lambs were part of a study on the animal welfare implications of 
prenatal stress which was approved by ScotlanG
V5XUDO&ROOHJH¶V658&$QLPDO([SHULPHQWV
Committee and was conducted under Home Office licence. At seven weeks old (mean age = 48.8 days 
± 0.8 standard deviation (SD); mean weight ± SD = 20.6 kg ± 2.6 kg), lambs were euthanized by 
barbiturate overdose then the cadavers were transported from the farm to the dissecting room (~5 
mins). Oropharyngeal swabs were taken using cotton tipped swabs (Swab Plain Wood Cotton Tip 
Sterile (710-0181), Copan, Italy). To prevent oral contamination, swabs were stored in protective 
plastic sheaths from which the swab could be advanced and retracted once it was positioned at the 
sampling site. Swabs were then transferred into a new plastic sheath and stored on ice.  
The ventral aspect of the neck was shaved and a sterile scalpel used to incise through the skin and 
subcutaneous tissues to expose the ventral surface of the trachea. A sampling site was identified on the 
exposed ventral surface and the trachea cranial to this site was completely closed off by both string 
ligature and clamp placement. The selected sampling site was then heat seared and 50 ml of sterile 
phosphate buffered saline (PBS) was injected through the seared section into the tracheal lumen. The 
head and neck were oriented such that the PBS would flow caudally down the thorax. A second clamp 
was immediately placed caudal to the site of injection to prevent backflow, leakage and potential 
contamination. The lamb cadavers were then tipped so that the PBS would run caudally into their 
lungs and then tipped back again so that the fluid would collect in the tracheal lumen immediately 
caudal to the position of the second clamp. A sampling site identified on the ventral surface of the 
trachea was seared and a needle and syringe were used to collect the pooled fluid. On average 4 ± 1.7 
ml (mean ± SD) of lung fluid was collected per animal. Lung fluid was stored on ice until further 
processing. Oropharyngeal swabs were sterilely cut into 500 µl PBS. Lung fluids were centrifuged at 
13,000g for 5 mins (Biofuge Fresco Heraeus, Germany). The supernatant was removed and the pellets 
were resuspended in 500 µl PBS. Oropharyngeal swabs and lung fluids were stored at -80°C until 
DNA extraction.  
 
DNA extraction, amplification, and sequencing 
DNA extractions using the PowerSoil DNA isolation Kit (Mo Bio, Carlsbad, USA) and quantitative 
PCR (qPCR) using the 16S rRNA gene qPCR primers UniF340 (5-
ACTCCTACGGGAGGCAGCAGT-3) and UniR514 (5-ATTACCGCGGCTGCTGGC-3) were 
performed as described previously (1). Extraction kit reagent controls, consisting of reagent only 
extractions, were produced for every day DNA extractions were performed. PBS controls were 
63 
 
created by extracting DNA from 500 µl of the PBS which had also been used to wash out the lamb 
lungs. A mock community control was included which has been described previously (1). 
A nested PCR reaction was used to produce amplicons for sequencing; this technique was chosen to 
reduce PCR bias caused by barcoded primers (181). The first round of PCR amplified the V1-V4 16S 
hypervariable regions using the primers 28F (5-GAGTTTGATCNTGGCTCAG-3) and 805R (5-
GACTACCAGGGTATCTAATC-3). The conditions were: 94°C for 2 mins followed by 20 cycles of 
94°C for 1 min, 55°C for 45 s, and 72°C for 1.5 mins followed by a final extension step of 72°C for 
20 mins. Clean-up was performed using the AMPure XP PCR purification system (Beckman Coulter, 
Brea, USA).  
In a previous study, we found that PCR bias in high template samples could be reduced by diluting 
amplicons from the first round of PCR to a similar concentration to those of lung fluid samples (1). 
Therefore, in this study we used our qPCR values to calculate the dilutions needed to achieve this. The 
second round of PCR used the barcoded V2-V3 primers 104F (5-GGCGVACGGGTGAGTAA-3) and 
519R (5-GTNTTACNGCGGCKGCTG-3). The dilutions and barcoded primers used for each sample 
can be found in Additional file 4.1. The PCR conditions were: 98°C for 30 s followed by 20 cycles of 
98°C for 10 s, 67°C for 30 s, and 72°C for 10 s followed by a final extension step of 72°C for 2 mins. 
The amplicons were again purified using the AMPure XP PCR purification system. 
 
Bioinformatic and statistical analysis 
Samples were sequenced via either Illumina MiSeq or HiSeq runs (Illumina, San Diego, USA) 
(Additional file 4.1) producing 250 base pair paired-end reads. Cutadapt (184) was used to remove 
primers. Quality control and taxonomic assignment of sequences was carried out within mothur (186) 
following a protocol created by the mothur developers (187), adjusted to suit our dataset (1). 
Sequences were subsampled before statistical analysis. The sequencing error rate, principal coordinate 
DQDO\VLVJUDSKV3&2$DQDO\VHVRIPROHFXODUYDULDQFH$029$*RRG¶VFRYHUDJHDQDO\VHV(219); 
richness (Chao 1 Index) and diversity (Inverse Simpson Index) calculations and indicator analyses 
(220) were all calculated within mothur. Clustering of microbial communities into metacommunities 
was also carried out within mothur using a probabilistic modelling technique based upon work by 
Holmes et al (201). The significance of differences between the diversity and richness of groups was 
calculated using either the two sample t-test (normal data) or the Mann-Whitney U test (non-normal 
data) within Minitab 16 for Windows (Minitab, Coventry, UK). Heatmaps were constructed in R 
Version 3.2.2 (204) using the Vegan (208), RColorBrewer (207), gplots (205) and heatplus (206) 
packages. Clustering within heatmaps was performed using the Bray-Curtis dissimilarity (209). 






Quality assurance of methodology  
11,878,769 sequence reads were produced in total with an average of 138,125 ± 29,306 per sample 
(mean ± SD). The sequencing error rate was calculated as 0.35%. The oropharyngeal swab sample 
from lamb 12773 was found to have very low read numbers and was therefore discarded from 
statistical analyses, as was its corresponding lung fluid sample. A total of 1061 OTUs were identified 
(Additional file 4.2) which were reduced to 750 after sub-sampling. AlO*RRG¶VFRYHUDJHYDOXHVZHUH
>0.999 indicating that at least 99.9% of the bacteria present in our samples are likely to have been 
identified. The most abundant bacterial OTUs from extraction kit reagent only controls are listed in 
Table 4.1. The similarity of the OTUs found on the 25th and 26th March 2015 is likely due to the fact 
that the same lot of extraction kit was used. Upon examining our data we found that lung fluid 
samples clustered by when they were processed (Appendix 3). Samples sequenced via MiSeq and 
HiSeq underwent DNA extraction and PCR amplification separately. We identified two OTUs which 
were significantly indicative (P <0.05) of samples from either the HiSeq or MiSeq run which were 
also present in all lung fluid samples from the run they were indicative of: OTU 4 (Pseudomonas) and 
OTU 112 (Yaniellaceae). These OTUs are likely due to contamination and were therefore removed 
prior to analysis.  
 
Table 4.1: Bacterial OTUs found to be >5% abundant in extraction kit reagent controls 
Date of DNA extraction OTUs  Abundance 




























Lamb oropharyngeal swabs cluster into two distinct community types 
Oropharyngeal swabs were taken from 40 lambs. Using the Laplace approximation it was found that 
swabs could be partitioned into two separate groups based upon the types of bacteria present. These 
appeared to correspond to either oropharyngeal-type (partition 1) or rumen-type (partition 2) bacteria 
(Appendix 4). Oropharyngeal-type communities were dominated by the OTUs Pasteurellaceae (22%), 
Mannheimia (14%), Fusobacterium (11%), Bibersteinia trehalosi (8%), Neisseriaceae (7%), 
Moraxella (6%) and Bibersteinia (5%). Rumen-type communities were dominated by the OTUs 
Prevotella (36%), Clostridiales (11%), Ruminococcaceae (7%), Lachnospiraceae (6%) and 
Butyrivibrio (6%).  
The richness (chao: non-normal data) and diversity (Inverse Simpsons: normal data) of the partitions 
were compared. There was no significant difference in richness or diversity between the rumen-type 
partition and the oropharyngeal-type partition.  
 
Dichotomous oropharyngeal microbiota are associated with different lung community 
structures  
The most common OTUs found in lung fluid samples were Staphylococcus equorum (13%), 
Staphylococcus sciuri (6%), Mannheimia (5%) and Prevotella (5%). Using the Laplace 
approximation, lung fluids did not cluster into more than one group. Lung fluids were then manually 
partitioned into the same groups as swabs. A significant difference in bacterial community structure 
was found between these groups (AMOVA: P = 0.016) and a small number of OTUs were found to be 
significantly different between the two groups. Prevotella (P = 0.03) and Sphingobium (P = 0.039) 
were significantly indicative of lambs from which rumen-type swabs were derived whereas 
Paracoccus aminovorans (P = 0.036) was indicative of lambs from which oropharyngeal-type swabs 
were derived. Fig. 4.1 and 4.2 contain visual representations of sample clustering.  
We compared the proportions of the dominant OTUs in rumen-type swabs with their corresponding 
proportions in lung samples. On average, these OTUs were found in the following proportions in lung 
samples: Prevotella (5%), Clostridiales (2%), Ruminococcaceae (3%), Lachnospiraceae (1%) and 
Butyrivibrio (1%). 
 
The presence of a lung specific microbiota  
Indicator species analysis determined that several OTUs were significantly more indicative of the 
lungs than of oropharyngeal swabs (Table 4.2). It is likely that reagent contamination will have had 
more of an impact on the lung fluid samples than on the oropharyngeal swabs, due to their lower 
biomass. However, when examining the indicative OTUs, the majority of samples were not found to 
contain the same proportions of these OTUs as the PBS controls processed alongside them (Fig. 4.3). 
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Of the indicative OTUs, by far the most common was Staphylococcus equorum which constituted, on 
average, 13.3% of the total bacteria present in lung fluids and which was only present in low numbers 
in controls and oropharyngeal swabs.  
 
 
Figure 4.1: PCOA graph showing the relatedness of upper aerodigestive tract samples 
from lambs partitioned into 2 groups using the Laplace approximation. Lung fluids 
belonging to the same animals were partitioned into the same groups. Lung fluid 
partitions clustered significantly separately by AMOVA (P = 0.016) as did 




Figure 4.2: Heatmap of OTUs found in lamb lung fluids, oropharyngeal swabs, 
extraction kit reagent and PBS controls. OTUs were included when they were >5% 
abundant in at least one sample. Oropharyngeal swabs partitioned into rumen-like 
bacterial communities are indicated by green whereas those which were upper 
aerodigestive tract-like are indicated by a red line. The lung fluid samples from the 
oropharyngeal-like animals are indicated by blue whereas those from the rumen-type 






Table 4.2: OTUs significantly more indicative of lung fluids than oropharyngeal 
swabs* 
Taxonomy P-value Average proportion 
in lung fluids 
(Mean ± SD) 
Average proportion 
in oropharyngeal 




Corynebacterium <0.001 1.9% ± 2.3% 0.065% ± 0.19% 0.044% 
Delftia <0.001 0.80% ± 1.7% 0% ± 0% 0% 
Oxalobacteraceae <0.001 0.96% ± 1.5% 0.012% ± 0.043% 3.0% 
Pelomonas <0.001 0.65% ± 1.1% 0.00057% ± 
0.0036% 
2.0% 
Propionibacterium acnes <0.001 0.84% ± 2.3% 0.0040% ± 0.020% 1.6% 
Pseudomonas 
citronellolis 
<0.001 0.51% ± 1.1% 0% ± 0% 1.0% 
SMB53 <0.001 0.71% ± 1.3% 0.0045% ± 0.018% 0% 
Sphingobium yanoikuyae <0.001 0.53% ± 0.56% 0% ± 0% 13% 
Staphylococcus  <0.001 3.9% ± 5.4% 0.060% ± 0.18% 8.6% 
Staphylococcus equorum <0.001 13.3% ± 9.6% 0.32% ± 0.97% 0.044% 
Staphylococcus sciuri <0.001 6.4% ± 5.3% 0.18% ± 0.59% 2.0% 
Streptomyces <0.001 2.0% ± 3.8% 0.025% ± 0.096% 0% 
Brevibacterium 0.002 1.2% ± 1.4% 0.064% ± 0.24% 0% 
Brachybacterium  0.006 1.0% ± 1.7% 0.035% ± 0.10% 0.022% 
Peptostreptococcaceae 0.006 1.8% ± 2.2% 0.050% ± 0.11% 0.044% 
Jeotgalicoccus 
psychrophilus 
0.008 1.6% ± 2.1% 0.040% ± 0.10% 0% 
Saccharopolyspora 0.009 0.52% ± 1.2% 0.0011% ± 0.0071% 0% 
Janthinobacterium 0.01 0.57% ± 1.4% 0.0023% ± 0.0068% 0% 
Variovorax paradoxus 0.011 1.2% ± 1.2% 0.024% ± 0.060% 0.022% 
Rathayibacter caricis 0.016 0.58% ± 1.2% 0.0057% ± 0.021% 0% 
Turicibacter 0.016 1.0% ± 1.8% 0.0074% ± 0.021% 0% 
Micrococcus 0.017 0.77% ± 1.6% 0.0080% ± 0.029% 4.4% 
Frigoribacterium 0.021 0.79% ± 1.4% 0.077% ± 0.31% 0% 
Enterobacteriaceae 0.023 0.65% ± 2.6% 0.0063% ± 0.029% 2.2% 
Microbacterium aurum 0.047 1.2% ± 2.8% 0.0045% ± 0.013% 0% 
*OTUs which were significantly more (P <0.05) indicative of lamb lung fluids than oropharyngeal 
swabs and which were on average >0.5% abundant in lung fluids.  
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Figure 4.3: Heatmap of bacterial OTUs found to be more indicative of lamb lung fluids 
than oropharyngeal swabs (P <0.05). Fluid and PBS samples from which DNA was 
extracted on specific dates are surrounded by coloured lines: 17th July 2014 (blue) 
and 25th March 2015 (red). DNA extractions carried out on 26th March 2015 only 
comprised oropharyngeal swabs which are not included in this figure. A larger 





4.2.5 Discussion  
Sheep are commonly used as large animals models of the respiratory system due to the physiological 
and immunological similarities of their lungs to those of humans (217, 218, 221, 222). We have 
previously used the sheep to study both the extent of variation in the lung microbiota (1) and the direct 
and remote changes in the lung microbiota caused by localised P.aeruginosa infection and antibiotic 
treatment (115). As the sheep is an important agricultural animal, studies of their respiratory microbial 
communities may also be of interest from an animal health perspective.  
It has previously been demonstrated that microaspiration of microbes from the upper aerodigestive 
tract is common in humans and can lead to an inflammatory phenotype (50). When microbial 
communities from healthy human lungs are characterised they are often found to contain microbes 
associated with the upper aerodigestive tract (49). The healthy human lung microbiota is thought to be 
formed predominantly from the neutral dispersal of these upper aerodigestive tract microbes into the 
lungs rather than by the differential growth of lung adapted microbial communities (23). We sought to 
identify whether this was also the case in sheep.  
Sheep oropharyngeal swabs could be partitioned into two separate groups which were predominantly 
composed of OTUs identified as bacteria which are well known members of either the rumen 
(Prevotella, Clostridiales, Ruminococcaceae, Lachnospiraceae and Butyrivibrio (223-225)) or 
respiratory tract microbiotas (Pasteurellaceae, Mannheimia, Fusobacterium, Bibersteinia trehalosi, 
Neisseriaceae, Moraxella and Bibersteinia (226-228)). These bacteria were also detected in a previous 
study examining sheep buccal swabs (44). 
It is not possible to identify whether this dichotomy reflected recent rumination, or some stochastic 
post-mortem leakage of rumen fluid into the oropharynx in some individuals. The lambs during this 
study were not weaned but were at an age when it is expected that they all would be regularly 
supplementing their diet with grass and would be ruminating.  
Regardless of the drivers of this oropharyngeal dichotomy, the microbial communities found in the 
lungs were very different to those found in both the rumen- and oropharyngeal-type swabs. A large 
number of bacterial OTUs were found to be significantly more abundant in lung fluids in comparison 
to oropharyngeal swabs, including Staphylococcus equorum which was by far the most common 
bacterial OTU found. Several OTUs which are commonly associated with the rumen were also 
identified in lung fluids. Our lung fluid samples will have been more affected by reagent 
contamination than the oropharyngeal swabs due to the lower quantity of bacterial DNA present 
(140). However, the microbial communities found in lung fluids did not reflect the bacteria found in 
reagent only controls processed on the same day so the presence of bacteria in the lamb lung cannot be 
attributed purely to sample contamination. Nor can it be attributed to disease as no lambs showed 
signs of respiratory illness during the study.  
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There are several reasons why the microbes found in lamb lungs might not reflect those found in the 
upper aerodigestive tract to the same extent as is found in humans. Sheep have evolved to cope with 
rumination and thereby may have more efficient anatomical barriers to microaspiration (229). 
Physiological differences such as the horizontal disposition of the lungs, increased nasal breathing and 
increased saliva production (230, 231) may also contribute.  
 
4.2.6 Conclusions 
In this study we examined oropharyngeal swab and lung fluid samples taken from healthy lambs to 
characterise the bacterial communities present and to assess the impact of rumination on these 
communities. We found that oropharyngeal swabs were dominated by either rumen-type or 
oropharyngeal-type microbial communities. We also found that lung bacteria did not greatly resemble 
either rumen- or oropharyngeal-type swabs and identified several bacterial OTUs which were more 
indicative of lung fluids. The lungs did contain several rumen associated bacteria which may indicate 
that there is a certain degree of microaspiration of ruminal contents in lambs.  
Sheep are not human but the opportunities that they and other large animals present, offer valuable 
insights into the dynamic relationship of the upper aerodigestive and lower respiratory tract 
microbiota in health. In the future, their value may extend to developing an understanding of the 
factors that predispose the upper aerodigestive tract microbiota towards disease in the lower 
respiratory tract.  
 
4.2.7 Additional files 
Additional file 4.1 (Additional file 4_1.xlsx): Dataset S1: Sample processing data for all samples. 
Additional file 4.2 (Additional file 4_2.xlsx): Dataset S2: Full list of bacterial OTUs and taxonomies. 
Appendix 3: Figure S1: Heatmap of OTUs found in lamb lung fluids, oropharyngeal swabs, PBS and 
extraction kit reagent only controls.  
Appendix 4: Table S1: OTUs responsible for partitioning of lamb oropharyngeal swabs into two 
groups (using Laplace value). 
Appendix 5: Larger version of Figure 4.2. 






Based upon my findings in Chapters and 3 and 4 there are differences between the sheep and human 
lung microbiotas in terms of both composition and dynamics. While these differences may preclude 
the use of sheep as a model for some lung microbiota studies it does not preclude their use for 
studying the utility of different lung sampling methods. Other than when sputum is utilised, lung 
microbiota sampling in living individuals requires the use of bronchoscopic procedures. If a non-
invasive method of lung microbiota sampling was developed this could reduce the procedural stress 
experienced by animals taking part in lung microbiota studies and reduce the likelihood that human 
volunteers would be dissuaded from participating in studies due to the perceived inconvenience and 
risk. Therefore, in Chapter 5 I explore the possibility of replacing invasive sampling techniques with 




Chapter 5: Microbiota in Exhaled Breath 




5.1 Introduction and aims 
In this Chapter I examine whether exhaled breath condensate samples (EBC) produce equivalent lung 
microbiota samples to those taken via protected specimen brushings, a technique which I previously 
used in Chapter 3. I also wanted to examine whether the healthy lung microbiota could be 
manipulated via antibiotic treatment and whether EBC samples were able to detect changes caused by 
treatment. In this study, all work was performed by myself except as further specified: colistimethate 
sodium (CMS) delivery and EBC collection in conscious animals were performed by myself and 
Gerry McLachlan. Anaesthesia was induced and monitored by Steven Wright, David Collie and Peter 
Tennant. EBC collection in anaesthetised animals was performed by myself, David Collie and Peter 
Tennant. Bronchoscopic procedures were carried out by David Collie and Peter Tennant. Blood was 
collected post mortem by Steven Wright, David Collie and Gerry McLachlan. HPLC was performed 
by Andy Gill. DNA libraries were sequenced by Edinburgh Genomics. Manuscript authors had input 
on the paper design and wording.  
Prior to this study, in order to verify that we were able to deliver bactericidal levels of CMS to the 
sheep epithelial lining fluid via nebulisation we treated one sheep with 2,000,000 IU nebulised CMS 
once per day for seven days (as described in Section 2.7: Dosage regime 1). One month prior to 
treatment, BAL fluid samples were collected in order to perform differential cell counts. Cell counts 
were within normal ranges, indicating that it is unlikely that infectious lung disease was present 
(counts performed by Steven Wright). 24 hours after the final CMS dose, BAL fluid samples were 
taken from the RC, RCD and LCD lung segments. 48 hours after the final CMS dose, further BAL 
fluid samples were taken from the RA, RVD1 and LVD2 lung segments. Serum samples were also 
taken at 24 and 48 hours post-treatment in order to calculate the dilution factor of the epithelial lining 
fluid in the BAL fluid. The concentrations of colistin in BAL fluid were measured by HPLC (Table 
5.1). The sheep did not show any adverse side-effects from treatment. 
The average colistin concentration in the lungs post-treatment at 24 hours was 154.24 µg/ml and at 48 
hours was 92.61 µg/ml. The lowest concentration found at either time-point was 50.76 ng/µl in the 
RA segment at 48 hours. This is a higher concentration than has previously been shown to 
successfully treat 4/5 of patients with ventilator-associated tracheobronchitis caused by polymyxin-
only susceptible Gram negative bacteria (232) and is higher than the minimum inhibitory 
concentration values repRUWHGIRUVXVFHSWLEOH*UDPQHJDWLYHEDFWHULDJPO(233)). This dosage 
regime was changed (see Section 2.7: Dosage regime 2) for the following study in order to reduce the 






Table 5.1: Colistin A levels in epithelial lining fluid after CMS treatment 
Lung segment Colistin concentration 




(Epithelial lining fluid) (Mean) 
RC (24 hours 
post-treatment) 
2.58 ± 0.058 ng/µl 21.6 55.73 ng/µl 
RCD (24 hours 
post-treatment) 
4.37 ± 0.12 ng/µl 
 
21.6 94.34 ng/µl 
LCD (24 hours 
post-treatment) 
9.62 ± 0.14 ng/µl 32.5 312.65 ng/µl 
RA (48 hours 
post-treatment) 
2.63 ± 0.34 ng/µl 19.3 50.76 ng/µl 
RVD1 (48 hours 
post-treatment) 
6.58 ± 0.21 ng/µl 14.5 95.41 ng/µl 
LVD2 (48 hours 
post-treatment) 




5.2 Research paper 
7KLVUHVHDUFKZDVSXEOLVKHGDVµMicrobiota in Exhaled Breath Condensate and the Lung¶LQApplied 
and Environmental Microbiology (2). For papers published in American Society of Microbiology 
journals, the American Society of Microbiology does not require authors to obtain permission to 
include these papers in their thesis, provided the original work is properly cited. For all sheep in this 
study, differential cell counts were found to be within normal ranges except for sheep ED952 which 
had an elevated eosinophil count (19.2%) and sheep ED956 which had a high lymphocyte count 
(19.6%) which may indicate that these animals had a lung infection during this study. A larger version 
of Figure 1 can be found in Appendix 7. Data Set S1 can be found as Additional file 5_1.xlsx. Data 
Set S2 can be found as Additional file 5_2.xlsx. Data Set S3 can be found as Additional file 5_3.xlsx.
Microbiota in Exhaled Breath
Condensate and the Lung
Laura Glendinning, Steven Wright, Peter Tennant, Andrew C. Gill, David Collie,
Gerry McLachlan
The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh,
Midlothian, United Kingdom
ABSTRACT The lung microbiota is commonly sampled using relatively invasive
bronchoscopic procedures. Exhaled breath condensate (EBC) collection potentially
offers a less invasive alternative for lung microbiota sampling. We compared lung
microbiota samples retrieved by protected specimen brushings (PSB) and exhaled
breath condensate collection. We also sought to assess whether aerosolized antibi-
otic treatment would influence the lung microbiota and whether this change could
be detected in EBC. EBC was collected from 6 conscious sheep and then from the
same anesthetized sheep during mechanical ventilation. Following the latter EBC
collection, PSB samples were collected from separate sites within each sheep lung.
On the subsequent day, each sheep was then treated with nebulized colistimethate
sodium. Two days after nebulization, EBC and PSB samples were again collected.
Bacterial DNA was quantified using 16S rRNA gene quantitative PCR. The V2-V3 re-
gion of the 16S rRNA gene was amplified by PCR and sequenced using Illumina
MiSeq. Quality control and operational taxonomic unit (OTU) clustering were per-
formed with mothur. The EBC samples contained significantly less bacterial DNA
than the PSB samples. The EBC samples from anesthetized animals clustered sepa-
rately by their bacterial community compositions in comparison to the PSB samples,
and 37 bacterial OTUs were identified as differentially abundant between the two
sample types. Despite only low concentrations of colistin being detected in bron-
choalveolar lavage fluid, PSB samples were found to differ by their bacterial compo-
sitions before and after colistimethate sodium treatment. Our findings indicate that
microbiota in EBC samples and PSB samples are not equivalent.
IMPORTANCE Sampling of the lung microbiota usually necessitates performing
bronchoscopic procedures that involve a hospital visit for human participants and
the use of trained staff. The inconvenience and perceived discomfort of participating
in this kind of research may deter healthy volunteers and may not be a safe option
for patients with advanced lung disease. This study set out to evaluate a less inva-
sive method for collecting lung microbiota samples by comparing samples taken via
protected specimen brushings (PSB) to those taken via exhaled breath condensate
(EBC) collection. We found that there was less bacterial DNA in EBC samples com-
pared with that in PSB samples and that there were differences between the bacte-
rial communities in the two sample types. We conclude that while EBC and PSB
samples do not produce equivalent microbiota samples, the study of the EBC micro-
biota may still be of interest.
KEYWORDS 16S rRNA, EBC, colistimethate sodium, colistin, lung microbiota,
respiratory microbiota, sheep
The study of the lung microbiota is a relatively new field in comparison to other areasof microbiota research. Although an increasing number of studies are linking
changes in the composition of the lung bacterial communities to various disease states,
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including allergies, autoimmune disorders, and inflammatory and infectious diseases
(1), the protocols for studying the lung microbiota are not standardized, making
comparisons between studies difficult.
One issue with studying the lung microbiota is the invasiveness of the sampling
techniques; the most common techniques are bronchoalveolar lavage (BAL) and the
collection of protected specimen brushings (PSB), both of which require the subject to
undergo bronchoscopy. The inconvenience and fear of complications associated with
bronchoscopic procedures can result in healthy and/or diseased individuals declining
to take part in studies (2), leading to a reduction in the potential pool of volunteers for
lung microbiota studies. It is also currently unknown whether these sampling methods
themselves can lead to changes in the lung microbiota.
Exhaled breath condensate (EBC) collection could potentially be a less invasive
method for taking lung microbiota samples. This method involves condensing exhaled
vapor into a liquid and has previously been used to study exhaled bacteria, viruses, and
fungi (3–8). However, there have been no studies using 16S rRNA gene sequencing to
compare the bacteria found in EBC samples to those found in samples taken directly
from the lungs. Therefore, it is not known whether it can be used as a surrogate for
more-invasive sampling techniques. We sought to assess the feasibility of using EBC in
sheep to study the lung microbiota composition. We have previously used sheep as a
model for studying the lung microbiota (9, 10) due to the anatomical and immuno-
logical similarity of their lungs to those of humans (11–13). In this study, we compared
EBC samples collected from conscious sheep and from the same sheep under anes-
thesia to PSB samples taken from four spatially disparate sites within the lungs.
We then extended this to address whether EBC analysis has the capacity to detect
changes in bacterial community compositions by attempting to directly manipulate the
lung microbiota with an inhaled antibiotic (colistimethate sodium [CMS], which is active
against Gram-negative bacteria). In a previous study, we examined the effect of
intravenous CMS on the lung microbiota (9). While we did identify changes in the lung
microbiota composition, the longer-term systemic antibiotic treatment used in that
study also likely affected the gut microbial populations. Immunological links between
gut and lung immunities, the gut-lung axis, raise the possibility that such changes may
have indirectly influenced the lung microbiota (14). In this study, we delivered nebu-
lized CMS, since this has been shown to lead to lower colistin plasma concentrations
than injected CMS (15), enabling us to discern the direct effect of antibiotic treatment
on respiratory bacterial communities.
A far greater quantity of bacterial DNA was isolated from PSB samples relative to EBC
samples. We found that while there was some overlap between the types of bacteria
found in these samples, EBC samples did cluster separately from PSB samples by their
bacterial community compositions. Lastly, despite our antibiotic treatment regime only
producing low concentrations of colistin in the lung epithelial lining fluids (the prodrug
CMS is hydrolyzed in vivo to the active form of the drug, colistin), significant differences
in community compositions were found between PSB samples derived pre- and
posttreatment.
RESULTS
Analysis of sequence quality and controls. DNA was extracted from respiratory
samples and controls, and the V2-V3 variable regions of the 16S rRNA gene were
amplified by PCR and then sequenced. After forming contigs from forward and reverse
reads, various quality control steps were undertaken, which reduced the total sequence
numbers by 25.8%. The lowest Good’s coverage estimate value among the samples was
0.996, indicating that at least 99.6% of the bacteria in this sample were identified. The
sequence error rate was 0.18% and the average number ( standard deviation [SD]) of
reads per sample was 39,195  11,535. In total, 867 operational taxonomic units (OTUs)
were identified.
The Human Microbiome Project mock community HM-783D, containing the 16S
rRNA genes of 20 bacterial species in staggered quantities and fixed ratios (1,000 to
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1,000,000 copies per organism per l), was processed alongside the samples. Some
biases were identified (see Data Set S2 in the supplemental material). Three species
were incorrectly identified at the species level (Acinetobacter baumannii was misiden-
tified as Acinetobacter rhizosphaerae, Clostridium beijerinckii was misidentified as Clos-
tridium butyricum, and Neisseria meningitidis was misidentified as Neisseria cinerea). Two
of the bacterial species which were present in low numbers in the original community
were not identified at any taxonomic level, namely, Actinomyces odontolyticus and
Bacteroides vulgatus. Their absence is likely due to the fact that they were in low
abundance rather than the inability of our protocol to amplify and identify them, as
they have previously been identified using the same protocol on a nonstaggered
version of the same mock community (10). We were also previously able to identify
Enterococcus faecalis at the genus level, whereas in this study, it could not be identified
except potentially as OTU 10, Bacilli (class). This discrepancy, combined with the fact
that E. faecalis is in low abundance in the staggered mock community, leads us to
believe that this identification is incorrect.
As lung bacteria are in low abundance, lung samples are at a particular risk for
contamination by bacterial DNA originating from DNA extraction kit reagents. There-
fore, as well as mock community controls, DNA extraction kit reagent controls were
produced. DNA was extracted from samples in four batches and a reagent control was
included with every batch. The bacterial OTUs identified in the extraction kit controls
did not occur consistently in samples from the same batch (Fig. 1). Samples were
clustered by DNA extraction batch (P  0.001 by analysis of molecular variance
[AMOVA]), and 30 OTUs were found to be indicative of specific batches (see Data Set
S3). However, when these OTUs were removed from the data set, samples still clustered
by extraction batch (P  0.014 by AMOVA), indicating that clustering was not entirely
due to the presence of these OTUs. It is possible that some of these OTUs may be found
naturally within the sheep respiratory system (e.g., Micrococcus luteus, a common
colonizer of the human upper respiratory tract). Therefore, we decided not to remove
these OTUs from our data set. Since samples were randomly assigned to extraction
batches, clustering by batch would be unlikely to lead to false-positive statistical results.
However, there is the possibility that the presence of contaminating organisms may
increase the heterogeneity and thereby also increase stochastic noise.
In controls, the most abundant OTUs on average were as follows: Corynebacterium,
14.4%; Enterobacteriaceae, 10.9%; and Intrasporangiaceae, 3.6% in PSB controls and
Burkholderia, 14.0%; Neisseriaceae, 10.5%; and Aggregatibacter, 7.7% in DNA extraction
kit reagent controls. The most abundant OTUs (on average) in the different sample
types were as follows: Staphylococcus equorum, 10.7%; Mannheimia, 6.5%; and Staph-
ylococcus sciuri, 5.6% in PSB samples; Staphylococcus equorum, 5.5%; Neisseriaceae,
4.7%; and Paracoccus, 4.3% in EBC samples from conscious sheep (cons); and Staphy-
lococcus equorum, 5.1%; Staphylococcus epidermidis, 3.7%; and Peptostreptococcus an-
aerobius, 3.2% in EBC samples from anesthetized sheep (anaes).
PSB samples contain more bacterial DNA than EBC samples. The V3 region of the
16S rRNA gene was quantified in our samples using quantitative PCR (qPCR). On
average, PSB samples contained 1.53  105  2.96  105 ng/l (mean  SD)
bacterial DNA (34,200  66,100 16S copy numbers/l), while EBC samples from
conscious and anesthetized sheep contained 4.28  107  5.34  107 ng/l (955 
1,190 16S copy numbers/l) and 2.38  107  7.12  108 ng/l (531  159 16S
copy numbers/l), respectively (Fig. 2). DNA extraction kit reagent controls contained
1.82  107  2.21  108 ng/l (406  49 16S copy numbers/l), while PSB controls
and qPCR water controls contained 1.84  107  1.05  108 ng/l (411  23 16S
copy numbers/l) and 1.98  107  2.06  108 ng/l (442  46 16S copy
numbers/l), respectively.
All respiratory samples contained significantly more DNA than the controls (P 
0.005 for all sample types by Mann-Whitney U test). EBC samples from conscious and
anesthetized animals did not contain significantly different quantities of DNA (P 
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FIG 1 Heatmap showing samples grouped by batch based on the time DNA was extracted from the samples. Bacterial OTUs were included where
they had an abundance of 5% in at least one sample. OTUs which were 5% abundant in a DNA extraction kit reagent control are indicated
by color (batch 1, green; batch 2, pink; batch 3, blue; and batch 4, yellow). DNA extraction kit reagent controls are labeled as Extraction Kit Batch
1 to 4. EBC samples from conscious and from anesthetized sheep are labeled EBC (cons) and EBC (anaes), respectively. OTUs which were 5%
abundant in an extraction kit control do not consistently appear in all samples in the same batch.
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0.182 by Wilcoxon signed-rank test); however, PSB samples contained significantly
more DNA than both EBC (cons) (P  0.002 by Wilcoxon signed-rank test) and EBC
(anaes) (P  0.002 Wilcoxon signed-rank test) samples.
No significant clustering of EBC by sampling method. Since EBC samples from
conscious sheep would be expected to include more bacteria from the upper respira-
tory tract than EBC samples from anesthetized sheep, it was expected that these two
groups of samples would cluster separately from one another. However, no significantly
separate clustering was observed (P  0.994 by AMOVA). Despite this lack of separate
clustering, EBC samples taken from the same sheep while it was conscious or anesthe-
tized did not contain the same bacterial communities, as can be observed in Fig. 3.
The richness and the diversity of bacterial communities were not significantly
different between the two groups (P  0.583 and P  0.595, respectively, by Wilcoxon
signed-rank test). When examined using Metastats, there were significant differences in
the quantities of several OTUs between these groups, but all of these OTUs were
present at low abundances (1% abundant on average in each group).
PSB samples and EBC (anaes) samples cluster separately by their bacterial
communities. We next investigated whether PSB and EBC samples contained equiva-
lent bacterial communities. We compared PSB samples with EBC (anaes) samples as we
hypothesized that these would be less likely to be contaminated by upper respiratory
tract microbes than EBC (cons) samples. As well as containing a larger quantity of
bacterial DNA, PSB samples also contained bacterial communities that were signifi-
cantly different from those of the EBC (anaes) samples (P  0.011 by AMOVA) (Fig. 4).
This may be explained by the difference in variation between the two groups (P 
0.026 by homogeneity of molecular variance [HOMOVA]). Bacterial communities from
PSB samples were also found to be significantly richer (P  0.006 by Wilcoxon
signed-rank test), but there was no significant difference in diversity (P  0.48 by
Wilcoxon signed-rank test). One OTU designated Pseudomonas veronii, which was the
4th most abundant OTU in PSB samples, was found to be significantly more abundant
in PSB samples (PSB samples [mean  SD], 3.9%  1.3%; EBC, only one sequence read
FIG 2 Boxplot showing the log 16S rRNA gene concentrations found in sheep respiratory samples (EBC
samples from conscious and anesthetized animals and PSB samples) and controls (protected specimen
brushes, DNA extraction kit reagents and qPCR reagents). Outliers were defined by SPSS as either “out”
values (circles) or “extreme” values (stars). PSB samples contained significantly more bacterial DNA (P 
0.005) than any other respiratory sample type or control.
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found in one sample; Metastats q value  0.046). The P. veronii OTU was not found in
any of the PSB controls, indicating that its presence is not likely due to contamination.
This indicates that the EBC samples do not simply contain a subset of the most
abundant OTUs from PSB samples. An additional 36 low-abundance OTUs (1%
abundant on average in either group) were found to be significantly different between
the two groups by Metastats.
We considered that since EBC (anaes) samples contained far less bacterial DNA than
PSB samples, they may have been more affected by contamination and this may be
why these sample types clustered separately. However, the five most abundant OTUs
found in DNA extraction kit reagent controls (Burkholderia, Neisseriaceae, Aggregatibac-
ter, Pseudomonadaceae, and Methylobacterium) were not found to be significantly
differently represented between PSB samples and EBC (anaes) samples (Metastats q
value  1). Therefore, it seems unlikely that the separate clustering of these groups was
due merely to the increased effect of contamination on EBC (anaes) samples.
Changes in the bacterial communities found in respiratory samples before and
after CMS treatment. For both EBC (cons) and EBC (anaes) samples, pre- and post-
treatment samples did not differ significantly by bacterial community structure (P 
FIG 3 Heatmap showing EBC samples grouped by sheep and time point. DNA extraction kit reagent controls are labeled as Extraction Kit Batch 1 to 4. EBC
samples from conscious and anesthetized sheep are labeled EBC (cons) and EBC (anaes), respectively. Bacterial OTUs were included where they had an
abundance of 5% in at least one sample. As can be observed, EBC samples taken from the same sheep when it was conscious and when it was anesthetized
did not necessarily contain the same bacterial OTUs.
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0.449 and P  0.094, respectively, by AMOVA). However, the bacterial communities
found in PSB samples were found to be significantly different pre- and posttreatment
(P  0.014 by AMOVA) (Fig. 5). This significantly separate clustering was not merely due
to differences in variation between the two groups (P  0.87 by HOMOVA). The OTU P.
veronii was increased in posttreatment samples (pretreatment [mean  SD], 0.74% 
0.39%; posttreatment, 7.1%  2.4%; Metastats q value  0.043), and a further 97
low-abundance (0.1%) OTUs were found to significantly differentiate pre- and post-
treatment samples.
Using the Wilcoxon signed-rank test, it was found that the concentrations of DNA in
respiratory samples before and after CMS treatment did not differ significantly: PSB
samples, P  0.689; EBC (cons) samples, P  0.345; and EBC (anaes) samples, P  0.248.
The concentrations of colistin A identified in sheep lungs are shown in Table 1.
DISCUSSION
In this study, we sought to identify whether invasive lung microbiota sampling
techniques could be replaced by a less invasive method. We compared the quantities
of bacterial DNA and the bacterial communities from samples taken by PSB and EBC
collection in six sheep at two sampling points. EBC was collected from both conscious
and anesthetized animals. During mechanical ventilation, the animals were intubated,
meaning that the exhaled breath collected was derived only from the lower respiratory
tract. By comparing these samples to those taken from conscious animals, it should be
FIG 4 PCoA graph showing the significantly separate clustering of EBC (anaes) and PSB samples from sheep (P  0.011 by
AMOVA), which may be due to the difference in variation between the two sample types (P  0.026 by HOMOVA). The OTUs
which most contributed to samples moving in a positive or negative direction along either axis and which had P values of 
0.00058 (defined by Bonferroni’s correction as 0.5 divided by the total number of OTUs), according to the corr.axes command
within mothur, are listed. As this graph is only representative of 20.3% of the total variability present between samples, caution
should be taken when interpreting how clustered the sample groups appear.
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possible to analyze the extent of contamination by bacteria from the upper respiratory
tract in EBC (cons) samples. We found that EBC samples contained significantly less
bacterial DNA than the PSB samples and that PSB samples clustered separately from
EBC (anaes) samples by the composition of their bacterial communities. EBC (anaes)
and EBC (cons) samples did not cluster separately from one another.
Studies examining the utility of EBC for identifying lung-colonizing microorganisms
have shown variable results. A study comparing EBC and sputum samples from asthma
patients showed a 100% overlap in the culturable fungi identified between the two
sample types (5), and a study examining the bacterial pathogens cultured from BAL and
EBC samples in patients with ventilator-associated pneumonia showed a high concor-
dance between the two sampling methods (16). In comparison, when PCR assays for 10
FIG 5 PCoA graph showing the significantly separate clustering of PSB samples from sheep before and after CMS treatment
(P  0.014 by AMOVA). The OTUs which most contributed to samples moving in a positive or negative direction along either
axis and which had P values of  0.00058 (defined by Bonferroni’s correction as 0.5 divided by the total number of OTUs),
according to the corr.axes command within mothur, are listed. As this graph is only representative of 24% of the total
variability present between samples, caution should be taken when interpreting how clustered the sample groups appear.





lining fluid in BAL
Mean colistin A concn
corrected for dilution
(ng/l)
ED951 0.346  0.056 5.45 1.89
ED952 0.320  0.034 4.18 1.34
ED953 0.290  0.061 6.45 1.87
ED954 1.549  0.251 15.75 24.40
ED955 0.625  0.159 11.43 7.15
ED956 0.222  0.017 29.5 6.56
aValues are the means  SD. Colistin B values were too low to be calculated accurately.
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common respiratory pathogens were performed on EBC and sputum samples from
chronic obstructive pulmonary disease patients, the results were found not to correlate
well (17). EBC collection has also previously been found to be inefficient for detecting
Mycobacterium tuberculosis (18), influenza viruses (19), and the common cystic fibrosis
pathogens Pseudomonas aeruginosa and Burkholderia cepacia (20).
Some concerns have been raised about the use of EBC in respiratory research, since
the epithelial lining fluid contained in these samples is often variable and is very highly
diluted with water vapor (21). This dilution could explain the far lower concentrations
of bacterial DNA we identified in EBC samples in comparison to those from PSB
samples. It is also likely that PSB would be more efficient for sampling biofilms adhered
to the lung mucosa, which could explain some of the differences observed between the
two sample types. The difference between the bacterial communities found in PSB and
EBC samples may also be partially explained by how EBC is formed. The exact origin of
EBC is still under debate, but it has been suggested that differences observed between
BAL and EBC samples could be explained by the fact that different compartments of the
lung are sampled (22). While it might be assumed that EBC would be derived from both
the central and peripheral airway compartments, which would perhaps explain the
differences between these samples and PSB samples, Bondesson et al. concluded that
the majority of EBC is in fact derived from the central airways (23). Without a better
understanding of how EBC is formed and what influences its composition, we are
unable to account for the differences we observed between the two sampling types.
Despite the fact that the concentrations of colistin found in the lungs were quite low
after nebulized CMS treatment, a significant difference was observed in the bacterial
communities from PSB samples pre- and posttreatment. In a previous study, we found
that the relative proportion of Gram-negative bacteria in the lung microbiota (exclud-
ing Pseudomonadales) was reduced after injected CMS treatment (9). However, mem-
bers of Pseudomonadales generally increased in relative abundance or remained stable
after treatment. Therefore, it is interesting to note that while in this study we did not
find a significant reduction in the abundance of Gram-negative bacteria in PSB samples
(data not shown), an OTU belonging to Pseudomonadales (P. veronii) was significantly
increased in these samples after CMS treatment. It is possible that, even at low
concentrations, the colistin may have had some effect on the lung bacteria or that the
sampling strategy may itself in some way lead to changes in the lung microbiota, but
at the moment, this is purely speculative. All samples were randomized prior to DNA
extraction and PCR amplification; therefore, the observed differences were not due to
samples from one time point being processed separately from those from the other
time point.
In conclusion, the differences we observed between PSB samples and EBC samples
lead us to not recommend using EBC collection as a replacement for more-invasive
lung sampling techniques. However, the EBC microbiota may still be an interesting
avenue of study despite the fact that the small quantities of bacterial DNA in these
samples leave them more vulnerable to contamination, and any future studies would
have to be designed with this in mind.
MATERIALS AND METHODS
Animals. Six commercially sourced, castrated male Suffolk-cross sheep aged 14 months were used
in this study. All animal experiments were approved by the Roslin Institute Animal Welfare and Ethics
Committee and were subject to the Animals (Scientific Procedures) Act of 1986. Sheep had previously
been housed outdoors as part of a large flock but were moved indoors before the study and remained
indoors until the study end. Sheep were separated into two pens sharing the same airspace. One pen
contained sheep ED951, ED952, and ED953, while the other contained sheep ED954, ED955, and ED956.
The rectal temperatures and weights of all animals were taken prior to the initial respiratory tract
sampling. The animals weighed on average ( SD) 49.2  3.4 kg and the rectal temperatures were
measured as 38.9  0.89°C.
Experimental design. Conscious animals were confined in a yoke head-restraint holding crate, and
EBC was collected for 10 min using an RTubeVENT with a cooling sleeve (Respiratory Research,
Charlottesville, VA, USA) attached to a face mask. The sheep inhaled through a one-way inspiratory valve
and expired through the RTubeVENT (Fig. 6). The exhaled breath condensate samples from conscious
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sheep (EBC [cons]) were transferred from the RTubeVENT into Eppendorf tubes according to the
manufacturer’s instructions and were frozen on dry ice within an hour of collection.
The sheep were then anesthetized (3 to 5 h later) according to a procedure that has previously been
described (24). Bronchoscopy was performed using an endotracheal tube. During anesthesia, EBC
samples were collected for 10 min by incorporating an RTubeVENT within the expiratory limb of the
anesthetic circuit (Fig. 6). The condensate was again transferred into Eppendorf tubes. The exhaled
breath condensate samples from the anesthetized sheep (EBC [anaes]) were frozen on dry ice within an
hour of collection. PSB samples (disposable microbiology brush; Conmed, Utica, NY, USA) were taken
from the left ventral diaphragmatic 1 (LVD1), right ventral diaphragmatic 1 (RVD1), right caudal
diaphragmatic (RCD), and left caudal diaphragmatic (LCD) lung segments (Fig. 7). Brushes were cut into
phosphate-buffered saline (PBS; Sigma-Aldrich, Irvine, UK) for storage. For each sampling day, an unused
protected specimen brush was cut into PBS to act as a control.
Eighteen hours after the recovery from anesthesia, sheep were administered 2,000,000 IU of CMS in
4 ml distilled water by inhalation (Colomycin for injection; Forest Laboratories UK Ltd., Dartford, UK).
Restraint of the conscious sheep was as described above, and the CMS was delivered using a face
mask connected via the inspiratory limb to an eFlow rapid nebulizer (PARI Respiratory Equipment
Inc., Midlothian, VA, USA). This treatment was repeated 6 h later. Two days after the first CMS dose
was administered, EBC (cons), EBC (anaes), and PSB samples were again collected as described
above. Sheep were killed by barbiturate overdose and exsanguination and blood samples were
collected. Blood was centrifuged at 2,500  g for 5 min and the serum was removed and frozen on
dry ice. Immediately postmortem, 20-ml aliquots of PBS were used to collect BAL fluid. The urea
concentrations in plasma and BAL fluid were used to calculate the dilution factor of lung epithelial
lining fluid in BAL fluid (25).
Quantitation of colistin in BAL fluid of sheep. BAL fluid was centrifuged at 1,400  g for 5 min to
remove cells prior to colistin quantification. The quantitation of colistin in ovine BAL fluid essentially
follows the method previously published by Marchand et al. (26). Briefly, colistin sulfate (item no. 17584
[mixture of A and B isoforms]; Cayman Chemicals, Ann Arbor, Ml, USA) was dissolved in H2O to 1 mg/ml
and a series of 7 calibrant solutions were created by diluting the stock solution into blank BAL fluid to
cover the range from 100 to 0.07 g/ml. Polymyxin B (Sigma-Aldrich, Irvine, UK) was used as an internal
standard and was dissolved in water to 300 g/ml. Two microliters of internal standard was added
to 200 l of each of the calibrant solutions and to 200 l of each of the test samples. Eight hundred
microliters of a solution of H2O and 0.1% (vol/vol) formic acid was added to each of the samples/
calibrants, and each was partially purified by binding to a DSC-18 SPE cartridge (Sigma-Aldrich,
Irvine, UK) and eluted with 400 l methanol (MeOH) and 0.1% (vol/vol) formic acid. The eluted
fractions were dried under vacuum and reconstituted in 50 l of H2O and 0.1% (vol/vol) formic acid
for subsequent analysis.
All calibrants and samples were centrifuged at 13,000  g for 5 min to pellet any precipitate and then
were analyzed by online liquid chromatography tandem-mass spectrometry (LC-MS/MS) in duplicate.
Aliquots of 5 l were injected into an Ace Ultracore 2.5 SuperC18 high-performance liquid chromatog-
raphy (HPLC) column (75 mm by 2.1 mm) preequilibrated with 98% (vol/vol) buffer A, where HPLC buffer
A was H2O with 0.1% (vol/vol) formic acid and 0.01% (vol/vol) trifluoroacetic acid, while HPLC buffer B
was acetonitrile with 0.1% (vol/vol) formic acid and 0.01% (vol/vol) trifluoroacetic acid. The HPLC
separation was developed by the following steps: from 2% buffer B at 0 min to 18% buffer B at 1 min,
22% buffer B at 3.5 min, 100% buffer B at 4 min, 100% buffer B at 5 min, and returning to 2% buffer B
at 6 min for 5 min to reequilibrate. The flow rate was 200 l/min and the eluent was passed directly to
FIG 6 (A) EBC was collected from conscious animals while they were restrained in a yoke head-restraint
holding crate. A face mask was attached and sheep inhaled through a short tube with an inlet valve and
exhaled through an RTubeVENT. (B) EBC was collected from anesthetized mechanically ventilated
animals by placing the RTubeVENT in-line with the expiratory limb of the ventilator, near the sheep’s
head.
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the electrospray source of an Amazon ETD ion trap mass spectrometer (Bruker, Billerica, MA, USA)
operated in positive-ion mode. The mass spectrometer was operated under multiple reaction monitoring
conditions, using parent ions of 578.3, 585.3, and 602.3 (representing the double-charged ion of colistin
B, colistin A, and polymyxin B, respectively), fragmentation amplitudes of 0.8, and cutoffs of 140 in each
case. Calibration curves and colistin concentrations were calculated by Bruker’s proprietary software
QuantAnalysis using the following reporter ions: 526.3, 535.3, 567.3, and 576.3 (colistin A); 519.3, 528.3,
560.800, and 569.3 (colistin B); and 543.300, 552.300, 584.300, and 593.3 (polymyxin B).
DNA extraction. DNA extraction was carried out as described previously (10) using the Mo Bio
PowerSoil DNA isolation kit (Mo Bio Laboratories Inc., Carlsbad, CA, USA). All DNA extractions were
carried out using extraction kits from the same lot, as the contamination present in different lots of the
same make of kit has been shown not to be consistent (27). Samples were randomly assigned to one of
four DNA extraction batches, and for each of these batches, an extraction kit reagent-only control was
produced (sample groupings can be found in Data Set S1 in the supplemental material).
16S rRNA gene amplification and sequencing. The V2-V3 variable regions of the 16S gene were
amplified as described previously (10). A nested PCR protocol was used to decrease the potential bias
introduced by the use of barcoded primers by only including primers with Illumina adaptor sequences
and barcodes in the second PCR round (28). The first round used the V1-V4 primers 28F (5=-GAGTTTG
ATCNTGGCTCAG-3=) and 805R (5=-GACTACCAGGGTATCTAATC-3=) and the second round used the V2-V3
primers 104F (5=-GGCGVACGGGTGAGTAA-3=) and 519R (5=-GTNTTACNGCGGCKGCTG-3=) with Illumina
adaptor sequences and barcodes (Data Set S1). The PCR conditions for the first round were 94°C for 2 min
followed by 20 cycles of 94°C for 1 min, 55°C for 45 s and 72°C for 1.5 min, followed by 72°C for 20 min.
The conditions for the second round were 98°C for 30 s followed by 20 cycles of 98°C for 10 s, 67°C for
30 s, and 72°C for 10 s, followed by 72°C for 2 min. Q5 High-fidelity 2 master mix (New England BioLabs,
Ipswich, MA, USA) was used for all reactions. After each PCR round, amplicons were purified using the
AMPure XP PCR purification system (Beckman Coulter, Brea, CA, USA). The Human Microbiome Project
mock community HM-783D (obtained through BEI Resources, NIAID, NIH) also underwent PCR alongside
samples and controls. The Qubit dsDNA HS assay kit (Thermo Fisher Scientific, Hemel Hempstead, UK)
was used to calculate the quantity of DNA in each sample, and then samples were pooled into a
sequencing library. Sequencing was performed using Illumina MiSeq (Illumina, San Diego, CA, USA)
producing 250-bp paired-end reads.
Bioinformatic and statistical analysis. Primers were removed with cutadapt (29) and sequences
with greater than one base error per 10 bases were discarded. Quality control, taxonomic assignment,
and OTU clustering were performed in mothur (30) as described previously (10). The data were
FIG 7 Diagram of the sheep lung. PSB samples were taken before and after colistimethate sodium
treatment from the right ventral diaphragmatic 1 (RVD1), left ventral diaphragmatic 1 (LVD1), right caudal
diaphragmatic (RCD), and left caudal diaphragmatic (LCD) lung segments. RC, right cardiac; RA, right
apical; LC, left cardiac; LVD2, left ventral diaphragmatic 2; RVD2, right ventral diaphragmatic 2. Adapted
from reference 24.
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subsampled to the minimum number of sequence reads found in one of our samples (11,675). Except
where stated, the following analyses were all performed within mothur.
Good’s coverage values were calculated to estimate sample coverage (31). Distance matrices were
constructed using Yue-Clayton theta values (32), and AMOVA was used to compare groups of samples
by their bacterial composition (33). HOMOVA was used to compare groups by their variation (34).
Principal-coordinate analysis (PCoA) graphs were constructed to visualize sample clustering. The mothur
command corr.axes was used to correlate bacterial OTUs to the axes of the PCoA graphs using the
Spearman’s rank correlation coefficient (r). Bonferroni’s correction was used to correct for multiple
statistical tests. The inverse Simpson’s index was employed to measure microbial diversity and the Chao
1 index was employed to measure richness. Metastats was used to identify OTUs which were significantly
different between groups (35) except where more than two groups were compared, in which case
indicator analysis was used (36).
To compare groups statistically when data were nonparametric, the Mann-Whitney U test was used
if the groups were independent and the Wilcoxon signed-rank test was used when samples were related
(performed in SPSS Statistics 21; IBM Analytics). Boxplots for qPCR data were constructed in SPSS.
Heatmaps were constructed in R (version 3.2.2; R Foundation for Statistical Computing) using the
packages gplots (37), heatplus (38), RColorBrewer (39), and Vegan (40).
qPCR. Quantification of the V3 region of the 16S rRNA gene was carried out using a previously
described method (10). A standard curve was generated using DNA extracted from Pseudomonas
aeruginosa strain PA0579 using 9 serial dilutions ranging from 14.2 ng/l to 1.42  107 ng/l
(quantified by the Qubit dsDNA HS assay). The 0.142 ng/l dilution served as a positive control for all
qPCRs. The average threshold cycle (CT) value of no-template controls was 28.7.
qPCR was performed using 1 l of extracted DNA solution, the primers UniF340 (5=-ACTCCTACGG
GAGGCAGCAGT-3=) and UniR514 (5=-ATTACCGCGGCTGCTGGC-3=) at a final concentration of 0.4 M, and
the LightCycler 480 SYBR green I master mix (Roche Applied Science, Mannheim, Germany). The qPCR
run consisted of a preincubation step (50°C for 2 min and 95°C for 10 s), an amplification step (45 cycles
of 95°C for 30 s and then 63°C for 30 s), and a melting cycle.
Accession number(s). Sequencing reads can be accessed under BioProject accession number
PRJNA337937.
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It is interesting to note that the concentrations of colistin achieved in this study were far lower than 
was achieved in the sheep described in Section 5.1. More doses were delivered to this sheep over a 
longer treatment period than were administered to the study sheep, which may explain this 
discrepancy. In future studies I would recommend using this more prolonged treatment regime in 
order to ensure that bactericidal levels of colistin are produced in the epithelial lining fluid.  
We were able to demonstrate that samples taken directly from the lung were not equivalent to samples 
taken by EBC. In Chapters 3, 4 and 5 samples have been collected directly from the lung in separate 
sheep populations. It is possible that by comparing the results from these Chapters more general 
conclusions about the composition of the sheep lung microbiota across populations could be reached.  
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Chapter 6: Identifying Core Members of the 





During the previous results chapters I have explored the variability of the lung microbiota spatially 
and between sheep, compared upper and lower respiratory tract samples and examined the potential 
use of exhaled breath condensate as a non-invasive lung microbiota sampling method. During each of 
these chapters lung sampling methods were chosen which did not expose samples to potential 
contamination from the upper respiratory tract; in Chapters 3 and 5 this consisted of protected 
specimen brushings in live animals and in Chapter 4 it consisted of PBS lung washes of dead animals. 
While the types of bacteria identified in these samples can begin to give us some idea of the 
composition of the sheep lung microbiota, none of these chapters individually are able to address 
ZKHWKHUWKHUHLVDµFRUH¶OXQJPLFURELRWDVKDUHGDFURVVVKHHSSRSXODWLRQVDVHDFKFKDSter contains 
samples from only one population of sheep. The differences observed between samples taken from the 
oropharynx and lower respiratory tracts of lambs in Chapter 4 would indicate that if a core sheep lung 
microbiota exists it is unlikely to be reminiscent of the oropharynx. If core bacterial OTUs can be 
identified in the sheep lung, it would be interesting to culture and better characterise these microbes, 
potentially leading to a better understanding of their significance and role in the lung.  
By comparing the bacterial OTUs found in lung samples across my results chapters it may be possible 
to identify OTUs which are found in lung samples from all three sheep populations. One potential 
issue with this approach is that differences in the methods used between chapters might lead to 
differences in results, including the use of different lung sampling techniques. Therefore, in this 
chapter I first compare sequencing errors, taxonomic identifications, coverage and DNA 
concentrations in control and lung samples between results chapters. I also compare staggered and 
even mock communities, in order to identify any biases which may be present due to my PCR 
amplification and sequencing strategies. Finally, I compare lung samples to reagent controls across 
results chapters to create a list of potential core members of the sheep lung microbiota. Where lung 
samples are referred to in this chapter this refers only to samples taken directly from the lungs (lung 
brushings and lung washes) and does not include EBC or upper respiratory tract samples (see Table 




Table 6.1: Samples included in this chapter 
Chapter Sample types Sample details 
3 Protected specimen 
brushings 
N=6 sheep (20 months old, 5 females and one castrated 
male): All brushings from all time-points. Total of 54 
samples. 
 
N=1 sheep (36 months old, female): Brushings A3-A9 and 
A13-A19. Total of 14 samples.  
4 Whole lung lavage N=40 sheep (48.8 days (mean) ± 0.8 (SD) old, 20 females 
and 20 males. All lung fluid samples, totalling 40 samples.  
5 Protected specimen 
brushings 
N=6 sheep (14 months old, 6 castrated males). All protected 
specimen brushing samples, totalling 48 samples.  
 
6.2 Results and discussion 
 
6.2.1 Differences in error rate, taxonomic identification, coverage and 
sequence numbers across results chapters 
Caution should be taken when comparing results across my thesis chapters as different methodologies 
were used in each chapter. While ideally I would have used the same sequencing platform and the 
same number of sequencing runs for every results chapter, this was unfortunately not possible. 
Differences caused by changes in sequencing methodology may make comparisons between chapters 
more difficult. When comparing sequence error rates, sequences per sample and the level of 
taxonomic depth to which sequences were classified, variation was observed between chapters (Table 
6.2). While the sequencing error rates are similar for Chapters 3 and 4 (0.39% and 0.35%), the error 
rate for Chapter 5 is substantially reduced (0.18%). Chapter 5 also had the highest percentage 
reduction in sequences during quality control. The average number of sequences per sample was also 
far less in Chapter 5 compared to the other results Chapters, which would be expected to cause 
decreased coverage. The lowest DYHUDJH*RRG¶VFRYHUDJHYDOXHZDVfound in Chapter 5 (0.992 ± 
0.00369 (mean ± SD), Table 6.2).  
Some of the differences between chapters can be accounted for by a problem which occurred in 2015 
with the Illumina MiSeq reagents which led to greatly decreased quality of longer reads (personal 
communication ± Edinburgh Genomics). As a result, samples from between June 2015 (when the 
problem arose) and May 2016 (when improved sequencing kits became available) were sequenced 
using the Illumina HiSeq. Some of the samples included in Chapters 3 and 4 were sequenced during 
this period and some were sequenced prior to it. All sequencing for Chapter 5 was done post May 
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2016. The Illumina HiSeq produces ten times as many reads per run than the MiSeq which explains 
the differences in average read numbers per sample. It is possible that the improved sequencing kits 
are responsible for the decrease in the error rate observed in Chapter 5 but this is currently speculative.  
Between chapters, a similar percentage of sequences were able to be assigned to the taxonomic level 
of family (Chapter 3: 95.6%, Chapter 4: 95.4%, Chapter 5: 95.5%) and only a small degree of 
variation was observed between the percentages of sequences assigned to a genus (Chapter 3: 79.1%, 
Chapter 4: 76.2%, Chapter 5: 75.2%). However, sequences in Chapter 4 were around half as likely to 
be assigned to a species (16.5% in comparison to 36.1% and 32%). Differences in the types of bacteria 
found in lung samples across results chapters may have had an impact on the taxonomic depth to 
which sequences could be assigned. 
Table 6.2: Comparing error rates, sequences per sample and taxonomic depth across 
results chapters 
 Chapter 3 Chapter 4 Chapter 5 
Sequencer used MiSeq and HiSeq MiSeq and HiSeq  MiSeq  
Sequence error rate  0.39% 0.35% 0.18% 
Reduction in 
sequences due to 
quality control* 
(Mean ± SD) 
22.4% ± 12.3% 16.2% ± 5.2% 25.8% ± 4.8% 
Average sequences per 
sample (Mean ± SD) 
205,625 ± 27,232 138,125 ± 29,306 39,241.5 ± 11,532.2 
*RRG¶VFRYHUDJHRI
samples (Mean ± SD) 
0.995 ± 0.00312 0.998 ± 0.000827 0.992 ± 0.00369 
Percentage of reads 





















* Includes reductions due to primer removal and quality control carried out within mothur  
It is also possible that sequencing errors may have led to errors in taxonomic assignments; the lowest 
error rate in my results chapters is 0.18% which for a 415 bp sequence would mean that on average 
there would be 0.747 base errors per sequence. Although it is unlikely that a small amount of 
sequencing errors would change the taxonomic assignment of sequences at genus level, it is possible 
that it would affect their assignment at species level as differences between the 16S rRNA gene 
sequences of species from the same genus are often small or completely absent (134). Also, it is likely 
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that the diversity of species from less well studied genera represented in 16S databases will be low. 
For these reasons, species level assignments must be treated with caution; this will be further 
discussed in the following section. 
 
6.2.2 Differences between mock communities 
In Chapter 3 a mock community was sequenced which contained even 16S rRNA gene copies of 
twenty bacterial species (1:100 dilution). In Chapter 5, a community containing the same species but 
using staggered quantities of the 16S gene (1,000 to 1,000,000 copies per organism per µl) was 
sequenced. As the sequencing error rate for these chapters was different, I wanted to check whether 
this affected the types of biases observed in the mock communities. Bias appears to be consistent 
between the two communities, with reductions or increases in actual vs expected reads for each 
species being roughly equivalent (Table 6.3). The fact that the majority of the members of the even 
mock community could be assigned to the correct genus gives me confidence that the protocol I used 
to generate my results is able to identify a wide range of bacterial taxonomies reliably down to genus 
level. While the majority of the bacteria in the staggered mock (Chapter 5) were identified correctly to 
genus level, three were incorrectly identified to species level. In contrast, all of the bacteria identified 
to species level in the non-staggered community were correctly identified (Chapter 3). This again 
emphasises the importance of caution when 16S OTUs are assigned to species level. 
,ZDVDOVRDEOHWRDVFHUWDLQXVLQJWKHPRFNFRPPXQLW\GDWDWKDWZKLOHP\*RRG¶V coverage values 
ZHUHRQDYHUDJHSHUFKDSWHUP\SURWRFROPDy still not be identifying rare species. Three of the 
bacterial species which were present in low numbers in the staggered community were not identified 
at any taxonomic level: Actinomyces odontolyticus, Bacteroides vulgatus and Enterococcus faecalis. 
In the even mock community these species were identified down to genus level therefore their absence 
in the staggered community is likely due to the fact that the sequencing depth was not high enough to 
capture these low abundance organisms rather than the inability of my protocol to amplify and 
identify them. It is not possible to assess whether the depth of sequencing in Chapters 3 and 4 would 
have been enough to identify these low abundance organisms as a staggered community was not 
included in these chapters. In future studies it might be useful to include both an even and staggered 
mock community in all sequencing runs in order to assess both bias and the adequacy of sequencing 
depth.   
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Table 6.3: Comparing even and staggered mock communities  
 Even community Staggered community 
Species Abundance 










5% : 1.12% Genus 0.022% : 0% Not identified 
Bacillus cereus   Family  Family 
Bacteroides vulgatus 5% : 10.90% Genus 0.022% : 0% Not identified 
Clostridium 
beijerinckii 




5% : 7.61% Genus 0.022% : 0.041% Genus 
Enterococcus faecalis 5% : 2.63% Genus 0.022% : 1.13% Not identified 
Escherichia coli  Family  Family 
Helicobacter pylori 5% : 12.65% Species 0.22% : 4.72% Species 
Lactobacillus gasseri 5% : 6.59% Genus 0.22% : 0.11% Genus 
Listeria monocytogenes  Family  Family 




5% : 1.77% Species 0.22% : 0.041% Species 
Pseudomonas 
aeruginosa 
5% : 3.70% Genus 2.19% : 3.82% Genus 
Rhodobacter 
sphaeroides 
5% : 5.29% Species 22.01% : 22.00% Species 
Staphylococcus aureus 5% : 1.12% Species 2.19% : 1.22% Species 
Staphylococcus 
epidermidis 
5% : 1.85% Species 22.01% : 21.56% Species 
Streptococcus 
agalactiae 
5% : 0.24% Species 24.12% : 1.38% Genus 
 
Streptococcus mutans 5% : <1.63% Genus 
Streptococcus 
pneumoniae 
5% : <1.63% Genus 




6.2.3 Difference between the quantities of DNA in controls and lung 
samples 
Different lung sampling methods may be more or less efficient at sampling the lung microbiota. The 
quantity of bacterial DNA in the original sample is inversely related to the quantity of contaminating 
DNA identified in the sample after sequencing (140); therefore, it is important to identify which 
sampling techniques lead to greater bacterial DNA yield. Samples in all chapters underwent qPCR as 
described in Section 2.14 to measure the quantity of bacterial DNA present. On average, DNA 
extraction kit reagent controls across all chapters contained 1.97 x 10-7 ± 1.10 x 10-7 ng/µl while lung 
samples contained 7.23 x 10-5 ± 3.89 x 10-4 ng/µl. Extraction kit controls contained significantly less 
bacterial DNA than lung samples (Kruskal-Wallis: P<0.001) (Fig. 6.1). Therefore, while 
contamination from reagents may have contributed towards the observed composition of the bacterial 
communities in samples, it is likely that the majority of the bacterial DNA in lung samples did not 
derive from contamination.  
 
Figure 6.1: Boxplot showing the log concentrations of bacterial DNA found in lung 
samples and DNA extraction kit reagent controls across results chapters. Amplified 
DNA consisted of a 179 bp fragment of the V3 region of the 16S rRNA gene. Lung 
samples from Chapters 3 and 5 were taken via bronchial brushings whereas lung 
samples in Chapter 4 were taken by post-mortem whole lung PBS washes. Lung 
samples contained significantly greater quantities of bacterial DNA than reagent 
controls (Kruskal Wallis: P<0.001) and significantly different concentrations of 
bacterial DNA across chapters (Kruskal Wallis: P<0.001). 
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The quantity of bacterial DNA found in lung samples was significantly different between results 
chapters (Kruskal Wallis: P<0.001). The concentration of bacterial DNA measured on average in lung 
samples was: Chapter 3: 9.90 x 10-6 ± 5.43 x 10-6 ng/µl; Chapter 4: 2.47 x 10-4 ± 7.48 x 10-4 ng/µl and 
Chapter 5: 1.53 x 10-5 ± 2.96 x 10-5 ng/µl. Lung samples from Chapters 3 and 5 consisted of protected 
specimen brushings whereas samples from Chapter 4 consisted of whole lung washes which may 
explain the greater bacterial DNA concentrations found in Chapter 4, as lung washings sample a larger 
lung area than brushings. Another possible explanation is that there was increased contamination from 
the PBS used to produce lung washings but this seems unlikely as on average PBS controls contained 
1.03 x 10-6 ± 1.31 x 10-6 ng/µl of bacterial DNA, two orders of magnitude lower than the average 
quantity of DNA found in the lung samples from this chapter.  
 
6.2.,GHQWLI\LQJµFRUH¶PHPEHUVRIWKHVKHHSOXQJPicrobiota 
It has previously been noted that different lots of DNA extraction kit from the same manufacturer can 
contain different types of bacterial DNA contamination (140). As I used several lots of the Mo Bio 
Powersoil DNA extraction kit to produce the results contained in my thesis I hypothesised that the 
types of contaminating DNA found in my reagent controls would change depending on the lot from 
which they were taken. Unfortunately, extraction kit lot information is not available for all of the 
DNA extraction kits I used during my thesis. However, it is still possible to make some conclusions 
based upon the available data.  
Differences can be observed in the predominant bacteria found in DNA extraction kit reagent controls 
based upon the DNA extraction batch in which they were processed (Fig. 6.2). Some samples were 
dominated by specific bacterial genera (Methylobacterium for 25/03/2015-1/05/2015 batches or 
Burkholderia for the 28/07/16 batch) whereas others contained more diverse bacterial communities. 
The controls produced between the 26/07/2016-28/07/2016 all originated from the same extraction kit 
lot yet differences can still be observed between them. 
Salter et al. concluded that the majority of contaminating DNA in extraction kit reagents originated 
from bacteria which are normally found in water, soil and human skin (140). Genera found at 5% 
abundance in at least one of my DNA extraction kit reagent controls contain some bacterial species 
which can be isolated from these environments including Acinetobacter, Actinomyces, Burkholderia, 
Corynebacterium, Enhydrobacter, Kocuria, Leuconostoc, Methylobacterium, Micrococcus, 
Paracoccus, Pelomonas, Propionobacterium, Pseudomonas and Staphylococcus. However, my data 
does not support removing all of the genera/OTUs found in extraction kit controls from my datasets as 
several of the genera reported in my controls also contain species which can colonise the respiratory 
tract including Actinobacillus, Aerococcus, Aggregatibacter, Anaerococcus, Burkholderia, 
Corynebacterium, Gamella, Mycobacterium, Micrococcus, Pseudomonas and Veilonella. Removing 
OTUs taxonomically assigned to these genera may mean removing reads belonging to true members 
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of the lung microbiota. As the majority of my sequencing reads were only assigned to genus and 
species level assignments are often inaccurate, it is not possible to tell the exact origin of the OTUs 
found in my controls and there is therefore no way of knowing whether they belonged to species 
which commonly inhabit environmental or respiratory samples.  
 
Figure 6.2+HDWPDSRIEDFWHULDOJHQHUDSUHVHQWDWDEXQGDQFHLQDWOHDVWRQH'1$
extraction kit reagent control. The bacterial genera found in reagent controls are 
highly variable between DNA extraction batches. The chapters to which each control 




which are able to be identified in lung samples across all of my results chapters but are not frequently 
identified in reagent controls. Several bacterial OTUs occurred on average in >1% of lung samples but 
in <0.1% of reagent controls in each chapter (Table 6.4). The only OTU for which this was the case in 
all chapters was Jeotgalicoccus psychrophilus. It was also found to be the case in two chapters for the 
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following OTUs: Staphylococcus sciuri, Staphylococcus equorum and Mannheimia. These OTUs 
were also found in lamb throat swabs produced in Chapter 4: J.psychrophilus (0.039% ± 0.10%), 
S.sciuri (0.18% ± 0.56%), S.equorum (0.32% ± 1.03%) and Mannheimia (8.85% ± 11.19%). It must 
be emphasised that species level assignments of OTUs using 16S sequences are highly unreliable and 
we may instead say that it is likely that at least one bacterial species of the genera to which these 
species belong were common colonisers of the sheep lung in my studies.  
Staphylococci and Mannheimia are common inhabitants of the upper respiratory tract in farm animals 
(234). Jeotgalicoccus spp. have also previously been found in low abundance in the upper respiratory 
tracts of sheep, cows, pigs, rabbits, hamsters, cats, humans, dogs and seals (44, 235-237). That this 
genus has not previously been identified during culture based studies of the sheep lung may be due to 
the fact that the microbes in the lung are low in abundance or it may be because this genus can easily 
be mistaken for coagulase-negative Staphylococcus spp. using traditional culturing and identification 
techniques (238). In future studies it might be of interest to attempt to isolate and culture 
Jeotgalicoccus from the sheep lung in order to better characterise it and to analyse whether it plays a 




Table 6.4: OTUs found on average in <0.1% of negative controls but >1% of lung 
samples 
Chapter OTU Abundance (%) in lung 
samples (Mean ± SD) 
Abundance (%) in reagent 
controls (Mean ± SD) 
Chapter 3* 
 
Staphylococcus sciuri 5.9 ± 5.0 0 ± 0 
Staphylococcus equorum 5.7 ± 6.0 0 ± 0 
Jeotgalicoccus psychrophilus 5.4 ± 6.0 0 ± 0 
Ruminococcaceae 2.6 ± 2.9 0 ± 0 
Granulicatella 1.6 ± 2.5 0 ± 0 
Prevotella 1.6 ± 4.0 0 ± 0 
Bacilli 1.5 ± 4.5 0 ± 0 
Bibersteinia 1.4 ± 5.8 0 ± 0 
Clostridiales 1.1 ± 1.9 0 ±0 
Neisseriaceae 1.1 ± 2.4 0 ± 0 
Staphylococcus epidermidis 1.1 ± 1.9 0 ± 0 
Chapter 4 Staphylococcus equorum 13.3 ± 9.6 0.01 ± 0.02 
Mannheimia 5.3 ± 21.6 0.03 ± 0.06 
Streptomyces 2.0 ± 3.8 0 ± 0 
Peptostreptococcaceae 1.8 ± 2.2 0.007 ± 0.02 
Jeotgalicoccus psychrophilus 1.6 ± 2.1 0 ± 0 
Microbacterium aurum 1.2 ± 2.8 0 ± 0 
Brevibacterium 1.2 ± 1.4 0 ± 0 
Variovorax paradoxus 1.2 ± 1.8 0.004 ± 0.009 
Turicibacter 1.0 ± 1.8 0 ± 0 
Chapter 5 Mannheimia 6.5 ± 16.6 0.005 ± 0.006 
Staphylococcus sciuri 5.6 ± 5.1 0.005 ± 0.009 
Pseudomonas veronii 3.9 ± 9.0 0.001 ± 0.003 
Jeotgalicoccus psychrophilus 2.4 ± 3.0 0.002 ± 0.004 
Paracoccus 1.6 ± 7.4 0.004 ± 0.01 
Brachybacterium 1.3 ± 1.6 0.001 ± 0.003 




When comparing results across my chapters it is important to keep in mind that I identified differences 
in terms of the error rates, quantity of sequences per sample and taxonomic assignment of sequences 
between chapters. I also identified significant differences in the quantities of bacterial DNA extracted 
from lung samples between chapters. Despite these differences, I identified several bacterial OTUs 
which were abundant in lung samples but not in their corresponding DNA extraction kit reagent 
controls, namely J.psychrophilus, S.sciuri, S.equorum and Mannheimia.   
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In this thesis I have investigated the composition, diversity and dynamics of the bacterial lung 
microbiota in sheep. There are still many basic questions left to answer about the bacterial 
communities in the lungs. For example, whether certain communities are better at providing 
colonisation resistance against pathogens; whether it is possible to manipulate the lung microbiota 
through the use of prebiotics or probiotics, and how longitudinally stable the lung microbiota is in the 
healthy individual. While some of these questions may be able to be answered by studies of humans, 
others would require the use of disease challenge experiments or the delivery of potentially infectious 
microorganisms into the lungs. There are obvious ethical problems with performing these types of 
experiments in humans, therefore a large animal model with a similar respiratory system to humans 
would be highly useful. The sheep has previously been used as large animal model in various 
respiratory disease studies due to the similarity of the sheep and human respiratory and immune 
systems (11, 12), which prompted us to explore whether they could be used to study the lung 
microbiota.  
During my PhD, a greater understanding of the impact which DNA contamination of reagents can 
have on lung microbiota studies has arisen in the research community. If I were to start my PhD again 
then I would have included more controls in my study described in Chapter 3, which would have 
potentially allowed me to explore how the lung microbiota changes over time. However, I did include 
appropriate negative controls in the studies which followed (Chapter 4 and Chapter 5) and I included 
mock community controls which allowed me to characterise the inevitable bias which arises from 
using 16S methodologies to study the microbiota. The presence of bacterial DNA contamination 
arising from equipment and reagents is unfortunately inevitable in microbiota studies and cannot be 
removed completely.  
Another factor which I would change if I were able to start my PhD again is the variable regions of the 
16S gene which were chosen for analysis. At the time our studies were designed the V2-V3 region 
was thought to be a good choice for studying the lung microbiota as it was thought that the long read 
produced would allow for our sequences to be identified to a greater taxonomic depth (see Section 
2.10). However, the use of an amplicon of this length led to greater sequencing errors due to the small 
overlap of the forward and reverse reads produced by the Illumina sequencers. It may therefore have 
been more advantageous to have used a shorter amplicon, such as that which would been produced by 
amplifying the V4 region of the 16S gene.  
Despite these issues, my thesis contains several studies which have allowed us to gain a better 
understanding of the sheep lung microbiota. In the following sections I will summarise the objectives, 
results and conclusions of each of my results chapters, along with the limitations associated with each 




7.1 Variability of the Lung Microbiota 
 
In Chapter 3 my objective was to provide one of the first descriptions of the sheep lung microbiota 
using 16S rRNA gene sequencing and to characterise the inter- and intra-individual variation present. 
I found that in some sheep there were large differences in the bacterial communities colonising each 
of the three sampled lung segments, while other sheep contained communities which were similar at 
all sampling locations (Chapter 3: Fig. 5). Although spatial variability was observed, samples still 
clustered by the sheep from which they were taken indicating that there are host factors which 
influence lung microbiota composition (Chapter 3: Fig. 6). Dickson et al. found similar results in 
humans and also observed that samples taken from closer to the upper respiratory tract resembled 
bacterial communities from that niche more than samples which were taken from lower in the 
respiratory tract (28). In my study, differences were also observed in the lung microbiota based upon 
sampling depth. When more extensive lung brushing samples were taken from an individual sheep, 
samples were found to cluster by the depth in the lung from which they were taken. While 
investigating samples from this sheep I also found that samples which were taken from lung sites 
located only a few centimetres away from one another did not have the same bacterial community 
compositions (Chapter 3: Fig. 7). This is the first time that the lung microbiota has been examined at 
this spatial scale in a healthy individual and it leads me to question whether it is possible to routinely 
include enough sampling locations in lung microbiota studies to take into account the full level of 
variation which may be present across the lung. 
The main limitation inherent to this study is that at the time it was carried out it was not yet well 
known that different lots of DNA extraction kit contained different types of bacterial DNA (140). As 
such, a DNA extraction kit control was not included for every lot of kit and for some samples reagents 
from multiple lots were used. This meant that, while this study included samples taken at three time-
points, I could not perform an analysis of the longitudinal variability of the sheep lung microbiota as 
the samples from each time-point were processed using different lots of kit and at different times. It 
was therefore not possible to separate out whether the clustering of samples by time-point was due 
only to differences in the contamination to which the samples had been exposed. Characterising the 
longitudinal variability of lung bacterial communities is still of interest and could be achieved by 
repeating this study with appropriate reagent controls and samples which were randomised into DNA 





7.2 Comparing microbiotas in the upper aerodigestive and 
lower respiratory tracts of lambs  
 
In Chapter 4 I sampled the lung microbiota in forty lambs in order to gain a better understanding of 
the types of bacteria which could be found in the sheep lung. I also compared upper and lower 
respiratory tract samples to see how similar the microbiota at these two sites were to one another. I 
found that swabs taken from the oropharynx separated into rumen-like and upper respiratory tract-like 
samples based upon their microbiota compositions. I was unable to conclude whether this represented 
recent rumination or the leakage of gut contents into the upper respiratory tract post-mortem. This is 
one of the main limitations of this study as my samples were donated from a separate study where the 
short time between death and sampling was crucial, and it was of more importance to get the lambs to 
the dissection table quickly rather than attempting to prevent any leakage of stomach contents while 
the lambs were being moved.  
Regardless, lamb lung fluids did not resemble either the rumen-like or upper respiratory tract-like 
samples or DNA extraction kit controls in terms of their microbiota composition (Figs. 4.1 and 4.2). 
In humans, although supraglottic samples do cluster separately from lung samples by their microbiota 
compositions (28), the upper and lower respiratory microbiotas are much more alike than in my 
samples (20, 23, 49). This may be due to anatomical differences between sheep and humans; for 
example, the fact that sheep ruminate may mean that they have more anatomical barriers to 
microaspiration (229). However, my results indicate that microaspiration may still occur in sheep as 
common members of the ruminal microbiota such as Prevotella, Clostridiales, Ruminococcaceae, 
Lachnospiraceae and Butyrivibrio could be identified in lung samples. Other possible differences 
between sheep and humans which could influence the lung microbiota composition are that sheep 
produce more saliva, have increased amounts of nasal breathing and have horizontally, rather than 
vertically, positioned lungs (230, 231).  
In future studies it would be interesting to compare samples taken from lambs to those taken from 
adult sheep from the same flock in order to see if there are any differences in the lung microbiota 
based on age. A longitudinal study which sampled the lung microbiota of the lamb as it aged in order 
to better understand how the respiratory microbiota develops would also be of interest and if samples 
were additionally taken from mother ewes it may be possible to detect if WKHPRWKHU¶VPLFURELRWD





7.3 Microbiota in exhaled breath condensate and the lung 
 
In Chapter 5 of my thesis I sought to assess whether exhaled breath condensate samples could be used 
as a replacement for more invasive lung sampling techniques. I also wanted to discover whether 
nebulised antibiotic treatment affects the lung microbiota composition. I found that samples produced 
by bronchial brushings contained significantly more bacterial DNA than samples taken by EBC 
collection (Chapter 5: Fig. 2). This is most likely due to the epithelial lining fluid in EBC being highly 
diluted with water vapour (239).  
As EBC from conscious animals has to pass through the upper respiratory tract but EBC from 
anaesthetised animals does not, I hypothesised that these samples would cluster separately by their 
microbiota compositions; however, they did not. This is not to say that these two sample types are 
interchangeable as EBC samples from the same animal when it was conscious or anaesthetised did not 
contain the same bacterial communities (Chapter 5: Fig. 3). Brushings and EBC samples from 
anaesthetised animals were found to contain significantly different bacterial communities (Chapter 5: 
Fig. 4), which may have been caused by the fact that EBC samples a larger area of the lung than is 
sampled by brushings (240). While some studies have found that EBC collection is an efficient 
method for sampling lung microbes (97, 241) other studies have found that it is inefficient at detecting 
the presence of potentially pathogenic lung microorganisms (242-245). Although my results lead me 
to conclude that EBC cannot be used to replace more invasive lung sampling methods when studying 
the lung microbiota, there are other potential uses for EBC collection in 16S studies. For example, 
collecting EBC from animals which are at risk of bovine respiratory disease or pasteurellosis could be 
useful for monitoring the types of exhaled bacteria which these animals are exposing each other to. 
During this study we also treated the sheep with colistimethate sodium and sampled the respiratory 
tract pre and post treatment. Although relatively low concentrations of colistin were detected in the 
epithelial lining fluid, brushing samples were found to cluster separately pre and post treatment by 
their microbiota compositions (Chapter 5: Fig. 5). Previously we showed that injection with 
colistimethate sodium was correlated with changes in the sheep lung microbiota (115). Studies 
examining the effects of antibiotic treatment on the human lung microbiota have all been carried out 
in patients with lung disease, therefore it is difficult to compare them directly to our findings. In two 
studies looking at changes in the lung flora due to antibiotic treatment, one in cystic fibrosis patients 
and one in cattle affected by bovine respiratory disease (74, 132), it was found that the effects of 
antibiotic treatment were transient. Both of these studies were carried out in individuals whose lungs 
were infected by pathogenic microorganisms and where antibiotic treatment was designed specifically 
to reduce the number of these organisms. To discover whether antibiotic effects are transient in the 
healthy lung, a similar experiment to the one described in this results chapter could be carried out, 
with a larger amount of sampling points post treatment. This would enable us to assess whether it is 




7.4 Identifying core members of the sheep lung microbiota  
 
In my final results chapter I analysed the inter-study variability across my three previous results 
FKDSWHUVDQGDWWHPSWHGWRLGHQWLI\SRWHQWLDOµFRUH¶PHPEHUVRIWKHVKHHSOXQJPLFURELRWD,IRXQGWKDW
there were differences between my results chapters in terms of the sequencing error rates, taxonomic 
identifications of sequences, coverage and sequence numbers per sample (Table 6.2). Some of this 
variation is likely to be due to the fact that different sequencing platforms, numbers of sequencing 
runs and versions of Illumina chemistry were used in the three chapters. I do not feel confident in 
stating that the species level assignments in my chapters are accurate as the sequencing error rates 
indicate that it is likely that errors will have been present in many of my sequences. As species within 
the same genus can have highly similar 16S rRNA gene sequences it is logical to treat species level 
assignments with caution. I have more confidence that my protocol is able to correctly assign 
sequences to genus as the mock community genus level assignments were all correct.  
Consistent biases were identified in my mock communities (Table 6.3) which may have been caused 
by my DNA extraction, PCR amplification, sequencing or bioinformatic methodologies (or by a 
combination of these) (158). One identified bias which is of some concern is the underrepresentation 
of Streptococcus species. Streptococcus are common members of the upper respiratory tract 
microbiota in many animals and it is therefore plausible that they might also form part of the lung 
microbiota. It is also possible that some rarer members of the lung microbiota will not have been 
identified in my samples as several of the rarer members of my staggered mock community were not 
found in my dataset after sequencing, despite the apparently high coverage values obtained for all of 
my samples. I would therefore recommend including in every sequencing run two mock communities, 
one with equal copies of the 16S genes from each bacterial species and one containing staggered 
quantities of the 16S genes from the same bacterial species. This will allow for both the identification 
of biases and for the level of coverage to be better characterised.  
DNA contamination originating from reagents or lab equipment may also cause bias in studies of low 
biomass microbial communities. While attempts were made to avoid the contamination of my samples 
some degree of contamination was practically unavoidable (Fig. 6.2). Salter et al. found that the 
majority of bacterial species in DNA extraction kits originated from skin, soil and water environments 
(140). Several of the bacteria I identified in my reagent only controls may have arisen from these 
environments; however, there were also many genera present which contain species which have been 
shown to colonise the respiratory tract. Where reagent only controls were dominated by one bacterial 
OTU which clearly would not colonise the lung (eg. Methylobacterium komagatae in Chapter 3) I felt 
confident in removing these OTUs from my datasets. However, if reagent controls contained a 
diversity of bacterial OTUs, which may or may not be colonisers of the respiratory tract, I did not 
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remove these OTUs from my datasets as I felt that this may lead to the removal of true members of the 
lung microbiota. While methods have been developed which attempt to remove contaminating DNA 
from datasets using sequence abundance data (39, 154), I did not use these methods as they have not 
yet been extensively adopted and tested. However, as future work it may be interesting to explore my 
datasets using these methods.  
Despite methodological variability between results chapters and the presence of bias and 
contamination, I was able to identify four OTUs which were common in lung samples but not in DNA 
extraction controls: J.psychrophilus, S.sciuri, S.equorum and Mannheimia. As previously stated, these 
species level assignments may not be accurate but we may be more confident that the genus level 
assignments are correct. Staphylococci and Mannheimia are both common members of the upper 
respiratory tract microbiota of farm animals (234). Jeotgalicoccus is a poorly studied genus (238) 
which has previously been identified in the upper respiratory tracts of several mammals including 
farm animals (44, 235-237). Using culturing and classical identification techniques these bacteria are 
indistinguishable from coagulase-negative Staphylococcus spp. (238) which may explain the fact that 
they have not previously been identified in the sheep lung during culture based studies. In future 
studies the isolation and characterisation of this Jeotgalicoccus species may be of interest, in order to 
establish whether it plays a role in host health and to assess whether the species level assignment of 
J.psychrophilus is accurate. More accurate species level assignments could also be achieved by 
sequencing the full 16S rRNA genes of bacteria from a wider variety of environments and by building 
16S reference databases which contain bacterial species specific to particular environmental niches 
(246).  
 
7.5 General conclusions 
 
My thesis contains the first extensive description of the sheep lung microbiota as characterised by 16S 
rRNA gene sequencing. While I found that there are some differences between the sheep and human 
lung microbiotas I feel that the sheep does have a use as a large animal model for studying the lung 
microbiota, including the assessment of different sampling techniques, as performed in Chapter 5.  
While my thesis contributes to our understanding of the healthy sheep lung microbiota, the scope of 
my thesis does not allow me to make conclusions as to whether the lung microbiota has an impact on 
the health of sheep or whether there are changes in the sheep lung microbiota during respiratory 
disease. This would be an interesting avenue for future research, as would studies in other livestock 
species.  
I feel that the eventual goal of lung microbiota research should be to provide treatments for diseases 
which involve lung microbial communities. These therapies may consist of probiotics, aerosolised 
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antibiotics, antibiotic treatments targeted at specific members of the lung microbiota or bacterial 
replacement therapy, such as is performed on the gut microbiota during faecal transplantation. 
However, in comparison to other areas of microbiota research the lung microbiota field is still in its 
infancy and it is likely to be some time before the complex interactions between the host, their 
environment and lung microbial communities are sufficiently understood to allow for the development 
of these kind of therapies.   
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Exacerbations associated with chronic lung infection with Pseudomonas aeruginosa are a
major contributor to morbidity, mortality and premature death in cystic fibrosis. Such exacer-
bations are treated with antibiotics, which generally lead to an improvement in lung function
and reduced sputum P. aeruginosa density. This potentially suggests a role for the latter in
the pathogenesis of exacerbations. However, other data suggesting that changes in P. aer-
uginosa sputum culture status may not reliably predict an improvement in clinical status,
and data indicating no significant changes in either total bacterial counts or in P. aeruginosa
numbers in sputum samples collected prior to pulmonary exacerbation sheds doubt on this
assumption. We used our recently developed lung segmental model of chronic Pseudomo-
nas infection in sheep to investigate the lung microbiota changes associated with chronic P.
aeruginosa lung infection and the impact of systemic therapy with colistimethate sodium
(CMS).
Methodology/Principal Findings
We collected protected specimen brush (PSB) samples from sheep (n = 8) both prior to and
14 days after establishment of chronic local lung infection with P aeruginosa. Samples were
taken from both directly infected lung segments (direct) and segments spatially remote to
such sites (remote). Four sheep were treated with daily intravenous injections of CMS
between days 7 and 14, and four were treated with a placebo. Necropsy examination at d14
confirmed the presence of chronic local lung infection and lung pathology in every direct
lung segment.
The predominant orders in lung microbiota communities before infection were Bacillales,
Actinomycetales and Clostridiales. While lung microbiota samples were more likely to share
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similarities with other samples derived from the same lung, considerable within- and
between-animal heterogeneity could be appreciated.
Pseudomonadales joined the aforementioned list of predominant orders in lung micro-
biota communities after infection. Whilst treatment with CMS appeared to have little impact
on microbial community composition after infection, or the change undergone by communi-
ties in reaching that state, when Gram negative organisms (excluding Pseudomonadales)
were considered together as a group there was a significant decrease in their relative pro-
portion that was only observed in the sheep treated with CMS. With only one exception the
reduction was seen in both direct and remote lung segments. This reduction, coupled with
generally increasing or stable levels of Pseudomonadales, meant that the proportion of the
latter relative to total Gram negative bacteria increased in all bar one direct and one remote
lung segment.
Conclusions/Significance
The proportional increase in Pseudomonadales relative to other Gram negative bacteria in
the lungs of sheep treated with systemic CMS highlights the potential for such therapies to
inadvertently select or create a niche for bacteria seeding from a persistent source of
chronic infection.
Introduction
Pseudomonas aeruginosa is considered to be the most important pathogen in cystic fibrosis
(CF), with up to 60% of adult patients infected (UK CF Registry Annual Data Report 2014 [1]),
and is also frequently isolated from patients with bronchiectasis [2]. In CF, early infections
with P. aeruginosa can be transient, and can clear spontaneously, but colonization with P. aeru-
ginosa usually occurs by the time patients reach their teenage years. In the later stages of infec-
tion, there is an adaptive shift from free-swimming planktonic P. aeruginosa to a sessile biofilm
mode involving mucoid alginate-producing variants of the original colonising strain [3]. This
important and characteristic shift is associated with more frequent and more severe pulmonary
exacerbations (PEs) that result in progressive decrements in lung function [4].
P. aeruginosa also dominates chronic infections in a proportion of patients with bronchiec-
tasis [5] and in chronic obstructive pulmonary disease (COPD) [6] where there is an increasing
association with acute exacerbations.
The factors linking chronic P. aeruginosa lung infection to PEs are currently unknown. Cer-
tainly studies indicating that there is a reduction of sputum P. aeruginosa density during antibi-
otic treatment for PE in CF patients—a change that correlates with an improvement in lung
function [7], tend to support a primary role for P aeruginosa. However, other data suggesting
that changes in P. aeruginosa sputum culture status may not reliably predict an improvement
in clinical status [8], and data indicating no significant changes in either total bacterial counts
or in P. aeruginosa numbers in sputum samples collected prior to pulmonary exacerbation [9]
sheds doubt on the specific role of P. aeruginosa in PE. Such uncertainty has been added to by
recent 16S ribosomal DNA sequencing data. In a recent study of fifteen CF patients followed
through 21 pulmonary exacerbations, sputum P. aeruginosa numbers did not increase immedi-
ately prior to a PE in CF adults [10]. These findings bear comparison with those of Carmody
et al (2013) who found that during PE in CF patients bacterial community diversity and
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bacterial density in sputum samples did not change between baseline and exacerbation [11],
and Price et al (2013) who similarly found that total and relative abundance of genera at the
population level were remarkably stable for individual patients regardless of clinical status [12].
These studies indicate that there are no generalizable ecological ‘signatures’ of PE in this type
of clinical sample.
Daniels et al (2013)[13] investigated the relative impact of antibiotics, used predominantly
to target P. aeruginosa during acute exacerbations, on other non-pseudomonal species. The rel-
ative abundance of viable P. aeruginosa and non-pseudomonal species was determined in
sputa from adult CF subjects in the days preceding an exacerbation, and during and after anti-
biotic therapy, by T-RFLP profiling. Overall, an increase in the relative abundance of P. aerugi-
nosa was observed, with a decrease in the total number of species detected. They raised the
possibility that, aside from the direct effect of systemic antimicrobials on P. aeruginosa, there is
coincident impact of antimicrobials on the remaining community members such that unspeci-
fied changes to P. aeruginosa gene expression may occur as a result of changes in interspecies
communication. The potential exists for such changes in gene expression to impact on viru-
lence and/or persistence [14].
Much of our current perceptions relating to the pathogenesis of PEs are driven by such stud-
ies relying on sputum to monitor inflammatory cells, bacterial densities, volatiles, mucin and
protein content of the airways [15]. However, sputum characteristics can be highly variable
between subjects and even within apparently stable subjects over time–reflecting, at least in
part, heterogeneity of pathology across different lung regions and/or the relative contribution
of different regions to the final sputum volume. Therefore sputum at best represents an averag-
ing process, and at worst provides a highly skewed view of lung physiology and pathophysiol-
ogy. These limitations may critically undermine our ability to u0nderstand the way in which
heterogeneous disease processes, and associated microbiota, trigger fulminant whole-organ
PEs.
Large animal models provide the means to dissect the pathophysiology of lung disease at a
local level. Motivated by the current dearth of information surrounding the pathogenesis of
PEs and speculation over the role of respiratory microbiota in this regard we recently devel-
oped a novel ovine model of chronic local lung infection with P. aeruginosa [16]. Our objec-
tives in this research were to develop an understanding of the local pulmonary and microbiota
response to chronic local lung infection with P. aeruginosa and to characterise the way in
which systemic antibiotic therapy impacts on this response. We selected colistimethate sodium
(CMS) as our antibiotic of choice. CMS undergoes hydrolysis in aqueous solutions to form a
complex mixture of derivatives, including colistin [17]. Colistin is a polymyxin antibiotic with
activity against Gram-negative organisms including P. aeruginosa. Whilst its use declined in
the 1970s over concerns about toxicity it has recently experienced a resurgence as a conse-
quence of the rise in resistance of P. aeruginosa and Acinetobacter spp to extended-spectrum




All experimental protocols were reviewed and approved by the local Roslin Institute ethical
review process (The Roslin Institute Animal Welfare and Ethics Committee) and were subject
to the provisions of the Animals (Scientific Procedures) Act 1986. During the course of the
experimental protocols the animals were assessed on a daily basis for any clinical signs of
adverse effect including dullness, depression, inappetence, coughing and/or dyspnoea.
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Animals
Eight Suffolk cross sheep (4F & 4MN; Bodyweight 40.5 [38–48] Kg (Median[Range])) were
used in this study. These sheep were commercially sourced and housed in groups on straw bed-
ding under standard management conditions appropriate to a research setting. Sheep were ran-
domly assigned to one of two treatment groups (Placebo (n = 4) and colistimethate sodium
(CMS)(n = 4)).
Experimental Design
A baseline examination was conducted in which each sheep was subject to clinical examination
and a blood sample taken from the jugular vein for routine haematological analysis. Thereafter
each sheep was anaesthetised to facilitate bronchoscopic examination and sample collection
according to standard protocol [16]. During this examination lung health was confirmed in
the form of direct visualisation of the airway tree and later cytological analysis of bronchoalveo-
lar lavage fluid (BALF). Protected specimen brush (PSB) samples were collected from the seg-
mental bronchus serving the right apical (RA) lobe, the first ventral diaphragmatic (RVD1)
segment of the right caudal diaphragmatic lobe, and the left cardiac (LC) segment of the apico-
cardiac lobe (Fig 1). BALF was subsequently collected from RA. After a recovery period of not
less than two weeks (23 [15–34] days), the sheep were re-anaesthetised and Pseudomonas in
agar beads (2.5x109 cfu in 2.5ml) instilled into the right cardiac (RC) lobe, the second ventral
diaphragmatic (RVD2) segment of the right caudal diaphragmatic lobe, the left cardiac (LC)
segment of the apicocardiac lobe, and the second ventral diaphragmatic (LVD2) segment of
the left caudal diaphragmatic lobe. The method of instillation followed that previously
described [16]. Three days later the sheep were blood sampled, anaesthetised again, and these
instillations repeated. Four days after the second instillation the sheep assigned to the CMS
group commenced daily treatment with intravenously administered systemic antibiotic (an
intravenous dose of 50,000 international units (IU) kg-1 of colistimethate sodium (Colomy-
cin1, Forest Laboratories UK Ltd, Dartford, Kent) every 24 h), with the placebo group com-
mencing daily injections of saline. Eleven days after the second instillation–after one week of
daily injections—blood samples were acquired before the sheep were anaesthetised and PSB
specimens obtained from the previously sampled lobes (RA, RVD1 and LC). The sheep were
then euthanized by intravenous injection of baribiturate, and the heart and lungs carefully
removed from the carcase following standard necropsy protocols before the heart was dissected
away and the lungs presented for further sampling and analysis. BALF was derived from each
segment under study (RA, RC, RVD1, RVD2, LC and LVD2) prior to further dissection, sam-
pling and recording using previously described methodology [16]. This experimental protocol
and sampling scheme therefore allowed us to evaluate the effects of local lung infection with P
aer., both within the direct segments (RC, LC, RVD2 and LVD2), within non-infected seg-
ments remote to the sites of direct infection (RA and RVD1), and systemically.
Anaesthesia
Food was withheld for 12 hours prior to anaesthesia. General anaesthesia was induced with
intravenously injected propofol (6–8mg/kg)(Fresenius propofol, 1%, Fresenius Kabi Ltd) and
anaesthesia maintained using positive pressure ventilation (Model 708; Harvard Apparatus,
Millis, MA) with a 2:1 mixture of oxygen and nitrous oxide, and 1–3% isoflurane. Tidal volume
was adjusted to 10ml/kg bodyweight and respiratory rate set to maintain end-tidal CO2 in the
range 4.5–5.5%.
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P. aeruginosa Culture and Bead Preparation
P. aeruginosa embedded beads were prepared according to previously published methodology
[16]. Briefly, broth cultures of P. aeruginosamucoid strain PA0579 were prepared and cell sus-
pensions mixed with molten agar before being injected into rapidly stirred heavy mineral oil.
Beads were recovered thereafter by centrifugation.
Bronchial Brush Biopsy
A bronchoscope (FG-16X; Pentax, Englewood, CO, USA) was advanced down the trachea and
mainstem bronchi and then into the relevant segmental bronchi until the predefined area
selected for brushing was identified. The protected specimen brush (ConMed Endoscopic
Technologies, Disposable Microbiology Brush 130) was then advanced through the biopsy
channel of the bronchoscope. The plug was expelled and the sheath was retracted before the
brush was applied to the epithelial mucosal surface. By advancing and retracting the brush in
Fig 1. Microbiota sampling protocol. During a baseline examination lung health was confirmed in the form of direct visualisation of the airway tree and later
cytological analysis of bronchoalveolar lavage fluid (BALF). Protected specimen brush (PSB) samples were collected from the segmental bronchus serving
the right apical (RA) lobe, the first ventral diaphragmatic (RVD1) segment of the right caudal diaphragmatic lobe, and the left cardiac (LC) segment of the
apicocardiac lobe (Pre-samples). BALF was subsequently collected from RA. At least two weeks later P. aeruginosa agar beads were instilled into the right
cardiac (RC) lobe, the second ventral diaphragmatic (RVD2) segment of the right caudal diaphragmatic lobe, the left cardiac (LC) segment of the
apicocardiac lobe, and the second ventral diaphragmatic (LVD2) segment of the left caudal diaphragmatic lobe. Three days later these instillations were
repeated. Four days after the second instillation sheep were randomly assigned to daily intravenous injections of either CMS or placebo. Eleven days after
the second instillation–after one week of daily injections—PSB specimens were obtained from the previously sampled lobes (RA, RVD1 and LC) (Post-
samples). After the sheep was killed and the lungs removed for further analysis, BALF was derived from each segment under study (RA, RC, RVD1, RVD2,
LC and LVD2) prior to further dissection, sampling and recording.
doi:10.1371/journal.pone.0142097.g001
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contact with the mucosa, a sample of epithelial lining cells and fluid was obtained. The bron-
chial brush biopsy (BBr) sample was taken to a sterile flow cabinet and the brush end cut off
directly into a non-stick Rnase free 1.5ml microfuge tube containing 1ml sterile phosphate
buffered saline (Sigma D8537) and stored on ice. BBr samples were vortexed then the brush
was removed under sterile conditions. Samples were centrifuged at 13000g for 15 minutes at
4°C and the pellet stored at -80°C.
Bronchoalveolar Lavage
The bronchoscope was wedged in selected segmental bronchi. Two 20ml aliquots of PBS
(Sigma D8537) were used to collect BALF from selected lung segments. BALF samples were
placed into sterile Falcon tubes and immediately placed on ice until subsequent analysis. BALF
was centrifuged at 400g for seven minutes to separate out the cellular fraction and the resultant
pellet was re-suspended in 2ml sterile PBS. The total cell number was counted before subse-
quent preparation of cytospins for differential cytology. Cells were counted using a Neubauer
haemocytometer and values expressed per millilitre BALF. Cyto-centrifuge slides were pre-
pared and stained using Leishman stain for differential counts on 500 cells. Cells were classified
as neutrophils, macrophages, eosinophils, lymphocytes or mast cells according to standard
morphological criteria. The remaining BALF was centrifuged at 13000g for 5 minutes at 4°C
and the pellet and supernatant stored at -80°C.
Necropsy
Following euthanasia by intravenous injection of baribiturate, the heart and lungs were care-
fully removed from the carcase following standard necropsy protocols before the heart was dis-
sected away and the lungs presented for further sampling and analysis. The trachea and right
and left major bronchi were carefully opened along their dorsal aspect to expose the primary
bronchial entrance to each lung segment of interest. Sterile polyethylene tubes were inserted in
turn, into each lung segment bronchus until a wedge point was achieved. Thereafter 40ml ster-
ile PBS (Sigma D8537) was instilled recovered and handled following the same principles
employed during bronchoalveolar lavage under anaesthesia. Control lung segments were
always sampled prior to handling segments previously exposed to Pseudomonas and all efforts
were directed towards minimising the potential for cross-contamination between lung seg-
ments. Lung segments were carefully isolated by gross dissection from surrounding lung tissue
before being separately examined and further dissected by parallel transverse sectioning along
the plane of the subsegmental bronchus into ~1cm thick lung slices. Photographic images of
the lung slices were collected. Samples were collected for assessing the degree of Pseudomonas
infection.
Pathology Grading
Photographic images of lung slices derived from each lung segment were assessed and scored
for the presence (1) or absence (0) of the following gross pathological features–pleural oedema,
pleural fibrosis, and the presence of fibrotic/granulomatous tissue or abscessation in the lung
parenchyma. The cumulative score (range 0–4) for each slice image was then multiplied by the
proportion, quantified using ImageJ ([18]), of the slice cut surface considered visibly abnormal
to give a total pathology score for each segment. Scores were then normalised to a scale of zero
(no pathology) to 100 (the most severe pathology) by dividing by the maximum score observed
amongst all lung slices and multiplying by 100.
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Pseudomonas Infection Level
Tissue samples were stored on ice and then finely chopped under sterile conditions. 300mg of
tissue was weighed and placed into Lysing Matrix D tubes (MP Biomedicals 6913–500) con-
taining 600μl sterile PBS. Samples were homogenised using a Fastprep FP120 (Thermo Elec-
tron) with 3 bursts of 20 seconds at setting 6.0 and 5 minute incubation on ice between each
homogenisation step. Equal volumes of BALF samples were centrifuged for 10 minutes at
2700g and each pellet re-suspended in 1ml sterile ice-cold PBS. BALF pellets were homoge-
nised as for the tissue samples. Bacterial load was assessed from all samples by preparation of
10 fold dilutions in ice-cold PBS and 100μl of chosen dilutions spread on Pseudomonas Isola-
tion Agar (PIA)(Sigma) plates and incubated overnight at 37°C. Bacterial counts were calcu-
lated by manual counting of colony forming units, multiplication by the dilution factor, and a
further 10 fold, to allow for 100μl inoculum to give a final count in cfu/ml.
Sensitivity
We assessed the sensitivity to CMS of the P. aeruginosamucoid strain PA0579 used to infect
the sheep, and isolates cultured from the infected lung tissue, using Etest strips (Etest, bioMér-
ieux, France).
DNA Isolation
DNA was extracted by modification of a previously published method [19]. Briefly, BBr pellets
were suspended in 60μls of solution C1, provided with the PowerSoil DNA Kit (PowerSoil DNA
Isolation Kit, MO-BIO). This suspension was transferred into PowerSoil Bead Tubes along with
750μl of PowerSoil Bead Solution. Bead Tubes were heated at 65°C for 10 minutes to aid cell lysis
then placed in a FastPrep FP120 Cell Disrupter for 45 seconds at 5.0m/sec. All further steps were
carried out following the manufacturer’s instructions except that the final elution volume was
changed to 50μl rather than 100μl. Extracted DNA was stored at -80°C until used in a nested PCR
with primers to amplify the hypervariable region V1-V4 of the 16S rRNA gene followed by bar
coded primers to amplify the hypervariable V2-V3. The PCR products were Agencourt AMPure
XP (Beckman Coulter) cleaned after each PCR run to remove smaller non-specific products and
unused primers then the purified amplicon products from each sample were pyrosequenced.
Triplicate 20μl reactions were performed per sample using the LightCycler1 480 SYBR
Green I Master mix (Roche), 1μl of extracted DNA solution and the 16S rRNA Q-PCR primers
UniF340 (5’–ACTCCTACGGGAGGCAGCAGT–3’) and UniR514 (5’–ATTACCGCGGCTG
CTGGC–3’) at a final concentration of 0.4μM. The following steps were performed: a pre-incu-
bation step of 50°C (ramp rate: 4.80°C/s for 2 minutes) then 95°C (ramp rate: 4.80°C/ for 10
seconds) and an amplification step consisting of 45 cycles of 95°C (ramp rate: 4.80°C/s for
30 seconds) then 63°C (ramp rate: 2.50°C/s for 30 seconds). This was followed by a melting
cycle consisting of 95°C (ramp rate: 4.80°C/s for 5 seconds) then 65°C (ramp rate: 4.80°C/s for
1 minute) followed by 97°C (ramp rate: 0.11°C/s, acquisition mode, continuous). A standard
curve beginning at 1.7 × 109 copies in nuclease free water and continuing in 1:10 dilutions to
1.7 × 100 was generated from a PCR product obtained from the genomic DNA of P. aeruginosa
mucoid strain PA0579 [20] using the 16S rRNA primers 28F and 805R (PCR method described
below), in order to calculate the total 16S rRNA gene copy numbers.
Barcoding of 16S Amplicons and Pyrosequencing
All PCR steps used 25μls of PCR master mix (Q51High-Fidelity 2X Master Mix, New
England Biolabs) and 2.5μls of both forward and reverse primers. A nested protocol of two
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rounds of PCR reactions was performed. A negative control was included in each PCR run con-
sisting of nuclease free water.
The V1-V4 variable region of the bacterial 16S rDNA was amplified using the primers 28F
(5’–GAGTTTGATCNTGGCTCAG–3’) and 805R (5’–GACTACCAGGGTATCTAATC–3’).
The conditions for the first round of PCR were: 94°C for 2 minutes followed by 30 cycles of
94°C for 1 minute, 55°C for 45 seconds and 72°C for 1.5 minutes followed by 72°C for 20
minutes.
The V2-V3 region was amplified using Truseq barcoded primers 104F (5’—GGACGGGT
GAGTAACACGTG–3’) and 519R (5’–GTNTTACNGCGGCKGCTG–3’)[21]. The conditions
for the second round of PCR were: 98°C for 30 seconds followed by 20 cycles of 98°C for 10 sec-
onds, 67°C for 30 seconds and 72°C for 10 seconds followed by 72°C for 2 minutes. Amplicons
from both rounds of PCR were purified using the AMPure XP system (AMPure XP PCR Puri-
fication, Agencourt).
Amplicons were sequenced using an Illumina MiSeq producing paired 250-nucleotide reads
[22]. Two negative PCR controls were included in the sequencing run.
Data Analysis
Primers were removed using Cutadapt [23]. The MOTHUR program [24] was used for quality
control and taxonomic assignment of reads, following a protocol developed for MiSeq by the
MOTHUR creators [22]. Sequences were phylotyped using the SILVA reference alignment and
any sequences which did not correctly align were removed. Chimeras were identified and
removed using UCHIME [25] within MOTHUR. Sequences were taxonomically classified,
using MOTHUR’s Bayesian classifier, against the Greengenes database [26]. Quality control
consisted of the removal of sequences if they were not assigned to bacteria; were identified as
chimeric; contained ambiguous bases or homopolymers< 9 bases; did not align to the correct
region of the 16S gene or were less than 359 bases long. All samples were found to have Good’s
coverage values greater than 0.99, indicating sequencing to sufficient depth for the purposes of
this study.
For quality control purposes, water samples were sequenced and analyzed through the bio-
informatics pipeline. These samples had a much less diverse microbial community composi-
tion with over 66% abundance accounted for by only three OTUs. Whilst these OTUs could
also be found in lung microbiota samples their proportional abundance was typically much
less with median [range] proportional abundances of 0.4 [0–6.5], 0.0 [0–14.5], and 0.0 [0–3.4]
respectively. No specific adjustment in analysis was made for OTUs present in water control
samples. Sequence data was submitted to the Sequence Read Archive (http://www.ncbi.nlm.
nih.gov/sra; accession number SRP064022).
P. aeruginosa Specific qPCR
Targeting the oprl gene was performed following a modification of a previously published
method [27]. Briefly, 1μl DNA samples were run in triplicate with 12.5μl Qiagen Quantitect
probe mastermix, 0.3μM of each OPRL primer and 0.2μM hydrolysis probe with the reaction
made up to a final volume of 25μl with water. Gene copy number was calculated from a stan-
dard curve of genomic DNA of P. aeruginosamucoid strain PA0579.
Statistical Approach
Where data was normally distributed parametric data analysis procedures were applied (t-test,
ANOVA), otherwise non parametric alternatives (MannWhitney Test, Kruskal Wallis Test,
Wilcoxon Signed-Ranks test and Spearman rank correlation) were used. Heatmaps were
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generated using the “heatmap.2” R package, version 2.10.1 (available at http://CRAN.R-
project.org/package=gplots). Non-metric multidimensional scaling (NMDS) analysis applied
to distance matrices of Bray-Curtis dissimilarities, and ordination plots were generated using
the “vegan” R package. Permutational ANOVA (PERMANOVA) (using the R-vegan function




There were no signs of adverse effect nor significant variation in bodyweight in any sheep dur-
ing the experimental period. All rectal temperatures lay within the range 39.0–40.2 (normal
range 37.9–40.3, n = 664; D Collie, unpublished observations) and there was no significant dif-
ference between the groups.
Routine Haematology
Instillation of P aer. was associated with a significant reduction in the total white blood cell
count in peripheral blood measured three days after the first instillation, a reduction that
reverted to baseline levels by fourteen days after the first instillation (ANOVA; p = 0.000, rela-
tive to baseline and to day 14). There was no difference between the groups in this respect.
There was no significant change in any other measured haematological parameters.
Bronchoalveolar Lavage Cytology
Infection with P aer. was associated with an increase in bronchoalveolar cellularity. The pre-
dominant cell types involved comprised alveolar macrophages, neutrophils and lymphocytes.
Bubble plots illustrating the relationship between the log-transformed absolute numbers of
these cell types (in baseline and post-infection samples from directly infected and remote lung
segments) and the level of infectivity in the same samples are depicted in S1 Fig. Cytospin
images representative of baseline and post-infection cytology are also depicted in S2 Fig.
Bacterial Load in BAL and Tissue Specimens
P aer. infection was reliably detected in all direct lung segments by culture of BALF and/or
lung tissue. Whilst BALF samples derived from direct lung segments had a significantly greater
burden of P aer. than remote lung segments (Wilcoxon Signed Rank Test of median = 0
versus median> 0; P = 0.030))(Fig 2A) there was no significant difference between the placebo
and CMS groups in this regard. Two BALF samples derived from remote lung segments
(2S065_RA and 2S037_RVD1 (CMS)) demonstrated evidence of infection. We also examined
tissue from lung segments for evidence of infection and again found that samples derived from
direct lung segments had a significantly greater burden of P aer. than remote lung segments
(Wilcoxon Signed Rank Test of median = 0 versus median> 0; P = 0.007)(Fig 2B) with no dif-
ference between the groups. Three tissue samples derived from remote lung segments
(2S037_RVD1 (CMS) and 2D616_RA & RVD1 (Placebo)) demonstrated evidence of infection.
The P. aeruginosamucoid strain PA0579 used to infect the lung was sensitive to CMS, and we
found no difference between the infecting strain, and isolates cultured from lung tissue
obtained at necropsy, in this respect (data not shown). In addition colony morphotypes were,
with one exception, uniform in appearance and mucoid in character. The exception concerned
colonies grown from tissue samples derived from a directly infected lung segment (LVD2) of a
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Fig 2. Bacterial burden in the lung. Boxplots showing the bacterial burden in A. bronchoalveolar lavage fluid (Log10(BAL cfu/ml + 1) and B. lung tissue
(Log10(lesion cfu+1)) samples derived from lung segments directly infected 14 days previously with 2.5x10
9 cfu P. aeruginosa in agar beads (B. Direct), and
lung segments spatially remote to such segments (A. Remote). Sheep were treated with daily intravenous CMS (n = 4), or placebo (n = 4), between days
7–14. Bronchoalveolar lavage fluid samples derived from direct lung segments had a significantly greater burden of P. aeruginosa than remote lung
segments (Wilcoxon Signed Rank Test of median = 0 versus median > 0; P = 0.030)); there was no significant difference between the placebo and CMS
groups in this regard. Lung tissue samples derived from direct lung segments had a significantly greater burden of P. aeruginosa than remote lung segments
(Wilcoxon Signed Rank Test of median = 0 versus median > 0; P = 0.007); there was no significant difference between the placebo and CMS groups in this
regard.
doi:10.1371/journal.pone.0142097.g002
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sheep treated with CMS (2D615). In this instance there was evidence of non-mucoid colonies
intermixed with mucoid colonies.
Pathology
Semi-quantitative scoring of the gross pathological features indicated that there was a signifi-
cant increase in gross pathology associated with direct infection with P aer. (Wilcoxon Signed
Rank Test of median = 0 versus median> 0; P = 0.007) and that there was no difference
between placebo- and CMS-treated sheep in this respect. Notably, with only one exception all
the remote segments scored zero (the exception scoring 1), whereas the median [range] for the
placebo sheep was 60.5 [12.3–95.0] and for the CMS sheep 30.5 [19.3–100.0]. There was a
significant correlation between the pathology score and the burden of infection in BALF and
tissue (Spearman Rho = 0.625 & 0.731, and P = 0.017 & 0.001 respectively).
Microbiota
The heatmap in Fig 3A illustrates that in the baseline (Pre) samples the most predominant con-
sistently represented taxa were Bacillales (25+14% [1–49])(Mean+SD [Range]), Actinomyce-
tales (18+9% [1–37]) and Clostridiales (14+10% [2–45]). Other taxa such as Enterobacteriales,
Bacteroidales, Caulobacterales, Pasteurellales and Pseudomonadales also featured prominently
but inconsistently.
For three sheep (2D616, 2S035 and 2D615) the predominant pattern was consistently repre-
sented in the samples derived from three different lung segments (Fig 4A), demonstrating
within-lung homogeneity of microbiota. The remaining samples were found in sheep in which
microbial communities were more diverse, demonstrating within-lung heterogeneity of micro-
biota. Visualisation of non-metric multi-dimensional scaling (NMDS) ordination analysis
applied to the distance matrix of Bray-Curtis dissimilarities confirmed the above visual percep-
tions (Fig 5).
We performed hierarchical cluster analysis to ascertain whether samples would cluster by
sheep and/or lung segment (Fig 3A) and employed permutational ANOVA (PERMANOVA)
using the Bray-Curtis distance matrix to assess the extent to which variability could be assigned
to the sheep, or lung segment, from which the communities were drawn. The results of the lat-
ter analysis indicated that a significant proportion of the variance (49%) could be explained by
a sheep effect (P = 0.003), whereas the lung segment had no significant effect (P = 0.155).
The inverse Simpson index was calculated for each of the samples (Fig 3A). This index takes
into account both species richness, and evenness of abundance among the species present. In
essence it measures the probability that two entities taken at random from the dataset of inter-
est represent the same type. Values ranged from 5.0 to 29.5, with an average of 14.1 and SD
6.25. There was no significant relationship between particular lung segments and the diversity
of microbiota contained therein as measured by the Simpson Diversity Index (Kruskal Wallis
Test, P = 0.735).
All sheep (n = 8) were then subjected to chronic local lung infection with P. aeruginosa.
Four sheep were systemically treated with intravenous CMS and four treated with a placebo
injection. The heatmap in Fig 3B illustrates that the four most predominant orders in the Post-
samples consisted of Bacillales, Actinomycetales, Clostridiales and Pseudomonadales.
Fig 4B depicts the proportional representation of different phylotypes in post-infection
(Post) samples derived from direct (LC) and remote (RA & RVD1) lung segments of each
sheep and the relationship of these samples to their baseline (Pre) counterparts.
Hierarchical cluster analysis of the Post- samples failed to indicate clustering according to
sheep, lung segment, treatment (placebo or CMS), or any change in diversity as reflected in the
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Post-Pre inverse Simpson Diversity index (Fig 3B). PERMANOVA analysis indicated that a
significant proportion of the variance (42%) for Post- samples could be explained by a sheep
effect (P = 0.01), and whether or not the segment had been directly infected (12%; P = 0.01).
Whether or not the sheep had been treated with CMS or placebo had no significant bearing on
the variance in the Post- samples.
We calculated the Log2(Post-/Pre-) fold-change for the phylotypes in each set of paired
samples (Fig 6) and examined the degree of relatedness between different samples by creating a
distance matrix of Pearson correlation coefficients using the formula (1-Pearson Correlation
Coefficient) as the index of dissimilarity. Hierarchical clustering failed to indicate any
overarching influence of treatment, or lung segment, on the elicited patterns of change.
PERMANOVA applied to a Euclidean distance matrix based on the sample-specific arrays of
fold-changes failed to highlight any significant contributor to the variance observed.
We determined whether systemic therapy with CMS had any influence on the proportion of
Gram negative bacteria (excluding Pseudomonadales) in lung microbiota. Whereas the pres-
ence of local lung infection with Ps aer did not significantly alter the proportion of Gram
negative bacteria (excluding Pseudomonadales)(Fig 7A) in the lung segments of sheep treated
with placebo (Paired t-test on Pre-Post differences (n = 4), P = 0.741), all of the direct segments
and all except one of the remote segments (7/8) of sheep treated with CMS experienced a
reduction in the proportion of Gram negative bacteria (excluding Pseudomonadales)(Fig 7B).
Fig 3. Abundance heatmaps for Pre- and Post-data. Heatmaps reflecting the proportional representation of microbiota (Order classification) in samples
derived from different lung segments at baseline (A), and after lung infection and/or treatment with systemic CMS (B). The identities of individual sheep are
indicated at the left side of each heatmap and the segment from which each sample was derived (LC, RA or RVD1) indicated in the annotation frame on the
right side of the heatmap. Orders with a proportional representation of less than 1% are not shown. The results of hierarchical clustering applied to a distance
matrix of Bray-Curtis measures between pairs of samples is shown for samples (left side) and bacteria (top). The remaining annotation in (A) reflects the
inverse Simpson index that characterizes the species diversity in each sample community, with higher values reflecting an increase in diversity. In (B) the
annotation frame also indicates whether the sample was derived from a sheep treated with CMS (Tx = CMS) or placebo (Tx = Placebo), and the change in
the inverse Simpson index (Post-Pre) relative to the values at baseline, with positive values reflecting an increase, and negative values a decrease, in
diversity.
doi:10.1371/journal.pone.0142097.g003
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The reduction in the proportion of G-ve bacteria (excluding Pseudomonadales) in lung seg-
ments of the CMS group was significant (Paired t-test on Pre-Post differences (n = 4),
P = 0.040). When only the remote lung segments were included in this analysis, again the pro-
portion of Gram negative bacteria (excluding Pseudomonadales) showed no significant change
in response to infection in the placebo group whereas there was a significant reduction in this
proportion in the sheep treated with CMS (Paired t-test on Pre-Post differences (n = 4),
P = 0.979, and P = 0.044 respectively).
We determined, for the same samples, whether there was a relationship between qPCR for
PA0579 and reads assigned to Pseudomonadales following 16SrRNA sequencing. There was a
highly significant positive correlation (Spearmans rho = 0.711 (n = 19, p<0.001)).
Discussion
Instillation of P. aeruginosa in agar beads consistently induced a chronic local lung infection
that resulted in gross pathology that remained confined to the areas where the instillate was
Fig 4. Proportional changes in microbiota from paired Pre- and Post- samples. Stacked column charts depicting the relative proportions of different
bacterial phylotypes (classified at the level of Order, and coloured according to the legend) in PSB samples derived from three lung segments (Left cardiac
(LC), Right apical (RA) and Right ventral diaphragmatic (RVD1)) prior to (Pre) and 14 days after (Post) the initiation of chronic lung infection with P.
aeruginosa in segment LC. Four sheep (2D616, 2S064, 2S036 and 2S035) were treated with daily intravenous injections of saline (A. Placebo Group), and
four sheep (2S037, 2D615, 2S065 and 2S034) were treated with daily intravenous injections of CMS (B. CMSGroup) between days 7–14.
doi:10.1371/journal.pone.0142097.g004
Chronic Pseudomonas aeruginosa Lung Infection
PLOS ONE | DOI:10.1371/journal.pone.0142097 November 6, 2015 13 / 21
delivered. The gross pathological features and changes in bronchoalveolar cytology were con-
sistent with our previous experience with this model system [16].
We were able to assess the composition of lung microbiota across the lung by sampling
from different airways of the same animals at the same point in time and to compare these
samples amongst different animals.
We found that the microbial communities of the samples obtained at baseline were largely
dominated by the orders Bacillales, Actinomycetales and Clostridiales. Whilst there was evi-
dence for both within-lung homogeneity and heterogeneity amongst different animals, samples
Fig 5. Non-metric multi-dimensional scaling (NMDS) ordination of bacterial communities in the lungs of healthy sheep. Individual plot data is
grouped according to sheep identity and can be related through shared colour, a process facilitated by the coloured ellipses. Whilst some sheep have
microbial communities that cluster tightly, and others are widely scattered, there is considerable overlap apparent between most of the sheep.
doi:10.1371/journal.pone.0142097.g005
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obtained from a given sheep were more likely to share similarity with other samples from the
same sheep than from samples from different sheep.
Lung microbiota data derived from healthy human subjects is becoming increasingly
available [19, 28, 29]. Charlson et al (2011) found that the predominant orders represented
in BALF and PSB samples were Bacteroidales (dominated by Prevotella spp.), Clostridiales,
Fig 6. Fold change heatmap.Heat map representing the Log2(Post-/Pre-) fold-change for the phylotypes in each set of paired samples. The degree of
relatedness between different samples was assessed by creating a distance matrix of Pearson correlation coefficients using the formula (1-Pearson
Correlation Coefficient) as the index of dissimilarity. Hierarchical clustering failed to indicate any overarching influence of treatment, or lung segment, on the
elicited patterns of change.
doi:10.1371/journal.pone.0142097.g006
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Lactobacillales (dominated by Streptococcal spp.) and Actinomycetales [19]. Hilty et al (2010)
[30] similarly found that samples from healthy human subjects (adults and children) were
dominated by Bacteroidales (Prevotella spp.), as did Dickson et al (2015) [29]. Indeed it is
perhaps the prevalence of Bacteroidales, and consistent presence of Lactobacillales, that links
these different studies of healthy human subjects. Otherwise, these separate studies are notable
for their respective differences that are largely unexplained–such as the notable presence of
Methylobacterium (Order: Rhizobiales) in the recent study of Dickson et al (2015) [29].
Bacteria of the order Baccillales, the most predominant members of the sheep lung micro-
biota, are therefore relatively infrequently found in human lungs whilst bacteria belonging to
the other predominant orders, Actinomycetales and Clostridiales, can be found in human
lungs but are inconsistently present.
The relatively minor contribution of Bacteroidales to ovine lung microbiota (~5%) is an
interesting observation given both the predominance of Prevotella in the human lung and its
high abundance in the rumen of sheep [31] where they help the breakdown of protein and car-
bohydrate foods. If measured lung microbiota in sheep are derived transiently from the oro-
pharynx (itself heavily influenced by rumen contents through the process of rumination) then
it would be reasonable to assume that Bacteriodales would feature more prominently.
Notably Dickson et al (2015) [29], in exploring whether the lung microbiome is spatially
varied in healthy adults, determined that intrapulmonary sites, when compared to each other,
did not contain consistently distinct microbiota, but that intra-subject variation was signifi-
cantly less than inter-subject variation. We similarly established that whilst sheep lung segment
had no significant bearing on the composition of microbiota, sheep identity did have a signifi-
cant impact. Coupling the latter finding with the sometimes observed high degree of within-
lung heterogeneity is conceptually difficult and raises obvious questions regarding both the
spatial extent of distinct microbial communities and their longitudinal stability. Indeed,
whilst we sampled from disparate lung segments and found heterogeneity in some sheep it is
Fig 7. Change in Gram negative bacteria (excluding Pseudomonadales) in Pre- and Post-samples. Line charts indicating the percentage of Gram
negative bacteria in PSB samples derived prior to (Pre) and 14 days after infection with P.aer (Post) from sheep treated with daily intravenous injections of A.
saline (Placebo), or B. CMS (CMS) between days 7–14. Symbols reflect the identity of sheep according to the legend entries, with filled symbols reflecting
samples derived from directly infected lung segments (LC), partially filled symbols from remote segment RA, and open symbols from remote segment RVD1.
doi:10.1371/journal.pone.0142097.g007
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conceivable that in these animals PSB samples from neighbouring bronchi within the same seg-
ment, or even different locations along the same bronchi, might also reflect heterogeneity.
Equally we currently have no idea whether lung microbiota ‘states’ are constant within individ-
ual sampling sites over time. Addressing such questions will be fundamental to developing a
hypothetical modelling framework for ovine lung microbiota that captures both individual
identity and potential within-individual heterogeneity at a given point in time.
Dickson, Erb-Downward and Huffnagle (2014)[32] highlighted in their recent review that
the invasive nature of microbiota sampling in the lower respiratory tract has hitherto precluded
the gathering of data to assess the extent of temporal and spatial heterogeneity of the lung
microbiome in healthy human subjects. We would contend that large animal models offer the
facility to probe such relationships and develop experience and methodology that will poten-
tially impact on our ability to understand the relevance of change in the composition of lung
microbiota in humans.
Whilst much interest surrounds the relationship between lung microbiota states and dis-
eases such as asthma, COPD and CF, these studies, by their nature, only reflect associations. If
such observations are to be usefully extended and the functional significance of lung micro-
biota established then there is a clear need to develop animal models of lung microbiota states
to test mechanistic hypotheses [32].
This model system provided us with the opportunity to determine, in the first instance,
whether local lung infection with P. aeruginosa would alter lung microbiota, as reflected in PSB
samples, in both the direct lung segments and in areas of the lung ‘remote’ to those segments.
Whilst lung infection resulted in consistent lung pathology PSB samples from only two of the
direct segments in the placebo group demonstrated a heavy proportional burden of Pseudomo-
nadales. It is worth noting that the airways from which these samples were derived could not
be visually differentiated from airways yielding lesser burdens at bronchoscopy (D Collie per-
sonal communication). The highly significant positive correlation between qPCR for PA0579
and reads assigned to Pseudomonadales following 16SrRNA sequencing indicates the likeli-
hood that the heavy proportional burden of Pseudomonadales represented the infecting strain,
PA0579.
Whilst the failure to demonstrate Pseudomonadalesin PSB samples derived from some sub-
segmental bronchi serving lung segments with obvious gross pathology and chronic P. aerugi-
nosa lung infection presumably reflects the particular pathophysiology underlying these
instances, the lack of relationship highlights important caveats in interpreting microbiota
changes in our model of lung infection–that PSB microbiota relate only to the precise location
wherefrom the sample was derived, and that lung pathology and infection may be highly locally
compartmentalised and closely juxtapose airways with minimal evidence of infection.
We also established that local lung infection was not associated with any uniform ‘lung-
wide’ change in lung microbiota sampled from areas distant to that infection. However it was
apparent that an increase in the proportion of Pseudomonadales occurred in three of the four
remote segments of the two sheep that demonstrated a profound increase in the proportion of
Pseudomonadales in their direct lung segments, whereas the sheep that failed to demonstrate
an increase in proportion of Pseudomonadales in their direct lung segments also failed to show
any appreciable change in the proportion of Pseudomonadales in any of their remote lung
segments.
We demonstrate in this ovine model of chronic local lung infection with P. aeruginosa that
7 days of once-daily intravenous treatment with CMS had no effect on the burden of P. aerugi-
nosa infection in the directly infected lung segments. It is considered that both the nature of
the lung pathology and the pharmacodynamics of CMS in sheep following intravenous delivery
will have conspired to undermine any therapeutic effect of CMS.
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The model protocol, in seeding P. aeruginosa in agar beads and delivering these beads to
lodge in the distal airways and lung parenchyma evoked a vigorous local inflammatory and
immune response that could not be fully resolved. The protective agar matrix, together with
abscessation and fibrosis, in representing the body’s attempts to limit spread of infection from
these chronic nidi of infection, would also potentially hinder access of therapeutics.
CMS has a concentration-dependent effect on Gram negative bacteria. To be effective it
must achieve bactericidal peak tissue concentrations in infected lung parenchyma and/or the
airway epithelial lining fluid. Whilst we measured neither in this study it is considered unlikely
that the dose, mode and frequency of therapy would have generated bactericidal concentrations
of CMS in the epithelial lining fluid of the airways. At the inception of this study there was, to
the authors’ knowledge, no available data concerning the pharmacokinetics of CMS following
intravenous administration in sheep, and neither was any specific published guidance available
concerning potential toxicity in this species following intravenous delivery. Our choice of dose,
mode and frequency of therapy were therefore driven by pragmatic considerations. More
recent data does however confirm that CMS is indeed not detected in airway epithelial lining
fluid after intravenous dosing in sheep [33]. Further, whilst Boisson et al (2014)[34] did dem-
onstrate an increase in ELF concentration of CMS and colistin after IV administration in criti-
cally ill patients, Imberti et al. (2010)[35], following intravenous administration of CMS to
adult patients with ventilator-associated pneumonia caused by Gram-negative bacteria, could
not measure CMS in BAL fluid. The results of both studies inferred a likely deficiency in thera-
peutic effect in the lung following intravenous delivery.
In line with these considerations, sheep that were treated with systemic CMS demonstrated
a similar spectrum of microbiota change as was seen in the placebo group and there was no evi-
dence of a specific effect of CMS on the proportion of Pseudomonadales detected in PSB sam-
ples. However, despite this apparent lack of effect and the unfavourable pharmacokinetic/
pharmacodynamic characteristics of intravenous CMS in sheep, therapy did reduce the pro-
portion of Gram negative bacteria (other than Pseudomonadales) and therefore increased the
relative proportion of Pseudomonadales to other Gram negative bacteria in these samples.
That sub-therapeutic doses can have such an effect may hold relevance when viewed in the
context of potentially changing ecological niche characteristics across the whole lung to those
more favourable to the survival of P. aeruginosa. Indeed, Rogers et al (2014) demonstrated that
in non-CF bronchiectasis patients without P. aeruginosa airway infection, erythromycin did
not significantly reduce exacerbations and promoted displacement ofHaemophilus influenzae
by more macrolide-tolerant pathogens including P. aeruginosa [14].
Despite, in some instances, evidence of considerable flux in lung microbiota between base-
line and 14 days after establishing chronic local lung infection with P. aeruginosa, sheep could
not be distinguished on the basis of observed clinical response. Whilst the inference might
therefore be construed that local lung microbiota have no functional impact on the pathophysi-
ology of PEs this would be presupposed on the validity of this system to reliably model the
pathophysiology and clinical features of PEs in humans. Whilst this presumption has yet to be
fully explored in this system, the need to develop novel model systems whereby the pathophysi-
ology of PEs can be investigated means that such studies must remain an imperative.
In conclusion, sheep lung microbiota are dominated in health by bacteria belonging to the
orders Bacillales, Actinomycetales and Clostridiales. Whilst chronic local lung infection with P.
aeruginosa led to increased predominance of Pseudomonadales, such predominance was not
uniformly consistent amongst either directly infected or remote lung segments. Treatment of
sheep with daily intravenous CMS, whilst failing to overtly influence lung microbiota, did sig-
nificantly increase the proportion of Pseudomonadales relative to other Gram negative bacteria
in infected sheep.
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Supporting Information
S1 Fig. Bacterial burden and bronchoalveolar lavage fluid cellularity. Bubble plots depicting
the relationship between bronchoalveolar lavage fluid cellular composition and bacterial bur-
den in samples derived at baseline (A. Pre) and after infection, both from areas of the lung sub-
ject to direct lung infection with P. aeruginosa (C. Post-direct) and areas remote to those sites
(B. Post-remote). Bubbles are coloured according to the sheep to which they relate and the leg-
end further specifies to which treatment group the sheep belong (Treatment_Sheep). The size
of each bubble relates to the bacterial burden present in that particular sample and can be
gauged through reference to the legend (BAL cfu/ml). Data relating to the log-transformed
absolute number of A. alveolar macrophages (Log10 (ABS AMs+1), B. neutrophils (Log10
(ABS Neuts+1), C. lymphocytes Log10 (ABS Lymph+1), D. mast cells Log10 (ABS Mast+1)
and E. eosinophils Log10 (ABS Eosin+1) are shown.
(TIFF)
S2 Fig. Bronchoalveolar lavage fluid cytology. Cytospin images representative of baseline (A)
and post-infection (B) cytology. Alveolar macrophages were the predominant cell type present
in baseline samples. Following the establishment of lung infection the proportion of neutro-
phils (arrowheads) and lymphocytes () increased in the directly infected lung segments.
(TIFF)
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Comparison of bacterial communities found in lung brushings from a previous study (1). 
Protected specimen brushings were taken in two sheep (2S064 and 2S065) from the first 
ventral diaphragmatic segment of the right caudal diaphragmatic lobe (RVD1). Samples were 
taken pre and post injection with either colisitin (2S065) or saline (2S064). The bacterial 
DNA in these samples was amplified twice; once in May 2013 (1.) and once in September 
2013 (2.). These amplicons were then sequenced and bioinformatically processed separately 
from one another. Despite some small differences, amplicons produced from the same sample 




The bacterial orders found at three separate lung segments (RA: right apical, RCD: right 
caudal diaphragmatic and LCD: left caudal diaphragmatic) in six sheep (A: 2D618, B: 2S066, 
C: 2D619, D: 2D620, E: 2D644, F: 2D645) at three time-points: baseline (day 0), one month 
and three months. 
  
Table S1: Dates of bronchial brushing samplings for six sheep at three time-points.  
Time-point Sheep Date  
Baseline (d0) 2D618 18/11/2013 
 2S066 18/11/2013 
 2D619 18/11/2013 
 2D620 20/11/2013 
 2D644 20/11/2013 
 2D645 20/11/2013 
   
One Month 2D618 16/12/2013 
 2S066 16/12/2013 
 2D619 16/12/2013 
 2D620 17/12/2013 
 2D644 17/12/2013 
 2D645 17/12/2013 
   
Three Months 2D618 17/02/2014 
 2S066 17/02/2014 
 2D619 17/02/2014 
 2D620 18/02/2014 
 2D644 18/02/2014 
 2D645 18/02/2014 
 
  



































   
Table S3: OTUs found to be significantly different between lung samples taken from 
sheep at the baseline and one month time-points (Metastats: P = 0.001) 
OTU phylotype Relative abundance (%) mean ± SEM * 
 Baseline One month 
Bacteroides  0.69 ± 0.51 0 ± 0 
Bradyrhizobium  0.19 ± 0.069 0.0051 ± 0.0051 
Burkholderia  3.34 ± 1.69 0 ± 0 
Burkholderia graminis 0.28 ± 0.15 0 ± 0 
Comamonas  0.028 ± 0.0001 0 ± 0 
Corynebacterium  0.72 ± 0.19 11.05 ± 3.54 
Corynebacterium kroppenstedtii 0.0025 ± 0.0025 2.97 ± 0.57 
Gallicola 0 ± 0 0.14 ± 0.095 
Granulicatella 3.85 ±0.62 0.82 ± 0.42 
MBA08  0 ± 0 0.12 ± 0.12 
Methylobacteriaceae  0.22 ± 0.093 0 ± 0 
Methylobacterium organophilum 0.12 ± 0.054 0 ± 0 
Mycobacterium llatzerense 0.015 ± 0.009 2.47 ± 0.97 
Roseburia  0.10 ± 0.081 0 ± 0 
Ruminococcus  0.10 ± 0.081 0 ± 0 
Sphingomonas yabuuchiae 0.78 ± 0.22 0 ± 0 
Staphylococcus haemolyticus 0 ± 0 0.63 ± 0.63 
Streptococcus infantis 1.51 ± 0.26 0.025 ± 0.02 
Tannerella  0.12 ± 0.12 0 ± 0 
Tepidimonas  0 ± 0 0.25 ± 0.25 
Tetragenococcus  0.11 ± 0.11 0 ± 0 
* OTUs are not included where they were less than 0.1% abundant at both time-points 
 
Table S4: OTUs found to be significantly different between lung samples taken from 
sheep at the one month and three month time-points (Metastats: P = 0.001) 
OTU phylotype Relative abundance (%) mean ± SEM* 
 One month Three months 
Actinobacillus parahaemolyticus 0 ± 0 0.12 ± 0.11 
Bacteroidales 0 ± 0 0.40 ± 0.39 
Blastomonas  0.0051 ± 0.0051 1.5 ± 0.18 
Blautia  0.20 ± 0.20 0 ± 0 
Caulobacter  0 ± 0 0.21 ± 0.16 
Cohnella  0 ± 0 0.11 ± 0.11 
Comamonas  0 ± 0 0.76 ± 0.21 
Helcococcus  0.23 ± 0.16 0 ± 0 
MBA08 0.12 0.12 0 ± 0 
Mycobacterium  0.048 ± 0.046 1.9 ± 0.46 
Mycobacterium llatzerense 2.47 ± 0.98 0 ± 0 
Myroides odoratimimus 0 ± 0 0.16 ± 0.16 
Novosphingobium  0.018 ± 0.013 0.32 ± 0.096 
Oligella  0 ± 0 0.11 ± 0.11 
Prevotella copri 0 ± 0 0.18 ± 0.18 
Prevotella tannerae 0 ± 0 0.12 ± 0.12 
Rubricoccus  0.35 ± 0.25 0 ± 0 
Schlegelella  0 ± 0 0.11 ± 0.11 
Sneathia  0.20 ± 0.20 0 ± 0 
Sphingobium yanoikuyae 0 ± 0 2.70 ± 0.31 
Tepidimonas  0.25 ± 0.25 0 ± 0 
* OTUs are not included where they were less than 0.1% abundant at both time-points 
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Appendix 3: Figure S1 for Chapter 4 
 
Heatmap of OTUs found in lamb lung fluids, oropharyngeal swabs, PBS and extraction kit reagent only controls. OTUs were included 
when they were > 5% abundant in at least one sample. Samples whose DNA was extracted on separate days are indicated by the following 
colours on the hierarchical clustering dendrogram: 17th July 2014 = blue; 25th March 2015 = red; 26th March 2015 = green.   
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Appendix 4: Table S1 for Chapter 4 
 
OTUs responsible for partitioning of lamb oropharyngeal swabs into two groups (using 
Laplace value). 
Taxonomy Indicator groups P value 
Bacteroides Partition 1 <0.001 
Bibersteinia trehalosi Partition 1 <0.001 
Campylobacter rectus Partition 1 <0.001 
Leptotrichia Partition 1 <0.001 
Moraxella Partition 1 <0.001 
Porphyromonas Partition 1 <0.001 
Streptococcus Partition 1 <0.001 
Streptococcus minor Partition 1 <0.001 
Kingella Partition 1 0.003 
Moraxella ovis Partition 1 0.003 
Pasteurellaceae Partition 1 0.003 
Comamonadaceae Partition 1 0.004 
Cardiobacteriaceae Partition 1 0.005 
Corynebacterium Partition 1 0.005 
Lactobacillales Partition 1 0.005 
Tannerella Partition 1 0.005 
BD1-5 Partition 1 0.006 
Bibersteinia Partition 1 0.006 
Fusobacterium Partition 1 0.007 
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Mannheimia Partition 1 0.007 
Streptococcus agalactiae Partition 1 0.007 
Actinomyces hyovaginalis Partition 1 0.008 
Aggregatibacter Partition 1 0.008 
Caulobacteraceae Partition 1 0.008 
Methylobacterium komagatae Partition 1 0.008 
Neisseriaceae Partition 1 0.008 
Conchiformibius kuhniae Partition 1 0.009 
Variovorax paradoxus Partition 1 0.009 
Dietzia Partition 1 0.01 
Hylemonella Partition 1 0.01 
Streptococcaceae Partition 1 0.01 
Lautropia Partition 1 0.011 
Frigoribacterium Partition 1 0.014 
Micrococcaceae Partition 1 0.014 
Peptostreptococcaceae Partition 1 0.014 
Actinomyces Partition 1 0.016 
Streptobacillus Partition 1 0.016 
Staphylococcus Partition 1 0.019 
Staphylococcus sciuri Partition 1 0.024 
Campylobacter Partition 1 0.025 
Peptostreptococcus anaerobius Partition 1 0.026 
Propionibacteriaceae Partition 1 0.026 
Brachybacterium Partition 1 0.027 
Erysipelotrichaceae Partition 1 0.029 
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Fusobacteriaceae Partition 1 0.029 
Parvimonas Partition 1 0.029 
Streptococcus equi Partition 1 0.032 
Facklamia Partition 1 0.037 
Microvirgula Partition 1 0.04 
Clavibacter michiganensis Partition 1 0.043 
Sphingomonas echinoides Partition 1 0.043 
Staphylococcus equorum Partition 1 0.045 
Acinetobacter venetianus Partition 1 0.046 
Acinetobacter lwoffii Partition 1 0.047 
Arthrobacter Partition 1 0.047 
Bacteroidales Partition 2 <0.001 
Blautia Partition 2 <0.001 
Butyrivibrio Partition 2 <0.001 
Carboxydocellaceae Partition 2 <0.001 
CF231 Partition 2 <0.001 
Clostridiales Partition 2 <0.001 
Clostridium Partition 2 <0.001 
Coprococcus Partition 2 <0.001 
Coriobacteriaceae Partition 2 <0.001 
Desulfovibrio D168 Partition 2 <0.001 
Eggerthella Partition 2 <0.001 
Faecalibacterium Partition 2 <0.001 
Fibrobacter succinogenes Partition 2 <0.001 
Lachnospiraceae Partition 2 <0.001 
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Mogibacteriaceae Partition 2 <0.001 
Mogibacterium Partition 2 <0.001 
Moryella Partition 2 <0.001 
Moryella indoligenes Partition 2 <0.001 
Oscillospira Partition 2 <0.001 
Oscillospira guilliermondii Partition 2 <0.001 
p-75-a5 Partition 2 <0.001 
Paraprevotellaceae Partition 2 <0.001 
Persicobacter Partition 2 <0.001 
Prevotella Partition 2 <0.001 
Prevotellaceae Partition 2 <0.001 
Prevotella ruminicola Partition 2 <0.001 
Pseudobutyrivibrio Partition 2 <0.001 
Pyramidobacter Partition 2 <0.001 
RFN20 Partition 2 <0.001 
Ruminococcaceae Partition 2 <0.001 
Ruminococcus flavefaciens Partition 2 <0.001 
S24-7 Partition 2 <0.001 
SHD-231 Partition 2 <0.001 
Shuttleworthia Partition 2 <0.001 
Succiniclasticum Partition 2 <0.001 
TTA_B6 Partition 2 <0.001 
Veillonellaceae Partition 2 <0.001 
YRC22 Partition 2 <0.001 
YS2 Partition 2 <0.001 
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Desulfovibrio Partition 2 0.002 
Ruminococcus Partition 2 0.004 
Fibrobacteraceae Partition 2 0.006 
Treponema Partition 2 0.006 
RF39 Partition 2 0.007 
Chloroherpetales Partition 2 0.009 
Thermogemmatisporales Partition 2 0.012 
Saprospirae Partition 2 0.013 
L7A_E11 Partition 2 0.014 
SSW63Au Partition 2 0.015 
Anaerofustis Partition 2 0.017 
Christensenellaceae Partition 2 0.018 
Elizabethkingia Partition 2 0.022 
Anaerostipes Partition 2 0.023 
Bosea Partition 2 0.024 
Spirochaetaceae Partition 2 0.024 
Kurthia Partition 2 0.029 
BS11 Partition 2 0.031 
Methylacidiphilae Partition 2 0.033 
Anaeroplasma Partition 2 0.034 
Rhodothermales Partition 2 0.036 
BF311 Partition 2 0.044 
Deferribacterales Partition 2 0.045 
Desulfovibrionaceae Partition 2 0.048 
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Selenomonas ruminantium Partition 2 0.048 
The OTUs sorted into partition 1 are more oropharyngeal-like whereas those sorted 
into partition 2 are more rumen-like. The OTUs which were significantly indicative of 













Appendix 7: Large version of Chapter 5: Figure 1 
 
